https://aimfa.es/comite-la-fda-rechaza-ultimo-momento-farmaco-grifols/ 2018-01-17T09:29:51+00:00 https://aimfa.es/wp-content/uploads/grifols.png https://aimfa.es/la-falta-financiacion-impide-todas-las-soluciones-cancer-salgan-al-mercado/ 2018-01-18T10:50:40+00:00 https://aimfa.es/wp-content/uploads/cancer.jpg https://aimfa.es/los-principales-grupos-farmacia-constituyen-la-asociacion-anacev/ 2018-01-22T07:57:59+00:00 https://aimfa.es/wp-content/uploads/anacev.jpg https://aimfa.es/novartis-roche-las-big-pharma-mas-valor-bolsa/ 2018-01-23T07:57:13+00:00 https://aimfa.es/wp-content/uploads/novartis-roche.jpg https://aimfa.es/ano-2017-se-cierra-una-subida-del-26-del-gasto-recetas/ 2018-01-24T07:36:03+00:00 https://aimfa.es/wp-content/uploads/medicamento-dinero.jpg https://aimfa.es/chiesi-considera-clave-talento-interno-la-evolucion-las-empresas/ 2018-01-25T08:06:15+00:00 https://aimfa.es/wp-content/uploads/Logo_Chiesi_home.jpg https://aimfa.es/2017-mercado-ha-experimentado-ligero-crecimiento-valores-07-alcanzando-los-19-800-me-pvp/ 2018-01-26T09:11:50+00:00 https://aimfa.es/farma-shopper-2018-dara-la-vision-lo-detras-venta-consumer-health/ 2018-01-29T08:11:47+00:00 https://aimfa.es/wp-content/uploads/medicamentos.jpg https://aimfa.es/la-mayoria-los-nuevos-medicamentos-aprobados-europa-cancer/ 2018-01-30T09:33:23+00:00 https://aimfa.es/wp-content/uploads/cancer.jpg https://aimfa.es/ministerio-publica-informe-los-sistemas-sanitarios-la-ue/ 2018-01-31T09:26:38+00:00 https://aimfa.es/wp-content/uploads/logo_ministerio.jpg https://aimfa.es/nace-aula-angelini/ 2018-02-02T10:07:39+00:00 https://aimfa.es/wp-content/uploads/angelini-1.jpg https://aimfa.es/la-ce-inicia-los-tramites-regular-la-cooperacion-estados-hta/ 2018-02-05T09:56:40+00:00 https://aimfa.es/wp-content/uploads/unioneuropea.jpg https://aimfa.es/iqvia-mejora-herramienta-gestion-la-farmacia/ 2018-02-06T09:29:35+00:00 https://aimfa.es/tjue-arropa-reglamento-transparencia-la-ema/ 2018-02-07T10:12:16+00:00 https://aimfa.es/wp-content/uploads/unioneuropea.jpg https://aimfa.es/sanidad-publica-cientos-indicadores-salud-espana-ue/ 2018-02-08T10:10:41+00:00 https://aimfa.es/wp-content/uploads/logo_ministerio.jpg https://aimfa.es/sanofi-presenta-una-nueva-web-mejorar-uso-los-medicamentos/ 2018-02-09T09:48:45+00:00 https://aimfa.es/wp-content/uploads/sanofi.png https://aimfa.es/jj-extiende-programa-incubadoras-jlabs-europa/ 2018-02-12T07:35:42+00:00 https://aimfa.es/wp-content/uploads/johnson.jpg https://aimfa.es/astrazeneca-promovera-la-inclusion-mujeres-puestos-responsabilidad/ 2018-02-14T10:22:33+00:00 https://aimfa.es/wp-content/uploads/astrazeneca_top.jpg https://aimfa.es/hacia-la-gestion-personalizada-la-diabetes/ 2018-02-15T07:25:47+00:00 https://aimfa.es/wp-content/uploads/roche_top.jpg https://aimfa.es/bitcoin-clave-la-caida-la-mayor-red-trafico-farmacos-online/ 2018-02-16T09:02:49+00:00 https://aimfa.es/wp-content/uploads/bitcoin.jpg https://aimfa.es/modelo-unitario-pagar-la-innovacion-los-expertos-lo-descartan/ 2018-02-19T07:35:27+00:00 https://aimfa.es/wp-content/uploads/unioneuropea.jpg https://aimfa.es/andalucia-eleva-los-540-millones-ahorro-obtenido-las-subastas/ 2018-02-20T09:23:08+00:00 https://aimfa.es/wp-content/uploads/andalucia-1.jpg https://aimfa.es/sanidad-adelanta-los-aspectos-clave-la-futura-estrategia-biosimilares/ 2018-02-22T08:51:08+00:00 https://aimfa.es/wp-content/uploads/logo_ministerio.jpg https://aimfa.es/iqvia-espana-estrena-perfil-twitter-pagina-corporativa-linkedin/ 2018-02-23T08:45:27+00:00 https://aimfa.es/autocuidado-ahorra-los-sistemas-sanitarios-europeos-mas-16-000-millones-euros/ 2018-02-26T09:08:39+00:00 https://aimfa.es/wp-content/uploads/medicamento-dinero.jpg https://aimfa.es/iqvia-preve-una-subida-farmacia-del-12-45-hospital-2018/ 2018-02-28T07:04:29+00:00 https://aimfa.es/mercado-mantiene-enero-crecimiento-positivo-del-08-valores-sin-embargo-decrece-1-volumen/ 2018-03-01T07:34:44+00:00 https://aimfa.es/biosim-pide-no-se-les-utilice-solo-herramienta-bajada-precio/ 2018-03-01T07:36:55+00:00 https://aimfa.es/wp-content/uploads/BioSim.jpg https://aimfa.es/cuatro-cinco-medicamentos-dispensados-estan-precio-referencia/ 2018-03-05T08:34:14+00:00 https://aimfa.es/wp-content/uploads/preu_medic.jpg https://aimfa.es/uno-tres-estudios-id-nuevos-medicamentos-europa-cuenta-participacion-espanola/ 2018-03-06T11:07:32+00:00 https://aimfa.es/wp-content/uploads/LogoFarmaindustria.jpg https://aimfa.es/top-10-companias-farmaceuticas-2018-nivel-mundial/ 2018-03-07T10:42:32+00:00 https://aimfa.es/wp-content/uploads/top10top.jpg https://www.aimfa.es/wp-content/uploads/2018/03/top10.jpg https://aimfa.es/la-inversion-publicitaria-los-laboratorios-farmaceuticos-disminuye-3-2017/ 2018-03-08T09:02:32+00:00 https://aimfa.es/wp-content/uploads/pantalla_azul.jpg https://aimfa.es/3-claves-impulsar-roi-content-marketing/ 2018-03-08T20:04:12+00:00 https://aimfa.es/wp-content/uploads/marketing-board-e1454402454256.jpg https://aimfa.es/estudio-gilead-resucita-la-esperanza-erradicar-vih/ 2018-03-12T08:09:58+00:00 https://aimfa.es/wp-content/uploads/gilead_top.jpg https://aimfa.es/esteve-teijin-healthcare-estrena-nuevo-centro-logistico/ 2018-03-13T10:25:13+00:00 https://aimfa.es/wp-content/uploads/esteve-teijin.jpg https://aimfa.es/uriach-conmemora-180-anos-infarma/ 2018-03-14T09:54:22+00:00 https://aimfa.es/wp-content/uploads/uriach_top.jpg https://aimfa.es/senado-pide-regular-intercambio-biologicos-biosimilares/ 2018-03-15T09:34:02+00:00 https://aimfa.es/wp-content/uploads/biologic.jpg https://aimfa.es/hefame-presenta-infarma-una-plataforma-enfocada-paciente/ 2018-03-16T10:11:26+00:00 https://aimfa.es/wp-content/uploads/milenials.jpg https://aimfa.es/amazon-tantea-mercado-farmaceutico-espanol/ 2018-03-19T07:38:42+00:00 https://aimfa.es/wp-content/uploads/amazon.jpg https://aimfa.es/cambio-paradigma-diagnostico-la-diabetes/ 2018-03-20T18:35:21+00:00 https://aimfa.es/wp-content/uploads/diabetes-1.jpg https://aimfa.es/proyecto-ciberment-la-formacion-tic-pacientes-trastorno-mental/ 2018-03-21T07:37:03+00:00 https://aimfa.es/wp-content/uploads/pacientes-internet.jpg https://aimfa.es/grifols-compra-haema-220-millones-euros/ 2018-03-22T08:33:34+00:00 https://aimfa.es/wp-content/uploads/grifols_top.jpg https://aimfa.es/bayer-aumentara-la-plantilla-centro-servicios-barcelona-100-personas/ 2018-03-23T07:08:39+00:00 https://aimfa.es/wp-content/uploads/bayer_top.jpg https://aimfa.es/iqvia-reconocida-great-place-to-work-una-las-mejores-empresas-trabajar-espana/ 2018-03-26T12:24:13+00:00 https://aimfa.es/mercado-presenta-crecimiento-tam-del-13-valores-decrece-volumen-03/ 2018-04-03T06:25:11+00:00 https://aimfa.es/aneimo-aedemo-pioneras-la-elaboracion-codigo-conducta-conforme-al-rgpd/ 2018-04-04T06:11:55+00:00 https://aimfa.es/wp-content/uploads/aedemo1250-e1457522979574.jpg https://aimfa.es/causas-la-caida-las-efg-2017/ 2018-04-05T08:12:33+00:00 https://aimfa.es/la-fundacion-merck-salud-desglosa-los-derechos-los-pacientes-cronicos/ 2018-04-06T08:47:00+00:00 https://aimfa.es/wp-content/uploads/merck_top.jpg https://aimfa.es/gasto-farmaceutico-hospitalario-publico-crecio-33-2017/ 2018-04-09T06:37:57+00:00 https://aimfa.es/wp-content/uploads/logo_ministerio.jpg https://aimfa.es/tus-datos-facebook-se-vieron-afectados-cambridge-analytica-solucionalo/ 2018-04-10T06:13:21+00:00 https://aimfa.es/wp-content/uploads/facebook.jpg https://aimfa.es/grifols-e-irsicaixa-impulsan-la-investigacion-vih/ 2018-04-10T21:32:59+00:00 https://aimfa.es/wp-content/uploads/grifols_top.jpg https://aimfa.es/caso-facebook-cambridge-analytica-reflexiones-uso-los-datos-secundarios/ 2018-04-11T10:45:48+00:00 https://aimfa.es/wp-content/uploads/aedemo1250-e1457522979574.jpg https://aimfa.es/nuevo-libro-investigacion-mercados-aplicacion-al-marketing-estrategico-empresarial/ 2018-04-11T11:07:57+00:00 https://aimfa.es/wp-content/uploads/libro_top.jpg https://www.aimfa.es/wp-content/uploads/2018/04/libro.jpg https://aimfa.es/ipsos-refuerza-equipo-directivo/ 2018-04-12T06:52:16+00:00 https://aimfa.es/wp-content/uploads/ipsos_top.jpg https://aimfa.es/aedemo-publica-informe-grit-report-espana/ 2018-04-13T07:01:40+00:00 https://aimfa.es/wp-content/uploads/aedemo1250-e1457522979574.jpg https://aimfa.es/cofares-afianza-liderazgo-cuota-hefame-gana-la-posicion-alliance/ 2018-04-16T07:09:42+00:00 https://aimfa.es/wp-content/uploads/Cofares.jpg https://aimfa.es/sanofi-vendera-negocio-europeo-genericos-zentiva-1-900-millones-euros/ 2018-04-18T08:51:19+00:00 https://aimfa.es/wp-content/uploads/sanofi_top.jpg https://aimfa.es/sector-la-tecnologia-sanitaria-facturo-3-mas-espana-2017/ 2018-04-19T07:59:08+00:00 https://aimfa.es/wp-content/uploads/fenin.jpg https://aimfa.es/salud-digital-10-retos-conseguir-la-transformacion-del-sistema-sanitario/ 2018-04-20T06:12:28+00:00 https://aimfa.es/wp-content/uploads/digital-1.jpg https://aimfa.es/legal-la-entrega-medicamentos-la-farmacia-traves-terceros/ 2018-04-23T07:39:28+00:00 https://aimfa.es/wp-content/uploads/medicinas_home.jpg https://aimfa.es/procter-gamble-compra-negocio-salud-del-consumidor-merck-3-400-millones-euros/ 2018-04-23T18:41:34+00:00 https://aimfa.es/wp-content/uploads/merck_top.jpg https://aimfa.es/campus-vall-dhebron-firma-prime-site-agreement-iqvia/ 2018-04-24T13:34:20+00:00 https://www.aimfa.es/wp-content/uploads/2018/04/Vall-dHebron_IQVIA_01.jpg https://aimfa.es/valencia-los-parados-rentas-menores-18-000-euros-no-pagaran-los-medicamentos/ 2018-04-25T08:21:47+00:00 https://aimfa.es/wp-content/uploads/medicamento-dinero.jpg https://aimfa.es/ultimo-ano-mercado-crece-valores-09-unidades-06/ 2018-04-26T06:08:45+00:00 https://aimfa.es/takeda-acuerda-la-compra-shire/ 2018-04-27T08:40:52+00:00 https://aimfa.es/wp-content/uploads/takeda-pharmaceutical-co-scaled.jpg https://aimfa.es/europa-avanza-compartir-informacion-evaluacion-medicamentos/ 2018-05-02T07:44:17+00:00 https://aimfa.es/wp-content/uploads/unioneuropea.jpg https://aimfa.es/sanidad-publica-la-orden-ministerial-la-regulacion-los-productos-homeopaticos/ 2018-05-03T08:07:26+00:00 https://aimfa.es/wp-content/uploads/homeopatia.jpg https://aimfa.es/denuncian-glovo-amazon-la-venta-ilegal-productos-farmaceuticos/ 2018-05-04T08:30:52+00:00 https://aimfa.es/wp-content/uploads/amazon.jpg https://aimfa.es/una-docena-medicamentos-llamados-blockbusters-se-lanzan-este-2018/ 2018-05-07T06:20:12+00:00 https://aimfa.es/wp-content/uploads/medicamentos.jpg https://aimfa.es/los-ensayos-clinicos-pacientes-pediatricos-aumentado-50-la-ultima-decada/ 2018-05-08T06:25:08+00:00 https://aimfa.es/wp-content/uploads/homeopatia.jpg https://aimfa.es/la-efpia-celebra-la-decision-la-ce-la-transformacion-digital-la-salud/ 2018-05-09T06:29:55+00:00 https://aimfa.es/wp-content/uploads/efpia.jpg https://aimfa.es/europa-desmonta-argumento-espana-no-prohibir-la-homeopatia/ 2018-05-10T06:33:28+00:00 https://aimfa.es/wp-content/uploads/medicamentos_genericos.jpg https://aimfa.es/cataluna-seguira-atendiendo-todos-los-ciudadanos-pese-al-constitucional/ 2018-05-11T06:38:41+00:00 https://aimfa.es/wp-content/uploads/bandera.jpg https://aimfa.es/administracion-e-industria-buscan-nuevos-modelos-financiacion/ 2018-05-14T00:16:16+00:00 https://aimfa.es/wp-content/uploads/medicamento-dinero.jpg https://aimfa.es/amazon-va-todas-sector-farmacia-salud/ 2018-05-16T10:39:31+00:00 https://aimfa.es/wp-content/uploads/amazon.jpg https://aimfa.es/cesif-convoca-la-iii-edicion-del-pae-regulatory-compliance-socios-estrategicos-sector-salud/ 2018-05-17T08:38:31+00:00 https://aimfa.es/wp-content/uploads/logo-cesif.gif https://aimfa.es/espana-se-aleja-los-paises-europeos-mas-inversion-sanidad/ 2018-05-18T08:25:24+00:00 https://aimfa.es/wp-content/uploads/gasto.jpg https://aimfa.es/llaman-al-gobierno-uk-buscar-acuerdo-la-ue-garantizar-acceso-la-estabilidad-del-sector/ 2018-05-21T08:52:01+00:00 https://aimfa.es/wp-content/uploads/unioneuropea.jpg https://aimfa.es/iqvia-lanza-servicio-ayudar-las-farmacias-adaptarse-al-nuevo-reglamento-proteccion-datos/ 2018-05-22T07:00:32+00:00 https://aimfa.es/himss-europe-health-2-0-soluciones-estrategias-digitales-la-sanidad-2-0/ 2018-05-23T08:31:16+00:00 https://aimfa.es/wp-content/uploads/himss_europe.jpg https://aimfa.es/farmaindustria-destaca-los-efectos-secundarios-positivos-derivados-los-medicamentos/ 2018-05-24T08:56:40+00:00 https://aimfa.es/wp-content/uploads/LogoFarmaindustria.jpg https://aimfa.es/ayudara-big-data-evaluar-los-farmacos/ 2018-05-28T05:55:35+00:00 https://aimfa.es/wp-content/uploads/big-data.jpg https://aimfa.es/mercado-crece-tam-13-valores-decrece-volumen-01/ 2018-05-28T16:18:32+00:00 https://aimfa.es/la-industria-innovadora-la-reduccion-los-derechos-propiedad-intelectual/ 2018-05-30T08:02:57+00:00 https://aimfa.es/wp-content/uploads/efpia.jpg https://aimfa.es/merck-celebra-350-anos-mirando-al-futuro/ 2018-05-30T19:12:14+00:00 https://aimfa.es/wp-content/uploads/merck_top.jpg https://aimfa.es/las-agencias-aeaps-invierten-una-media-90-000-euros-mas-2-000-horas-trabajo-anuales-concursos/ 2018-06-01T07:17:00+00:00 https://aimfa.es/wp-content/uploads/logo_aeaps.jpg https://aimfa.es/la-fundacion-farmaindustria-convoca-iv-edicion-los-premios-somos-pacientes/ 2018-06-04T08:04:01+00:00 https://aimfa.es/wp-content/uploads/LogoFarmaindustria.jpg https://aimfa.es/mercado-oncologia-llegara-los-200-000-millones-cinco-anos/ 2018-06-05T08:27:08+00:00 https://aimfa.es/expertos-analizan-introducir-la-innovacion-una-forma-sostenible/ 2018-06-06T08:52:51+00:00 https://aimfa.es/wp-content/uploads/msd-top.jpg https://aimfa.es/accionistas-takeda-critican-acuerdo-shire/ 2018-06-07T08:55:56+00:00 https://aimfa.es/wp-content/uploads/takeda-pharmaceutical-co-scaled.jpg https://aimfa.es/anefp-participa-54o-encuentro-anual-la-aesgp/ 2018-06-08T08:11:00+00:00 https://aimfa.es/wp-content/uploads/anefp.jpg https://aimfa.es/estados-unidos-mejor-pais-lanzamiento-nuevos-medicamentos/ 2018-06-11T08:51:24+00:00 https://aimfa.es/wp-content/uploads/medicinas_home.jpg https://aimfa.es/fenin-advierte-parque-tecnologico-los-hospitales-espana-esta-anticuado/ 2018-06-12T06:29:57+00:00 https://aimfa.es/wp-content/uploads/fenin.jpg https://aimfa.es/pfizer-destina-515-millones-euros-pfizer-ventures/ 2018-06-13T06:49:31+00:00 https://aimfa.es/wp-content/uploads/pfizer_top.jpg https://aimfa.es/boehringer-ingelheim-recibe-la-certificacion-web-medica-acreditada-portales/ 2018-06-15T06:53:16+00:00 https://aimfa.es/wp-content/uploads/boehringer-1.jpg https://aimfa.es/recomendaciones-uso-generacion-bases-datos-telefonos-moviles-estudios-mercados/ 2018-06-19T08:15:55+00:00 https://aimfa.es/wp-content/uploads/aedemo_top.jpg https://aimfa.es/sesion-informativa-esic-programa-superior-direccion-marketing-life-sciences/ 2018-06-19T15:00:26+00:00 https://aimfa.es/wp-content/uploads/esic_top.jpg https://aimfa.es/nace-masquemarcas-nuevo-blog-kantar-millward-brown/ 2018-06-20T06:13:37+00:00 https://aimfa.es/wp-content/uploads/kantarlillward.jpg https://aimfa.es/coste-total-del-cancer-2015-ascendio-7-168-millones-euros-sns/ 2018-06-21T06:31:53+00:00 https://aimfa.es/wp-content/uploads/cancer.jpg https://aimfa.es/mercado-crece-tam-mayo-11-valores-decrece-volumen-02/ 2018-06-21T11:34:59+00:00 https://aimfa.es/los-copagos-farmaceuticos-no-servido-disuadir-del-consumo-medicamentos-innecesarios/ 2018-06-22T08:38:52+00:00 https://aimfa.es/wp-content/uploads/preu_medic.jpg https://aimfa.es/iese-sanofi-abordan-los-retos-la-digitalizacion-big-data-sector-sanitario/ 2018-06-25T07:41:19+00:00 https://aimfa.es/wp-content/uploads/sanofi_top.jpg https://aimfa.es/grupo-cofares-refuerza-actividad-hospitalaria/ 2018-06-26T10:36:48+00:00 https://aimfa.es/wp-content/uploads/Cofares.jpg https://aimfa.es/esteve-estrena-nueva-sede/ 2018-06-27T10:09:05+00:00 https://aimfa.es/wp-content/uploads/esteve_top.jpg https://www.aimfa.es/wp-content/uploads/2018/06/esteve_torre.jpg https://aimfa.es/generico-valor-anadido-trampolin-empresas-medianas/ 2018-06-28T08:01:14+00:00 https://aimfa.es/wp-content/uploads/generic.jpg https://aimfa.es/la-industria-publica-las-colaboraciones-los-agentes-del-sector/ 2018-06-29T08:23:15+00:00 https://aimfa.es/wp-content/uploads/farmaindustria_top.jpg https://aimfa.es/amazon-entra-sector-sanitario-la-compra-una-farmacia-online/ 2018-07-02T08:48:15+00:00 https://aimfa.es/wp-content/uploads/amazon.jpg https://aimfa.es/la-aemps-publicara-este-ano-nuevo-plan-estrategico-2019-2020/ 2018-07-03T08:56:21+00:00 https://aimfa.es/wp-content/uploads/logo_ministerio.jpg https://aimfa.es/conectando-pacientes-una-iniciativa-estrechar-lazos-traves-la-web/ 2018-07-04T07:09:45+00:00 https://aimfa.es/wp-content/uploads/pacientes-internet.jpg https://aimfa.es/gasto-facturado-traves-recetas-crece-3-los-ultimos-doce-meses/ 2018-07-05T05:25:16+00:00 https://aimfa.es/wp-content/uploads/dinero.jpg https://aimfa.es/la-industria-farmaceutica-bate-record-inversion-id/ 2018-07-06T08:46:15+00:00 https://aimfa.es/wp-content/uploads/farmaindustria_top.jpg https://aimfa.es/la-ema-publica-una-guia-basica-la-industria-acerca-del-brexit/ 2018-07-09T06:26:20+00:00 https://aimfa.es/wp-content/uploads/unioneuropea.jpg https://aimfa.es/tres-formas-capturas-pantalla-windows-10/ 2018-07-10T06:05:45+00:00 https://aimfa.es/wp-content/uploads/windows10.jpg https://aimfa.es/fenin-la-fundacion-cotec-pondran-marcha-proyecto-indice-transformacion-madurez-digital-clinica/ 2018-07-11T08:24:30+00:00 https://aimfa.es/wp-content/uploads/fenin.jpg https://aimfa.es/las-fusiones-mundiales-superaran-los-170-000-millones-euros/ 2018-07-12T10:59:24+00:00 https://aimfa.es/wp-content/uploads/preu_medic.jpg https://aimfa.es/recomendaciones-otorgar-incentivos-entrevistados-personas-participen-procesos-investigacion-parte-i/ 2018-07-13T08:10:10+00:00 https://aimfa.es/wp-content/uploads/aedemo_top.jpg https://aimfa.es/espana-penultimo-pais-desarrollado-comunicacion-medico-paciente/ 2018-07-16T07:35:51+00:00 https://aimfa.es/wp-content/uploads/pacientes-internet.jpg https://aimfa.es/iu-propone-suprimir-copago-farmaceutico-todos-los-jubilados/ 2018-07-17T07:49:28+00:00 https://aimfa.es/wp-content/uploads/dinero.jpg https://aimfa.es/pfizer-se-reorganizara-tres-areas-negocio-principios-2019/ 2018-07-18T08:19:02+00:00 https://aimfa.es/wp-content/uploads/pfizer_top.jpg https://aimfa.es/2017-ano-crecimiento-las-empresas-aneimo/ 2018-07-19T06:28:22+00:00 https://aimfa.es/siete-diez-medicamentos-autorizados-espana-prescripcion/ 2018-07-20T07:08:48+00:00 https://aimfa.es/wp-content/uploads/medicamentos_genericos.jpg https://aimfa.es/canal-online-gana-relevancia-farma/ 2018-07-23T08:21:40+00:00 https://aimfa.es/lilly-elige-una-metodologia-colaborativa-trabajo/ 2018-07-24T07:00:35+00:00 https://aimfa.es/wp-content/uploads/EliLillyLogo.jpg https://aimfa.es/usar-bien-los-nuevos-hashtags-youtube/ 2018-07-25T08:13:18+00:00 https://aimfa.es/wp-content/uploads/youtube.jpg https://aimfa.es/infomep-la-base-datos-los-medicamentos-peligrosos/ 2018-07-26T09:07:38+00:00 https://aimfa.es/wp-content/uploads/medicamentos.jpg https://aimfa.es/techos-gasto-riesgo-compartido-tambien-los-productos-sanitarios/ 2018-07-27T09:11:05+00:00 https://aimfa.es/wp-content/uploads/logo_ministerio.jpg https://aimfa.es/la-herramienta-mensajes-linkedin-estrena-6-nuevas-funciones/ 2018-08-29T08:33:30+00:00 https://aimfa.es/wp-content/uploads/linkedin.jpg https://aimfa.es/mercado-presenta-crecimiento-tam-julio-del-17-valores-del-05-unidades/ 2018-08-30T09:29:16+00:00 https://aimfa.es/la-aplicacion-la-nueva-orden-precios-referencia-afectara-mas-800-presentaciones/ 2018-09-03T09:11:25+00:00 https://aimfa.es/wp-content/uploads/logo_ministerio.jpg https://aimfa.es/chiesi-adquiere-la-compania-francesa-suplementos-nhco-nutrition/ 2018-09-03T22:29:01+00:00 https://aimfa.es/wp-content/uploads/Logo_Chiesi_home.jpg https://aimfa.es/amgen-lanza-primer-biosimilar-espana-cancer-mama-gastrico/ 2018-09-05T06:43:14+00:00 https://aimfa.es/wp-content/uploads/amgen_top.jpg https://aimfa.es/la-farmacia-declara-la-guerra-glovo/ 2018-09-06T07:42:38+00:00 https://aimfa.es/wp-content/uploads/glovo.jpg https://aimfa.es/plan-del-cancer-espana-revision-15-anos-despues/ 2018-09-07T09:17:44+00:00 https://aimfa.es/wp-content/uploads/cancer.jpg https://aimfa.es/espana-lidera-las-ventas-mundiales-antimicrobianos-habitante/ 2018-09-10T07:19:40+00:00 https://aimfa.es/wp-content/uploads/medicamentos.jpg https://aimfa.es/comunicado-fallecimiento-d-juan-jose-hernandez-royo/ 2018-09-10T16:02:36+00:00 https://aimfa.es/wp-content/uploads/juanjo_top-1.jpg https://www.aimfa.es/wp-content/uploads/2018/09/juanjo.jpg https://aimfa.es/maria-luisa-carcedo-nueva-ministra-sanidad-sustitucion-monton/ 2018-09-12T07:43:28+00:00 https://aimfa.es/wp-content/uploads/logo_ministerio.jpg https://aimfa.es/gasto-publico-medicamentos-productos-sanitarios-crecio-463-ultimo-ano/ 2018-09-13T07:51:47+00:00 https://aimfa.es/wp-content/uploads/dinero.jpg https://aimfa.es/25-anos-mercado-unico-europeo-farmaceutico-progresos-desafios/ 2018-09-14T09:31:28+00:00 https://aimfa.es/wp-content/uploads/unioneuropea.jpg https://aimfa.es/alcura-alianza-pulso-hacerse-fuerte-home-delivery-programas-soporte/ 2018-09-17T07:14:03+00:00 https://aimfa.es/wp-content/uploads/alliance.jpg https://aimfa.es/la-salud-digital-imprescindible-frente-al-continuo-cambio-experimenta-la-atencion-sanitaria/ 2018-09-18T07:52:43+00:00 https://aimfa.es/wp-content/uploads/digitalizacion.jpg https://aimfa.es/mercado-presenta-crecimiento-del-21-valores-del-09-unidades-tam-agosto/ 2018-09-20T07:24:02+00:00 https://aimfa.es/fenin-pone-valor-la-tecnologia-sanitaria-espanola/ 2018-09-21T09:36:24+00:00 https://aimfa.es/wp-content/uploads/fenin.jpg https://aimfa.es/la-crisis-del-valsartan-pasa-factura-los-laboratorios-molecula-afectados/ 2018-09-25T09:08:25+00:00 https://aimfa.es/wp-content/uploads/valsartan.jpg https://aimfa.es/revision-analisis-completo-las-10-mejores-companias-consumer-care-2018-nivel-global/ 2018-09-26T08:02:44+00:00 https://aimfa.es/wp-content/uploads/medicinas_home.jpg https://aimfa.es/sentencia-europea-favor-del-sistema-doble-precio-los-farmacos/ 2018-09-27T07:18:50+00:00 https://aimfa.es/wp-content/uploads/unioneuropea.jpg https://aimfa.es/gasto-farmaceutico-receta-publica-crece-3-agosto/ 2018-09-28T07:44:43+00:00 https://aimfa.es/wp-content/uploads/dinero.jpg https://aimfa.es/563-farmacos-desarrollo-tratamiento-la-enfermedad-cardiovascular/ 2018-10-01T08:25:13+00:00 https://aimfa.es/wp-content/uploads/IIHI_Global_Medicines_Use_in_2020-1.jpg https://aimfa.es/industria-acreditara-la-igualdad-genero-del-sector-farmaceutico-2019/ 2018-10-02T08:12:57+00:00 https://aimfa.es/wp-content/uploads/gente.jpg https://aimfa.es/mas-3-900-sellos-anefp-desde-2013-garantizar-una-publicidad-medicamentos-adecuada/ 2018-10-03T08:58:08+00:00 https://aimfa.es/wp-content/uploads/anefp.jpg https://aimfa.es/tuitear-la-informacion-del-21cnf-premio/ 2018-10-04T08:32:05+00:00 https://aimfa.es/wp-content/uploads/almirall_top.jpg https://aimfa.es/master-investigacion-mercados-marketing-digital-la-uclm/ 2018-10-05T06:28:50+00:00 https://aimfa.es/wp-content/uploads/digital-1.jpg https://aimfa.es/la-industria-innovadora-creo-1-172-empleos-2017-promete-mas/ 2018-10-05T09:46:02+00:00 https://aimfa.es/wp-content/uploads/farmaindustria_top.jpg https://aimfa.es/los-precios-referencia-funcionan-cierto-punto-bajar-precio-los-biologicos-segun-lens/ 2018-10-08T09:40:02+00:00 https://aimfa.es/wp-content/uploads/dinero.jpg https://aimfa.es/68-hospitales-nominados-los-mejores-espana/ 2018-10-10T07:11:01+00:00 https://aimfa.es/wp-content/uploads/hospit.jpg https://aimfa.es/espana-se-diagnostican-cerca-135-casos-cancer-colon-al-dia/ 2018-10-11T06:43:52+00:00 https://aimfa.es/wp-content/uploads/cancer.jpg https://aimfa.es/sector-la-tecnologia-sanitaria-elevara-ventas-5-siete-anos/ 2018-10-15T06:43:18+00:00 https://aimfa.es/wp-content/uploads/tecnologia-1.jpg https://aimfa.es/estados-unidos-establece-marco-comun-desarrollo-terapias-dirigidas/ 2018-10-16T09:21:42+00:00 https://aimfa.es/wp-content/uploads/fda.jpg https://aimfa.es/los-pacientes-reclaman-una-atencion-multidisciplinar-especializada-dolor/ 2018-10-17T08:11:06+00:00 https://aimfa.es/wp-content/uploads/dolor.jpg https://aimfa.es/mercado-presenta-crecimiento-del-18-valores-del-05-unidades-tam-septiembre/ 2018-10-18T08:17:08+00:00 https://aimfa.es/alliance-defiende-modelo-home-delivery/ 2018-10-22T06:36:49+00:00 https://aimfa.es/wp-content/uploads/alliance.jpg https://aimfa.es/2017-estabilidad-sector-la-investigacion-mercados-mundial/ 2018-10-22T16:40:53+00:00 https://aimfa.es/wp-content/uploads/aedemo_top.jpg https://aimfa.es/real-decreto-prescripcion-enfermera-ya-esta-aprobado-boe/ 2018-10-24T06:39:57+00:00 https://aimfa.es/wp-content/uploads/logo_ministerio.jpg https://aimfa.es/la-startup-ehealth-mediquo-cierra-segunda-ronda-financiacion-15-millones/ 2018-10-25T07:04:38+00:00 https://aimfa.es/wp-content/uploads/digitalizacion.jpg https://aimfa.es/la-inversion-marketing-espana-2017-crecio-4/ 2018-10-26T07:05:44+00:00 https://aimfa.es/wp-content/uploads/aneimo.jpg https://aimfa.es/medicines-for-europe-denuncia-la-presion-ee-uu-la-discusion-los-spc/ 2018-10-29T08:10:40+00:00 https://aimfa.es/wp-content/uploads/medicines.jpg https://aimfa.es/carcedo-anuncia-fin-del-copago-los-activos-hijos-rentas-bajas/ 2018-10-30T07:13:56+00:00 https://aimfa.es/wp-content/uploads/logo_ministerio.jpg https://aimfa.es/6329-2/ 2018-10-31T07:23:47+00:00 https://aimfa.es/wp-content/uploads/cardiovascular.jpg https://aimfa.es/pfizer-se-une-la-universidad-impulsar-la-e-salud/ 2018-11-05T09:54:47+00:00 https://aimfa.es/wp-content/uploads/pfizer_top.jpg https://aimfa.es/proposito-la-sustitucion-del-intercambio-terapeutico-contexto-hospitalario/ 2018-11-06T07:42:05+00:00 https://aimfa.es/wp-content/uploads/europa_top.jpg https://aimfa.es/la-efpia-fija-posiciones-cara-las-proximas-elecciones-europeas/ 2018-11-08T08:25:05+00:00 https://aimfa.es/wp-content/uploads/efpia.jpg https://aimfa.es/ocultar-fotos-chats-concretos-whatsapp/ 2018-11-12T08:06:18+00:00 https://aimfa.es/wp-content/uploads/whatsapp.jpg https://aimfa.es/core-research-investiga-la-home-delivery-tratamientos-hospitalarios/ 2018-11-13T08:13:42+00:00 https://aimfa.es/wp-content/uploads/core_research.jpg https://aimfa.es/instituto-puede-facilitar-al-cliente-datos-personales-los-participantes-estudio-ha-contratado/ 2018-11-14T07:29:38+00:00 https://aimfa.es/wp-content/uploads/aedemo_top.jpg https://aimfa.es/situacion-actual-del-mercado-la-prescripcion-espana-epoc-asma/ 2018-11-15T07:23:49+00:00 https://aimfa.es/wp-content/uploads/closeup.jpg https://aimfa.es/mercado-ilegal-medicamentos-cambia-del-lifestyle-al-livesaving/ 2018-11-16T07:36:57+00:00 https://aimfa.es/wp-content/uploads/lifestyle.jpg https://aimfa.es/europa-destina-12-000-millones-euros-al-cancer-la-sangre/ 2018-11-19T08:10:17+00:00 https://aimfa.es/wp-content/uploads/cancer.jpg https://aimfa.es/20-las-entidades-reciben-financiacion-europea-investigacion-farmaceutica-biotecnologicas/ 2018-11-21T09:09:45+00:00 https://aimfa.es/wp-content/uploads/biosimilares.jpg https://aimfa.es/undergraf-se-incorpora-aeaps-reforzando-la-representatividad-esta-asociacion-sector-salud/ 2018-11-22T07:48:14+00:00 https://aimfa.es/wp-content/uploads/undergraf.jpg https://aimfa.es/anefp-pide-avanzar-desarrollo-cuestiones-pendientes/ 2018-11-23T09:33:15+00:00 https://aimfa.es/wp-content/uploads/anefp.jpg https://aimfa.es/nuevo-codigo-colores-clasificar-los-alimentos-divide-los-nutricionistas/ 2018-11-26T07:52:12+00:00 https://aimfa.es/wp-content/uploads/codialiments.jpg https://aimfa.es/la-mejor-manera-impulsar-los-biosimilares-consenso-gain-sharing/ 2018-11-27T07:57:04+00:00 https://aimfa.es/wp-content/uploads/Biosimilar.jpg https://aimfa.es/gasto-farmaceutico-innecesario-lastra-los-sistemas-salud-europeos/ 2018-11-28T07:42:43+00:00 https://aimfa.es/wp-content/uploads/gasto.jpg https://aimfa.es/segun-iqvia-mercado-presenta-crecimiento-del-24-valores-del-12-unidades-tam-octubre/ 2018-11-29T09:26:33+00:00 https://aimfa.es/los-ehealth-awards-2018-reconocen-las-mejores-iniciativas-esalud/ 2018-11-30T08:31:01+00:00 https://aimfa.es/wp-content/uploads/aies.jpg https://aimfa.es/la-rentabilidad-esperada-los-medicamentos-innovadores-baja-36-ciento-2017/ 2018-12-02T23:56:41+00:00 https://aimfa.es/wp-content/uploads/farmaindustria_top.jpg https://aimfa.es/la-revolucion-los-biosimilares/ 2018-12-04T10:06:19+00:00 https://aimfa.es/wp-content/uploads/medicinas_home.jpg https://aimfa.es/la-fda-otorga-prioridad-una-solicitud-aprobacion-del-zolgensma-novartis/ 2018-12-05T07:45:14+00:00 https://aimfa.es/wp-content/uploads/novartis-2.jpg https://aimfa.es/iqvia-cifra-66-millones-euros-impacto-la-opr-2018-farmacias/ 2018-12-07T08:52:33+00:00 https://aimfa.es/reino-unido-advierte-la-falta-acuerdo-del-brexit-podria-dar-lugar-una-reduccion-temporal-significativa-acceso/ 2018-12-10T08:20:07+00:00 https://aimfa.es/wp-content/uploads/brexit.jpg https://aimfa.es/una-app-facilita-la-toma-decisiones-deteccion-precoz-del-cancer-colon/ 2018-12-11T09:42:51+00:00 https://aimfa.es/wp-content/uploads/movil.jpg https://aimfa.es/los-compradores-consumer-health-se-acercan-al-canal-online/ 2018-12-12T12:14:02+00:00 https://aimfa.es/bruselas-no-previsto-modificar-marco-normativo-medicamentos-homeopaticos/ 2018-12-13T09:24:41+00:00 https://aimfa.es/wp-content/uploads/europa_top.jpg https://aimfa.es/unas-60-000-personas-diagnosticadas-ano-tumor-digestivo/ 2018-12-14T09:28:44+00:00 https://aimfa.es/wp-content/uploads/cancer.jpg https://aimfa.es/informe-europeo-medicamentos-otc-apunta-crecimiento-la-automedicacion/ 2018-12-17T08:41:16+00:00 https://aimfa.es/wp-content/uploads/anefp.jpg https://aimfa.es/las-cifras-constatan-exito-del-codigo-etico-fenin/ 2018-12-18T10:29:00+00:00 https://aimfa.es/wp-content/uploads/fenin.jpg https://aimfa.es/gobierno-podria-proponer-cambios-convenio-farmaindustria/ 2018-12-19T09:30:06+00:00 https://aimfa.es/wp-content/uploads/farmaindustria_top.jpg https://aimfa.es/gsk-pfizer-fusionaran-divisiones-consumer-care/ 2018-12-20T07:29:39+00:00 https://aimfa.es/wp-content/uploads/gsk-1.jpg https://aimfa.es/la-ifpma-actualiza-codigo-buenas-practicas/ 2019-01-07T08:05:07+00:00 https://aimfa.es/wp-content/uploads/ifpma.jpg https://aimfa.es/daiichi-sankyo-obtiene-los-derechos-comercializacion-europa-del-acido-bempedoico-esperion/ 2019-01-08T07:55:40+00:00 https://aimfa.es/wp-content/uploads/daiichi-sankyo-1.jpg https://aimfa.es/lilly-compra-la-biofarmaceutica-loxo-oncology/ 2019-01-09T10:54:29+00:00 https://aimfa.es/wp-content/uploads/EliLillyLogo.jpg https://aimfa.es/mercado-los-genericos-sigue-estancado/ 2019-01-10T11:06:38+00:00 https://aimfa.es/wp-content/uploads/aeseg.jpg https://aimfa.es/fenin-anuncia-nuevos-pasos-compromiso-etico-cara-2019/ 2019-01-11T11:15:03+00:00 https://aimfa.es/wp-content/uploads/fenin.jpg https://aimfa.es/las-fusiones-adquisiciones-alcanzaron-los-198-000-millones-dolares-2018/ 2019-01-14T08:01:12+00:00 https://aimfa.es/wp-content/uploads/ey.jpg https://aimfa.es/cgcof-salud-sin-bulos-se-alian-las-fake-news/ 2019-01-15T10:36:18+00:00 https://aimfa.es/wp-content/uploads/fakenews_top.jpg https://aimfa.es/impacto-los-datos-la-sanidad-del-futuro-debate-barcelona/ 2019-01-16T09:04:06+00:00 https://aimfa.es/wp-content/uploads/betterdata.jpg https://aimfa.es/segun-iqvia-mercado-crecio-22-valores-10-unidades-2018/ 2019-01-17T10:02:02+00:00 https://aimfa.es/hacienda-confirma-la-prorroga-del-convenio-farmaindustria/ 2019-01-18T07:46:57+00:00 https://aimfa.es/wp-content/uploads/farmaindustria_top.jpg https://aimfa.es/deloitte-da-claves-la-industria-optimizar-retorno-inversiones/ 2019-01-21T07:23:07+00:00 https://aimfa.es/wp-content/uploads/deloitte_top.jpg https://aimfa.es/la-industria-disconforme-reglamento-europeo-patentes/ 2019-01-22T10:32:56+00:00 https://aimfa.es/wp-content/uploads/efpia.jpg https://aimfa.es/la-comision-europea-autoriza-erleada-janssen-cancer-prostata/ 2019-01-23T09:28:36+00:00 https://aimfa.es/wp-content/uploads/Janssen-1.jpg https://aimfa.es/gasto-productos-farmaceuticos-sanitarios-crecio-al-546-noviembre-2018/ 2019-01-24T10:26:39+00:00 https://aimfa.es/wp-content/uploads/logo_ministerio.jpg https://aimfa.es/bayer-anuncia-ere-afectara-torno-65-empleos-espana/ 2019-01-25T10:45:38+00:00 https://aimfa.es/wp-content/uploads/bayer_top.jpg https://aimfa.es/ministerio-no-renueva-colaboracion-la-plataforma-pacientes/ 2019-01-28T08:32:14+00:00 https://aimfa.es/wp-content/uploads/pacientes-internet.jpg https://aimfa.es/ya-casi-300-terapias-genicas-celulares-fase-investigacion-desarrollo/ 2019-01-29T10:25:47+00:00 https://aimfa.es/wp-content/uploads/enfermera-1.jpg https://aimfa.es/servier-e-iktos-anuncian-exitosa-colaboracion-campo-la-inteligencia-artificial/ 2019-01-30T10:36:52+00:00 https://aimfa.es/wp-content/uploads/servier.png https://aimfa.es/iqvia-preve-alzas-del-3-6-gasto-farmaceutico-global-2023/ 2019-01-31T10:08:39+00:00 https://aimfa.es/ferrer-vende-tarbis-farma-division-genericos-amarox-limited/ 2019-02-01T09:39:09+00:00 https://aimfa.es/wp-content/uploads/Laboratorios-Ferrer-logo.png https://aimfa.es/expertos-del-sector-apuestan-promover-uso-del-real-world-data-la-cronicidad/ 2019-02-04T07:52:32+00:00 https://aimfa.es/wp-content/uploads/enfermera-1.jpg https://aimfa.es/mayor-impacto-los-biosimilares-se-ha-producido-los-estados-unidos/ 2019-02-05T12:08:10+00:00 https://aimfa.es/wp-content/uploads/biosimilares.jpg https://aimfa.es/la-ce-llama-mantener-la-vigilancia-frente-las-practicas-anticompetitivas-la-industria/ 2019-02-06T12:15:38+00:00 https://aimfa.es/wp-content/uploads/europa_top.jpg https://aimfa.es/cofares-ganar-amazon-no-sera-facil-daremos-guerra/ 2019-02-07T08:49:53+00:00 https://aimfa.es/wp-content/uploads/Cofares.jpg https://aimfa.es/las-companias-salud-los-espanoles-las-mejor-uso-hacen-los-datos-personales/ 2019-02-11T08:48:17+00:00 https://aimfa.es/wp-content/uploads/ipsos_top.jpg https://aimfa.es/farmaindustria-confirma-todas-las-companias-ya-cumplen-sevem/ 2019-02-12T07:13:54+00:00 https://aimfa.es/wp-content/uploads/farmaindustria_top.jpg https://aimfa.es/nace-linkedin-live-la-red-social-profesional-apuesta-video-directo/ 2019-02-13T10:34:36+00:00 https://aimfa.es/wp-content/uploads/linkedin.jpg https://aimfa.es/astrazeneca-premiada-politicas-conciliacion-laboral/ 2019-02-14T10:12:45+00:00 https://aimfa.es/wp-content/uploads/astrazeneca_top.jpg https://aimfa.es/hospital-la-fe-novartis-analizan-los-beneficios-del-big-data/ 2019-02-15T09:49:32+00:00 https://aimfa.es/wp-content/uploads/novartis-2.jpg https://aimfa.es/alertan-la-fuga-empleados-cualificados-brexit/ 2019-02-18T07:39:20+00:00 https://aimfa.es/wp-content/uploads/brexit.jpg https://aimfa.es/pharmamar-firma-primer-acuerdo-comercializacion-mercado-chino/ 2019-02-20T08:10:10+00:00 https://aimfa.es/wp-content/uploads/pharmamar__baja-1.jpg https://aimfa.es/la-oms-constata-aumento-del-gasto-salud-alcanzar-10-del-pib-mundial/ 2019-02-21T09:32:37+00:00 https://aimfa.es/wp-content/uploads/salud.jpg https://aimfa.es/la-ue-debate-futuro-las-inversiones-sanidad/ 2019-02-22T09:52:07+00:00 https://aimfa.es/wp-content/uploads/europa_top.jpg https://aimfa.es/cuanto-tiempo-se-deben-guardar-cuestionarios-imagenes-videos-audios-estudio-mercado/ 2019-02-25T08:02:09+00:00 https://aimfa.es/wp-content/uploads/aedemo_top.jpg https://aimfa.es/tecnologias-medicas-catalanas-mwc/ 2019-02-26T10:08:50+00:00 https://aimfa.es/wp-content/uploads/tecnologia-1.jpg https://aimfa.es/novartis-impulsa-cartera-medicamentos-cardiovasculares/ 2019-02-27T10:20:27+00:00 https://aimfa.es/wp-content/uploads/novartis-2.jpg https://aimfa.es/segun-iqvia-mercado-presenta-crecimiento-del-19-valores-del-08-unidades-tam-enero/ 2019-02-28T10:34:19+00:00 https://aimfa.es/jornada-docente-talento-farmaceutico-la-aeaps/ 2019-03-01T07:59:59+00:00 https://aimfa.es/wp-content/uploads/gente-1.jpg https://www.aimfa.es/wp-content/uploads/2019/02/gente.jpg https://aimfa.es/evolucion-tendencias-del-mercado-farmaceutico-espanol/ 2019-03-04T07:53:40+00:00 https://www.aimfa.es/wp-content/uploads/2019/03/graf1iqvia.jpg https://www.aimfa.es/wp-content/uploads/2019/03/graf2iqvia.jpg https://aimfa.es/teva-renueva-web-estrena-podcast-la-farmacia-comunitaria/ 2019-03-05T08:21:59+00:00 https://aimfa.es/wp-content/uploads/podcast.jpg https://aimfa.es/sector-farmaceutico-ve-futuro-prometedor-la-idi-espana/ 2019-03-06T11:16:30+00:00 https://aimfa.es/wp-content/uploads/farmaindustria_top.jpg https://aimfa.es/pharmamar-incrementa-ingresos-anuales-23-los-162-millones/ 2019-03-07T07:41:04+00:00 https://aimfa.es/wp-content/uploads/pharmamar__baja-1.jpg https://aimfa.es/la-industria-supera-los-600-millones-euros-ensayos-clinicos-espana/ 2019-03-11T07:41:10+00:00 https://aimfa.es/wp-content/uploads/farmaindustria_top.jpg https://aimfa.es/cesif-convoca-una-nueva-oferta-formativa-real-world-evidence/ 2019-03-12T07:37:59+00:00 https://aimfa.es/wp-content/uploads/logo-cesif.gif https://aimfa.es/la-implantacion-la-salud-digital-espana-una-labor-lenta-practicamente-concluida-plantea-nuevos-retos/ 2019-03-13T09:30:41+00:00 https://aimfa.es/wp-content/uploads/digital-1.jpg https://aimfa.es/la-ceoe-pide-reducir-iva-sanitario-al-4-avanzar-sns-digital/ 2019-03-14T10:04:15+00:00 https://aimfa.es/wp-content/uploads/ceoe.jpg https://aimfa.es/la-agencia-holandesa-proteccion-datos-cuestiona-la-legalidad-las-cookies/ 2019-03-19T08:01:37+00:00 https://aimfa.es/wp-content/uploads/esomar_top.jpg https://aimfa.es/sanidad-inicia-la-publicacion-del-gasto-recetas-las-mutualidades/ 2019-03-20T10:21:25+00:00 https://aimfa.es/wp-content/uploads/preu_medic.jpg https://aimfa.es/cesif-convoca-una-nueva-oferta-formativa-product-launch-management/ 2019-03-21T07:24:57+00:00 https://aimfa.es/wp-content/uploads/logo-cesif.gif https://www.aimfa.es/wp-content/uploads/2015/04/logo-cesif.gif https://aimfa.es/la-inversion-investigacion-se-mantendra-este-ano-segun-barometro-trend-score/ 2019-03-22T10:22:05+00:00 https://aimfa.es/wp-content/uploads/aedemo_top.jpg https://aimfa.es/las-distribuidoras-enfrian-la-opcion-crear-marketplace-comun/ 2019-03-25T07:55:35+00:00 https://aimfa.es/wp-content/uploads/medicamentos_genericos.jpg https://aimfa.es/segun-iqvia-mercado-crece-17-valores-del-07-unidades-tam-febrero/ 2019-03-26T09:36:43+00:00 https://aimfa.es/e-commerce-una-oportunidad-la-farmacia-segun-la-distribucion/ 2019-03-27T07:45:46+00:00 https://aimfa.es/wp-content/uploads/Farmacia-online.jpg https://aimfa.es/la-industria-farmaceutica-elevo-inversion-publicidad-1-segun-estudio-arce-media-berbes/ 2019-03-28T09:50:31+00:00 https://aimfa.es/wp-content/uploads/comunicacion_salud.jpg https://aimfa.es/farmaforum-abre-puertas/ 2019-03-29T09:27:15+00:00 https://aimfa.es/wp-content/uploads/farmaforum_top.jpg https://www.aimfa.es/wp-content/uploads/2019/03/farmaforum.jpg https://aimfa.es/fallece-josep-esteve-expresidente-del-grupo-esteve-fundador-expresidente-farmaindustria/ 2019-04-01T10:04:23+00:00 https://aimfa.es/wp-content/uploads/josep_esteve_top.jpg https://www.aimfa.es/wp-content/uploads/2019/04/josep-esteve-150x150.jpg https://aimfa.es/celgene-bms-ya-ponen-fecha-fusion/ 2019-04-02T07:28:30+00:00 https://aimfa.es/wp-content/uploads/celgene-1-scaled.jpg https://aimfa.es/la-industria-farmaceutica-dificultades-cubrir-ciertas-vacantes/ 2019-04-04T06:34:05+00:00 https://aimfa.es/wp-content/uploads/gente.jpg https://aimfa.es/ia-iot-big-data-3-desafios-guiaran-la-3a-edicion-on-digital-healthcare/ 2019-04-05T06:49:57+00:00 https://aimfa.es/wp-content/uploads/ondigital.jpg https://aimfa.es/doctora-moss-se-incorpora-aeaps/ 2019-04-09T07:26:51+00:00 https://aimfa.es/wp-content/uploads/logo_aeaps.jpg https://aimfa.es/stada-planea-lanzar-primer-biosimilar-espana-finales-2019/ 2019-04-10T09:07:15+00:00 https://aimfa.es/wp-content/uploads/stada.jpg https://aimfa.es/chiesi-refuerza-modelo-paciente-asmatico-informado-comprometido/ 2019-04-11T06:40:54+00:00 https://aimfa.es/wp-content/uploads/Logo_Chiesi_home.jpg https://aimfa.es/las-ccaa-deben-775-millones-al-sector-tecnologia-sanitaria/ 2019-04-24T09:27:21+00:00 https://aimfa.es/wp-content/uploads/fenin.jpg https://aimfa.es/ocho-consejos-valorar-la-calidad-una-investigacion-mercados/ 2019-04-25T06:20:00+00:00 https://aimfa.es/wp-content/uploads/aedemo_top.jpg https://aimfa.es/kantar-unifica-todas-marcas/ 2019-04-26T06:26:20+00:00 https://aimfa.es/wp-content/uploads/kantar.jpg https://aimfa.es/comienza-postgrado-business-data-analytics-marketing-lntelligence-del-lnstitut-formacio-continua-il3/ 2019-04-29T06:36:12+00:00 https://aimfa.es/wp-content/uploads/idec.jpg https://aimfa.es/pharmamar-se-introduce-mercado-chino/ 2019-04-30T07:11:14+00:00 https://aimfa.es/wp-content/uploads/pharmamar__baja-1.jpg https://aimfa.es/fedefarma-incluye-simulador-precios-stock-la-app-business-intelligence-ofrece-la-farmacia/ 2019-05-02T08:52:02+00:00 https://aimfa.es/wp-content/uploads/farmacia-1.jpg https://aimfa.es/las-startups-catalanas-salud-multiplican-diez-inversores-internacionales/ 2019-05-03T07:10:41+00:00 https://aimfa.es/wp-content/uploads/catalunya.jpg https://aimfa.es/mercado-global-farmacos-huerfanos-alcanzara-los-242-000-millones-2024/ 2019-05-06T07:03:22+00:00 https://aimfa.es/wp-content/uploads/medicinas_home.jpg https://aimfa.es/riesgo-grifols-esta-los-margenes/ 2019-05-07T07:08:40+00:00 https://aimfa.es/wp-content/uploads/grifols_top.jpg https://aimfa.es/novo-nordisk-producira-solo-electricidad-renovable-partir-2020/ 2019-05-08T07:12:39+00:00 https://aimfa.es/wp-content/uploads/novonordisk.jpg https://aimfa.es/roche-presenta-nuevos-avances-terapias-enfermedades-neurologicas/ 2019-05-09T07:16:12+00:00 https://aimfa.es/wp-content/uploads/roche_top.jpg https://aimfa.es/las-5-actitudes-fatales-tienes-la-oficina-probablemente-no-detectado/ 2019-05-10T07:21:26+00:00 https://aimfa.es/wp-content/uploads/lealtad.jpg https://aimfa.es/aimfa-celebra-xxx-asamblea-nacional-socios/ 2019-05-13T07:27:00+00:00 https://aimfa.es/wp-content/uploads/Aimfa_tira_baja.jpg https://www.aimfa.es/wp-content/uploads/2019/05/aimfa_grupo.jpg https://aimfa.es/novartis-acerca-las-terapias-cart-los-ninos-traves-cuentos-comics/ 2019-05-14T08:26:39+00:00 https://aimfa.es/wp-content/uploads/novartis-2.jpg https://aimfa.es/crean-bote-pastillas-inteligente-avisa-sobredosis-mal-uso/ 2019-05-15T08:30:23+00:00 https://aimfa.es/wp-content/uploads/medicinas.jpg https://aimfa.es/abstract-pharmamar-los-mejores-asco/ 2019-05-16T08:02:28+00:00 https://aimfa.es/wp-content/uploads/pharmamar__baja-1.jpg https://aimfa.es/mas-900-medicamentos-bajaran-precio-la-nueva-opr/ 2019-05-17T07:52:37+00:00 https://aimfa.es/wp-content/uploads/logo_ministerio.jpg https://aimfa.es/estos-los-avances-inteligencia-artificial-mas-demandados-sanidad/ 2019-05-20T07:26:10+00:00 https://aimfa.es/wp-content/uploads/tecnologia.jpg https://aimfa.es/impacto-mercado-farmaceutico-del-borrador-la-opr-scb-mayo-2019/ 2019-05-21T06:52:53+00:00 https://aimfa.es/gasto-farmaceutico-encadena-2-anos-subidas-alcanza-5-588-millones/ 2019-05-23T06:01:51+00:00 https://aimfa.es/wp-content/uploads/dinero_gasto.jpg https://aimfa.es/master-class-puestos-futuro-los-departamentos-marketing-comercial-la-industria/ 2019-05-24T09:21:10+00:00 https://aimfa.es/wp-content/uploads/logo-cesif.gif https://aimfa.es/segun-iqvia-mercado-tam-abril-crece-18-valores-09-unidades/ 2019-05-27T07:27:40+00:00 https://aimfa.es/iqvia-celebra-primer-foro-anual-madrid/ 2019-05-28T06:21:26+00:00 https://aimfa.es/wp-content/uploads/ForoIQVIA_3_top.jpg https://www.aimfa.es/wp-content/uploads/2019/05/ForoIQVIA_1.jpg https://aimfa.es/grifols-destinara-1-400-millones-euros-inversiones-capital-periodo-2018-2022/ 2019-05-29T07:11:32+00:00 https://aimfa.es/wp-content/uploads/grifols_top-1.jpg https://aimfa.es/la-cesta-compra-promedio-la-farmacia-online-espana-6050-euros/ 2019-05-30T08:17:54+00:00 https://aimfa.es/farmaindustria-ve-claro-perjuicio-la-industria-innovadora-fomento-la-utilizacion-los-medicamentos-reguladores/ 2019-05-31T06:04:04+00:00 https://aimfa.es/wp-content/uploads/farmaindustria_top.jpg https://aimfa.es/biosim-lamenta-informe-la-airef-no-haya-reflejado-la-idiosincrasia-del-biosimilar/ 2019-06-03T06:01:15+00:00 https://aimfa.es/wp-content/uploads/medicinas-1.jpg https://aimfa.es/sanidad-prepara-plan-genericos-biosimilares/ 2019-06-04T06:14:24+00:00 https://aimfa.es/wp-content/uploads/logo_ministerio.jpg https://aimfa.es/iqvia-preve-gasto-global-terapias-oncologicas-seguira-al-alza/ 2019-06-05T07:43:34+00:00 https://aimfa.es/grunenthal-pone-marcha-la-academia-gerencial-junto-instituto-empresa/ 2019-06-06T07:27:32+00:00 https://aimfa.es/wp-content/uploads/grunenthal_top.jpg https://aimfa.es/abbvie-reconocida-la-4a-mejor-multinacional-trabajar-europa/ 2019-06-10T08:44:42+00:00 https://aimfa.es/wp-content/uploads/abbvie_top.jpg https://aimfa.es/sanidad-elimina-control-previo-guia-publicidad-farmacos/ 2019-06-11T07:19:11+00:00 https://aimfa.es/wp-content/uploads/logo_ministerio.jpg https://aimfa.es/msd-tendra-medicamento-mayores-ventas-del-mundo-2024/ 2019-06-12T06:20:16+00:00 https://aimfa.es/wp-content/uploads/msd-top.jpg https://aimfa.es/69-los-medicos-espanoles-quiere-formacion-herramientas-digitales/ 2019-06-13T07:18:09+00:00 https://aimfa.es/wp-content/uploads/digital-3.jpg https://www.aimfa.es/wp-content/uploads/2019/06/digital-derma.jpg https://aimfa.es/josefina-consuegra-se-incorpora-nueva-investigacion/ 2019-06-14T07:08:39+00:00 https://aimfa.es/wp-content/uploads/josefina_top.jpg https://www.aimfa.es/wp-content/uploads/2019/06/josefina.jpg https://aimfa.es/pharmamar-entrega-forma-gratuita-163-631-acciones-empleados/ 2019-06-17T06:37:33+00:00 https://aimfa.es/wp-content/uploads/pharmamar_top.jpg https://aimfa.es/farmaindustria-la-medicina-precision-no-amenaza-la-sostenibilidad-del-sns/ 2019-06-18T07:56:13+00:00 https://aimfa.es/wp-content/uploads/farmaindustria_top.jpg https://aimfa.es/kantar-estrena-nuevas-salas-realizar-grupos-cualitativos-la-matriz/ 2019-06-19T06:13:55+00:00 https://aimfa.es/wp-content/uploads/salas_top.jpg https://www.aimfa.es/wp-content/uploads/2019/06/salas_kantar.jpg https://aimfa.es/segun-iqvia-mercado-presenta-crecimiento-del-19-valores-del-09-unidades-tam-mayo/ 2019-06-20T07:49:25+00:00 https://aimfa.es/alexa-se-cardiologa-detecta-infartos-la-respiracion-del-usuario/ 2019-06-24T07:57:51+00:00 https://aimfa.es/wp-content/uploads/amazon.jpg https://aimfa.es/sector-las-tecnologias-sanitarias-da-pasos-autocontrol-mensajes-publicitarios/ 2019-06-25T08:22:59+00:00 https://aimfa.es/wp-content/uploads/fenin.jpg https://aimfa.es/farmaindustria-compensara-al-gobierno-la-subida-del-gasto-farmaceutico-2018/ 2019-06-26T07:41:37+00:00 https://aimfa.es/wp-content/uploads/farmaindustria_top.jpg https://aimfa.es/atrys-health-adquiere-100-real-life-data/ 2019-06-26T22:43:10+00:00 https://aimfa.es/wp-content/uploads/real_life.jpg https://aimfa.es/la-industria-transfirio-118-millones-profesionales-la-sanidad-2018/ 2019-06-28T07:06:20+00:00 https://aimfa.es/wp-content/uploads/farmaindustria_top.jpg https://aimfa.es/los-masters-cesif-los-mejores-segun-mundo/ 2019-07-01T06:06:41+00:00 https://aimfa.es/wp-content/uploads/logo-cesif.gif https://www.aimfa.es/wp-content/uploads/2019/07/CESIF-29-MAD-BCN-LIS.jpg https://aimfa.es/la-industria-reivindica-aportacion-la-economia-la-salud-la-ue/ 2019-07-02T06:56:39+00:00 https://aimfa.es/leo-pharma-completa-la-adquisicion-del-negocio-dermatologia-bayer/ 2019-07-03T08:12:48+00:00 https://aimfa.es/wp-content/uploads/logo-leo.jpg https://aimfa.es/las-autoridades-europeas-recuerdan-los-promotores-ensayos-clinicos-obligacion-publicar-resultados/ 2019-07-04T08:14:48+00:00 https://aimfa.es/wp-content/uploads/tecnologia-1.jpg https://aimfa.es/la-airef-critica-la-opacidad-hacienda-los-estudios-gasto-sanitario/ 2019-07-08T08:40:37+00:00 https://aimfa.es/wp-content/uploads/logo_ministerio.jpg https://aimfa.es/las-farmaceuticas-ganan-la-batalla-trump-no-publicaran-precios-tv/ 2019-07-10T09:05:12+00:00 https://aimfa.es/wp-content/uploads/simpsons.jpg https://aimfa.es/la-sanidad-francesa-dejara-costear-productos-homeopaticos-partir-2021/ 2019-07-11T11:51:21+00:00 https://aimfa.es/wp-content/uploads/homeopatia_top.jpg https://aimfa.es/gebro-pharma-acelera-espana-preve-facturar-mas-70-millones-2019/ 2019-07-12T08:46:46+00:00 https://aimfa.es/wp-content/uploads/gebro_top.jpg https://aimfa.es/wpp-pretende-vender-60-kantar-bain-capital/ 2019-07-15T08:16:47+00:00 https://aimfa.es/wp-content/uploads/kantar-1.jpg https://aimfa.es/segun-iqvia-mercado-crece-14-valores-04-unidades-tam-junio/ 2019-07-16T07:19:03+00:00 https://aimfa.es/ana-argelich-nueva-presidenta-directora-general-msd-espana/ 2019-07-18T05:00:51+00:00 https://aimfa.es/wp-content/uploads/msd-top.jpg https://aimfa.es/wp-content/uploads/plgs_cabecera.jpg https://aimfa.es/la-nueva-directiva-aeaps-potenciara-grupos-trabajo-internos/ 2019-07-19T06:55:31+00:00 https://aimfa.es/wp-content/uploads/logo_aeaps.jpg https://www.aimfa.es/wp-content/uploads/2019/07/aeaps.jpg https://aimfa.es/francia-aprueba-la-prescripcion-farmaceutica-la-renovacion-recetas/ 2019-07-22T07:06:24+00:00 https://aimfa.es/wp-content/uploads/farmacia-2.jpg https://aimfa.es/bloque-paises-desarrollados-critica-la-resolucion-acceso-aprobada-consejo-derechos-humanos/ 2019-07-23T07:17:06+00:00 https://aimfa.es/wp-content/uploads/consejo.jpg https://aimfa.es/comercio-electronico-espanol-crece-260-supera-la-media-europea/ 2019-07-24T06:26:55+00:00 https://aimfa.es/wp-content/uploads/ecommerce-1.jpg https://aimfa.es/marc-perez-pey-nombrado-nuevo-presidente-fenin-cataluna/ 2019-07-25T06:34:58+00:00 https://aimfa.es/wp-content/uploads/fenin.jpg https://www.aimfa.es/wp-content/uploads/2019/07/marc-perez-150x150.jpg https://aimfa.es/la-ue-ee-uu-culminan-historico-acuerdo-reconocimiento-mutuo/ 2019-07-26T06:44:45+00:00 https://aimfa.es/wp-content/uploads/europa_top.jpg https://aimfa.es/iqvia-mercado-crece-17-valores-06-unidades-tam-julio/ 2019-08-26T06:26:10+00:00 https://aimfa.es/pharmamar-alcanza-objetivo-estudio-farmaco-lurbinectedina/ 2019-08-28T06:35:44+00:00 https://aimfa.es/wp-content/uploads/pharmamar_top.jpg https://aimfa.es/la-implementacion-mas-herramientas-digitales-mejoraria-rendimiento-los-laboratorios-farmaceuticos/ 2019-08-29T07:11:48+00:00 https://aimfa.es/wp-content/uploads/digital.jpg https://aimfa.es/84-los-pacientes-considera-las-organizaciones-pacientes-la-industria-deberian-trabajar-juntos/ 2019-08-30T07:11:27+00:00 https://aimfa.es/wp-content/uploads/accenture.jpg https://aimfa.es/la-biotecnologia-impacto-7-000-millones-euros-la-economia-espanola/ 2019-09-02T09:46:21+00:00 https://aimfa.es/wp-content/uploads/asebio.jpg https://aimfa.es/europa-estados-unidos-coinciden-mas-del-90-las-aprobaciones-nuevos-medicamentos/ 2019-09-03T09:16:21+00:00 https://aimfa.es/wp-content/uploads/europa_top.jpg https://aimfa.es/cancer-provoca-doble-muertes-las-enfermedades-cardiovasculares-los-paises-ricos/ 2019-09-04T08:14:09+00:00 https://aimfa.es/wp-content/uploads/cancer.jpg https://aimfa.es/xix-encuentro-la-industria-farmaceutica-pone-foco-los-avances-biomedicos/ 2019-09-06T08:14:32+00:00 https://aimfa.es/wp-content/uploads/farmaindustria_top.jpg https://aimfa.es/grifols-firma-acuerdo-mondragon-desarrollar-proyectos-automatizacion-robotica/ 2019-09-09T09:03:40+00:00 https://aimfa.es/wp-content/uploads/grifols_top.jpg https://aimfa.es/seis-tendencias-marketing-farmaceutico-2020/ 2019-09-10T07:33:26+00:00 https://aimfa.es/wp-content/uploads/gente.jpg https://aimfa.es/close-up-symphony-health-forjan-una-alianza-expandir-servicios-datos/ 2019-09-11T07:17:29+00:00 https://aimfa.es/wp-content/uploads/closeup.jpg https://aimfa.es/google-estrecha-cerco-la-publicidad-medica/ 2019-09-12T07:17:57+00:00 https://aimfa.es/wp-content/uploads/google.jpg https://aimfa.es/mercado-diagnostico-imagen-factura-3-200-millones-euros-anuales/ 2019-09-13T06:13:06+00:00 https://aimfa.es/wp-content/uploads/Radiografia.jpg https://aimfa.es/crecimiento-del-gasto-farmaceutico-hospitalario-se-estabiliza-cerca-del-7/ 2019-09-16T07:34:50+00:00 https://aimfa.es/wp-content/uploads/dinero_gasto.jpg https://aimfa.es/segun-iqvia-mercado-crece-15-valores-03-unidades-tam-agosto/ 2019-09-17T07:08:50+00:00 https://aimfa.es/los-sueldos-la-industria-farmaceutica-se-situan-10-del-resto-sectores-espana/ 2019-09-19T07:46:38+00:00 https://aimfa.es/wp-content/uploads/gente-1.jpg https://aimfa.es/boe-publica-la-opr-tendra-efecto-farmacias-1-noviembre/ 2019-09-20T07:00:07+00:00 https://aimfa.es/wp-content/uploads/logo_ministerio.jpg https://aimfa.es/la-industria-farmaceutica-valor-mas-seguro-apostar-bolsa/ 2019-09-23T07:05:58+00:00 https://aimfa.es/wp-content/uploads/bolsa.jpg https://aimfa.es/quien-propietario-los-datos-una-investigacion/ 2019-09-24T07:16:22+00:00 https://aimfa.es/wp-content/uploads/esomar_top.jpg https://aimfa.es/biocat-barcelona-tech-city-colaboraran-la-innovacion-salud/ 2019-09-25T07:42:31+00:00 https://aimfa.es/wp-content/uploads/biocat.jpg https://aimfa.es/genericos-las-farma-espanolas-apuestan-marca/ 2019-09-26T07:13:12+00:00 https://aimfa.es/wp-content/uploads/genericos.jpg https://aimfa.es/la-orden-precios-referencia-podria-suponer-una-reduccion-del-mercado-57me/ 2019-09-27T07:02:24+00:00 https://aimfa.es/competencias-mas-buscadas-los-profesionales-del-sector-farma/ 2019-09-30T07:15:59+00:00 https://aimfa.es/wp-content/uploads/adecco.jpg https://aimfa.es/los-oncologos-defienden-esmo-la-libertad-prescripcion-los-biosimilares/ 2019-10-01T09:00:05+00:00 https://aimfa.es/wp-content/uploads/ESMO.jpg https://aimfa.es/la-industria-modera-crecimiento-bolsa-sube-365-tercer-trimestre/ 2019-10-02T07:06:23+00:00 https://aimfa.es/wp-content/uploads/bolsa-1.jpg https://aimfa.es/microsoft-lanza-nuevos-crm-omnichannel/ 2019-10-03T07:27:01+00:00 https://aimfa.es/wp-content/uploads/microsoft.jpg https://aimfa.es/la-venta-online-productos-farma-crece-97-primer-trimestre-593-millones/ 2019-10-07T08:07:30+00:00 https://aimfa.es/wp-content/uploads/Farmacia-online.jpg https://aimfa.es/novo-nordisk-se-alia-noom-traer-soluciones-digitales-la-obesidad/ 2019-10-08T07:11:12+00:00 https://aimfa.es/wp-content/uploads/novonordisk.jpg https://aimfa.es/sale-cuenta-comprar-medicamentos-baratos/ 2019-10-09T09:41:52+00:00 https://aimfa.es/wp-content/uploads/preu_medic.jpg https://aimfa.es/espana-se-mueve-los-puestos-bajos-la-ue-uso-biosimilares/ 2019-10-10T07:22:21+00:00 https://aimfa.es/wp-content/uploads/Biosimilar.jpg https://aimfa.es/modelo-precios-dinamicos-nuevo-plan-genericos-biosimilares/ 2019-10-11T07:11:31+00:00 https://aimfa.es/wp-content/uploads/logo_ministerio.jpg https://aimfa.es/papel-del-big-data-la-personalizacion-tratamientos-la-creacion-nuevos-farmacos/ 2019-10-15T08:14:01+00:00 https://aimfa.es/wp-content/uploads/bolsa-1.jpg https://aimfa.es/2-3-companias-farmaceuticas-ya-invierten-10-50-servicios-digitales/ 2019-10-16T08:24:44+00:00 https://aimfa.es/wp-content/uploads/logo_aeaps.jpg https://aimfa.es/segun-iqvia-mercado-crece-18-valores-06-unidades-tam-septiembre/ 2019-10-17T07:00:26+00:00 https://aimfa.es/gilead-ve-reducir-negocio-la-entrada-genericos-la-reduccion-pacientes/ 2019-10-18T06:49:49+00:00 https://aimfa.es/wp-content/uploads/gilead_top.jpg https://aimfa.es/las-mujeres-se-afianzan-las-mas-van-la-consulta-del-dr-google/ 2019-10-21T07:47:36+00:00 https://aimfa.es/wp-content/uploads/google.jpg https://aimfa.es/aedemo-y-aneimo-se-fusionan-y-crean-insightsanalytics-espana/ 2019-10-22T07:06:10+00:00 https://aimfa.es/wp-content/uploads/INSIGHTS_ANALYTICS..jpg https://aimfa.es/bms-lanza-en-espana-la-plataforma-online-bms-study-connect/ 2019-10-23T11:06:54+00:00 https://aimfa.es/wp-content/uploads/tecnologia-1.jpg https://aimfa.es/visitar-o-asesorar-al-profesional-de-la-salud/ 2019-10-24T09:01:31+00:00 https://aimfa.es/wp-content/uploads/VISITADOR.jpg https://aimfa.es/boehringer-ingelheim-se-une-al-programa-d%c2%b7health-barcelona/ 2019-10-25T08:23:18+00:00 https://aimfa.es/wp-content/uploads/boehringer-1.jpg https://aimfa.es/xi-encuentro-la-investigacion-a-analisis/ 2019-10-28T07:38:59+00:00 https://aimfa.es/wp-content/uploads/INSIGHTS_ANALYTICS..jpg https://aimfa.es/amazon-compra-la-start-up-health-navigator/ 2019-10-29T07:29:09+00:00 https://aimfa.es/wp-content/uploads/amazon.jpg https://aimfa.es/heineken-se-alza-con-el-premio-oro-a-la-investigacion-en-los-premios-eficacia/ 2019-10-30T07:29:29+00:00 https://aimfa.es/wp-content/uploads/premiosefiTOP.jpg https://www.aimfa.es/wp-content/uploads/2019/10/premioseficacia.jpg https://aimfa.es/bayer-presenta-un-ere-para-75-personas-en-barcelona/ 2019-10-31T07:25:32+00:00 https://aimfa.es/wp-content/uploads/bayer_top.jpg https://aimfa.es/google-compra-fitbit-pionera-de-los-wearables/ 2019-11-04T09:41:56+00:00 https://aimfa.es/wp-content/uploads/google.jpg https://aimfa.es/el-sector-farmaceutico-espanol-preparado-para-el-brexit/ 2019-11-05T08:08:18+00:00 https://aimfa.es/wp-content/uploads/brexit.jpg https://aimfa.es/faes-farma-adquiere-la-colombiana-bcn-medical/ 2019-11-06T08:16:15+00:00 https://aimfa.es/wp-content/uploads/faes-1.jpg https://aimfa.es/saludsinbulos-y-fefcam-publican-un-listado-de-webs-fiables-creadas-por-farmaceuticos/ 2019-11-07T07:54:35+00:00 https://aimfa.es/wp-content/uploads/digitalizacion.jpg https://aimfa.es/nace-go-access-club-como-punto-de-encuentro-de-profesionales-del-market-access/ 2019-11-11T08:38:29+00:00 https://aimfa.es/wp-content/uploads/GoAccessClub_TOP.jpg https://www.aimfa.es/wp-content/uploads/2019/11/GoAccessClub.jpg https://aimfa.es/la-gestion-de-los-medicamentos-car-t-un-reto-para-la-farmacia-hospitalaria/ 2019-11-12T11:11:59+00:00 https://aimfa.es/wp-content/uploads/carT.jpg https://aimfa.es/farmaindustria-recuerda-que-la-transparencia-es-un-medio-no-un-fin/ 2019-11-13T08:44:40+00:00 https://aimfa.es/wp-content/uploads/farmaindustria_top.jpg https://aimfa.es/el-farma-espanol-suspende-en-sostenibilidad/ 2019-11-18T09:32:49+00:00 https://aimfa.es/wp-content/uploads/contaminacion.jpg https://aimfa.es/segun-iqvia-el-mercado-crece-un14-en-valores-y-un-01-en-unidades-en-el-tam-de-octubre/ 2019-11-19T07:40:14+00:00 https://aimfa.es/cesif-celebra-la-apertura-del-nuevo-curso-2019-20-en-madrid/ 2019-11-20T07:26:43+00:00 https://aimfa.es/wp-content/uploads/cesif_top.jpg https://aimfa.es/cotec-realiza-un-informe-sobre-digitalizacion-en-salud/ 2019-11-21T07:33:47+00:00 https://aimfa.es/wp-content/uploads/digital-1.jpg https://aimfa.es/pfizer-desarrolla-a-tu-lado-una-app-que-acompana-a-los-pacientes-con-cancer/ 2019-11-22T07:40:24+00:00 https://aimfa.es/wp-content/uploads/pfizer_top.jpg https://aimfa.es/la-digitalizacion-ya-es-una-realidad-en-el-sector-del-autocuidado/ 2019-11-26T09:17:31+00:00 https://aimfa.es/wp-content/uploads/anefp.jpg https://aimfa.es/el-paciente-es-el-centro-de-atencion-de-la-industria-farmaceutica/ 2019-11-27T10:36:39+00:00 https://aimfa.es/wp-content/uploads/farmaindustria_top.jpg https://aimfa.es/otsuka-celebra-su-40-aniversario-en-espana/ 2019-11-28T08:19:06+00:00 https://aimfa.es/wp-content/uploads/otsuka_top.jpg https://www.aimfa.es/wp-content/uploads/2019/11/otsuka_madrid.jpg https://aimfa.es/medicos-y-pacientes-comprometidos-en-la-busqueda-de-una-informacion-veraz/ 2019-12-02T08:53:06+00:00 https://aimfa.es/wp-content/uploads/comunicacion_salud.jpg https://aimfa.es/chiesi-impulsa-rare-chip-un-proyecto-de-formacion-en-enfermedades-raras/ 2019-12-03T09:44:19+00:00 https://aimfa.es/wp-content/uploads/Logo_Chiesi_home.jpg https://aimfa.es/la-oms-alerta-de-los-escasos-fondos-que-se-destinan-para-proteger-la-salud-del-cambio-climatico/ 2019-12-04T09:49:46+00:00 https://aimfa.es/wp-content/uploads/clima.jpg https://aimfa.es/nueva-publicacion-todo-lo-que-debe-saber-sobre-market-access-y-relaciones-institucionales/ 2019-12-05T08:57:30+00:00 https://aimfa.es/wp-content/uploads/LIBROMARKETACCESS.jpg https://aimfa.es/atrys-health-completa-una-ampliacion-de-capital-de-cinco-millones/ 2019-12-09T09:30:38+00:00 https://aimfa.es/wp-content/uploads/atrys_top.jpg https://aimfa.es/amazon-ayudara-a-novartis-a-optimizar-sus-procesos-con-inteligencia-artificial/ 2019-12-10T08:38:21+00:00 https://aimfa.es/wp-content/uploads/novartis-2.jpg https://aimfa.es/69-hospitales-nominados-a-ser-los-mejores-de-espana/ 2019-12-12T08:11:47+00:00 https://aimfa.es/industria-y-distribucion-dan-su-version-sobre-los-desabastecimientos-en-la-ue/ 2019-12-13T08:24:33+00:00 https://aimfa.es/wp-content/uploads/europa_top.jpg https://aimfa.es/sanidad-elimina-la-categoria-de-especial-control-medico/ 2019-12-16T10:23:00+00:00 https://aimfa.es/wp-content/uploads/logo_ministerio.jpg https://aimfa.es/novartis-pfizer-y-janssen-las-farmas-que-rompen-el-mito-de-la-opacidad-en-el-sector/ 2019-12-17T08:03:47+00:00 https://aimfa.es/wp-content/uploads/novartis-2.jpg https://aimfa.es/segun-iqvia-el-mercado-crece-15-en-valores-y-un-03-en-unidades-en-el-tam-de-noviembre/ 2019-12-19T08:57:47+00:00 https://aimfa.es/el-analisis-de-datos-entre-las-tendencias-clave-para-impulsar-la-medicina-de-precision/ 2019-12-20T10:23:51+00:00 https://aimfa.es/wp-content/uploads/tecnologia.jpg https://aimfa.es/pharma-mar-y-faes-disparan-el-farma-en-bolsa-en-2019/ 2020-01-02T09:43:44+00:00 https://aimfa.es/wp-content/uploads/pharmamar_top.jpg https://aimfa.es/el-gasto-publico-hospitalario-aumenta-un-49-hasta-octubre/ 2020-01-03T08:52:29+00:00 https://aimfa.es/wp-content/uploads/dinero_gasto.jpg https://aimfa.es/farmaindustria-negociara-un-nuevo-convenio-de-colaboracion-con-el-gobierno-para-2020/ 2020-01-07T08:14:44+00:00 https://aimfa.es/wp-content/uploads/farmaindustria_top.jpg https://aimfa.es/top-10-medicos-influencers-del-2019-a-nivel-nacional/ 2020-01-09T08:00:30+00:00 https://aimfa.es/wp-content/uploads/tecnologia.jpg https://aimfa.es/salvador-illa-un-experto-mediador-para-reconducir-las-relaciones-con-el-sector/ 2020-01-10T17:28:38+00:00 https://aimfa.es/wp-content/uploads/illa.jpg https://aimfa.es/la-ema-dio-66-opiniones-positivas-30-para-farmacos-nuevos-en-2019/ 2020-01-13T09:21:38+00:00 https://aimfa.es/wp-content/uploads/europa_top.jpg https://aimfa.es/el-porcentaje-de-poblacion-con-cinco-o-mas-farmacos-prescritos-simultaneamente-sube-al-9/ 2020-01-14T09:29:19+00:00 https://aimfa.es/wp-content/uploads/medicinas_home.jpg https://aimfa.es/novartis-y-el-nhs-inician-un-ensayo-de-la-vacuna-contra-el-colesterol/ 2020-01-14T23:42:26+00:00 https://aimfa.es/wp-content/uploads/novartis-2.jpg https://aimfa.es/el-investigador-joan-massague-descubre-el-origen-de-la-metastasis/ 2020-01-16T08:33:08+00:00 https://aimfa.es/wp-content/uploads/cancer.jpg https://aimfa.es/la-inteligencia-artificial-detecta-la-hipoglucemia-sin-necesidad-de-analizar-la-sangre/ 2020-01-17T07:24:40+00:00 https://aimfa.es/wp-content/uploads/movil.jpg https://aimfa.es/segun-iqvia-el-mercado-crece-un-16-en-valores-y-03-en-unidades-en-2019/ 2020-01-20T08:31:02+00:00 https://aimfa.es/la-app-medicamento-accesible-plus-supera-las-50-000-descargas/ 2020-01-22T08:30:47+00:00 https://aimfa.es/wp-content/uploads/movil.jpg https://aimfa.es/estas-son-las-nueve-marcas-sanitarias-mas-valiosas-del-mundo/ 2020-01-23T09:49:07+00:00 https://aimfa.es/wp-content/uploads/novartis-roche.jpg https://aimfa.es/el-gasto-farmaceutico-cierra-2019-con-un-crecimiento-del-297/ 2020-01-24T10:09:34+00:00 https://aimfa.es/wp-content/uploads/dinero_gasto.jpg https://aimfa.es/el-precio-de-los-medicamentos-en-espana-crece-un-11-en-2019/ 2020-01-27T08:33:23+00:00 https://aimfa.es/wp-content/uploads/dinero.jpg https://aimfa.es/atrys-health-recibe-mas-de-un-millon-de-euros-en-financiacion-del-cdti/ 2020-01-28T10:10:13+00:00 https://aimfa.es/wp-content/uploads/atrys.jpg https://aimfa.es/pfizer-gana-un-46-mas-en-2019-gracias-a-la-fusion-con-gsk/ 2020-01-29T10:14:55+00:00 https://aimfa.es/wp-content/uploads/pfizer_top.jpg https://aimfa.es/10-recomendaciones-en-big-data-para-apoyar-la-investigacion-y-la-salud/ 2020-01-30T07:54:05+00:00 https://aimfa.es/wp-content/uploads/big-data.jpg https://aimfa.es/genomica-de-pharma-mar-desarrolla-un-kit-para-frenar-el-coronavirus/ 2020-01-31T08:24:05+00:00 https://aimfa.es/wp-content/uploads/virus.jpg https://aimfa.es/el-numero-de-usuarios-de-internet-en-el-mundo-crece-un-7-y-alcanza-los-4-540-millones/ 2020-02-03T08:50:55+00:00 https://aimfa.es/wp-content/uploads/pacientes-internet.jpg https://aimfa.es/el-retorno-de-la-inversion-en-id-de-medicamentos-en-su-punto-mas-bajo-de-los-ultimos-10-anos/ 2020-02-04T07:47:04+00:00 https://aimfa.es/wp-content/uploads/farmaindustria_top.jpg https://aimfa.es/la-inteligencia-artificial-predice-la-progresion-de-las-enfermedades-neurodegenerativas/ 2020-02-05T08:30:01+00:00 https://aimfa.es/wp-content/uploads/tecnologia.jpg https://aimfa.es/las-ventas-de-farmacos-en-europa-cierran-2019-con-un-aumento-del-32/ 2020-02-06T08:56:10+00:00 https://aimfa.es/wp-content/uploads/europa_top.jpg https://aimfa.es/asi-es-el-nuevo-google-maps/ 2020-02-07T09:32:42+00:00 https://aimfa.es/wp-content/uploads/google.jpg https://aimfa.es/campana-contra-la-promocion-irresponsable-de-medicamentos-por-influencers/ 2020-02-10T09:06:14+00:00 https://aimfa.es/wp-content/uploads/medicinas_home.jpg https://aimfa.es/jose-luis-fernandez-nuevo-director-general-de-iqvia-espana/ 2020-02-11T08:50:52+00:00 https://aimfa.es/no-hay-ninguna-razon-sanitaria-para-suspender-el-mobile-world-congress/ 2020-02-12T10:06:26+00:00 https://aimfa.es/wp-content/uploads/mobile.jpg https://aimfa.es/la-universidad-ceu-san-pablo-reconoce-todas-las-titulaciones-de-cesif/ 2020-02-13T10:33:31+00:00 https://aimfa.es/wp-content/uploads/cesif_top.jpg https://www.aimfa.es/wp-content/uploads/2020/02/CESIF_CEU_Direccion.jpg https://aimfa.es/el-consejo-de-ministros-autoriza-la-compra-centralizada-de-medicamentos-por-un-valor-de-391-millones/ 2020-02-17T07:44:56+00:00 https://aimfa.es/wp-content/uploads/logo_ministerio.jpg https://aimfa.es/madrid-eliminara-el-cupon-precinto-en-junio-y-prepara-numerosas-innovaciones-tecnologicas/ 2020-02-18T07:55:42+00:00 https://aimfa.es/wp-content/uploads/medicinas-2.jpg https://aimfa.es/segun-iqvia-el-mercado-crece-un-16-en-valores-y-02-en-unidades-en-el-tam-de-enero/ 2020-02-20T08:59:34+00:00 https://aimfa.es/hay-que-estrechar-la-relacion-entre-la-ue-y-el-reino-unido-en-materia-de-medicamentos/ 2020-02-24T09:49:46+00:00 https://aimfa.es/wp-content/uploads/brexit.jpg https://aimfa.es/la-usd-de-farmaindustria-hizo-en-2019-seguimiento-de-casi-4-000-reuniones-cientificas-sin-apenas-incidencias/ 2020-02-25T07:41:36+00:00 https://aimfa.es/wp-content/uploads/farmaindustria_top.jpg https://www.aimfa.es/wp-content/uploads/2020/02/grafico_3_v2-1.png https://aimfa.es/wp-content/uploads/brillpharma.jpg https://aimfa.es/radical-cambio-en-20-anos-en-las-enfermedades-raras-de-8-medicamentos-a-169/ 2020-02-26T07:24:58+00:00 https://aimfa.es/wp-content/uploads/medicamentos.jpg https://aimfa.es/la-salud-digital-ofrece-soluciones-para-la-sostenibilidad-del-sistema-sanitario/ 2020-02-27T08:20:26+00:00 https://aimfa.es/wp-content/uploads/digitalizacion.jpg https://aimfa.es/takeda-y-shire-completan-su-fusion-por-absorcion-en-espana/ 2020-03-02T08:20:29+00:00 https://aimfa.es/wp-content/uploads/takeda-pharmaceutical-co-scaled.jpg https://aimfa.es/mas-de-640-ensayos-clinicos-de-terapias-avanzadas-en-enfermedades-raras/ 2020-03-03T07:58:54+00:00 https://aimfa.es/wp-content/uploads/enfermera-1.jpg https://aimfa.es/la-plitidepsina-aplidin-de-pharmamar-podria-ser-eficaz-frente-al-coronavirus/ 2020-03-04T09:12:52+00:00 https://aimfa.es/wp-content/uploads/pharmamar_top.jpg https://aimfa.es/el-empleo-en-salud-en-espana-mantiene-el-ritmo-y-crece-un-6-en-febrero/ 2020-03-05T08:00:39+00:00 https://aimfa.es/wp-content/uploads/empleo.jpg https://aimfa.es/roche-pone-en-marcha-el-centro-de-servicios-globales-de-it-en-madrid/ 2020-03-06T07:31:45+00:00 https://aimfa.es/wp-content/uploads/roche_top.jpg https://aimfa.es/salud-de-la-mujer-datos-y-cifras/ 2020-03-09T08:49:44+00:00 https://aimfa.es/wp-content/uploads/migrana.jpg https://aimfa.es/el-mercado-farmaceutico-online-en-espana/ 2020-03-10T09:43:06+00:00 https://aimfa.es/wp-content/uploads/Farmacia-online.jpg https://aimfa.es/la-industria-farmaceutica-tiene-en-desarrollo-600-farmacos-cardiovasculares/ 2020-03-13T06:38:12+00:00 https://aimfa.es/wp-content/uploads/corazon_cardio.jpg https://aimfa.es/coronavirus-ya-hay-30-medicamentos-y-cuatro-vacunas-en-desarrollo/ 2020-03-16T10:35:40+00:00 https://aimfa.es/wp-content/uploads/virus-1.jpg https://aimfa.es/gebro-pharma-se-une-al-ensayo-clinico-para-prevenir-la-propagacion-del-coronavirus/ 2020-03-17T10:01:59+00:00 https://aimfa.es/wp-content/uploads/gebro_top.jpg https://aimfa.es/menarini-dona-5-toneladas-a-la-semana-de-gel-desinfectante-en-italia/ 2020-03-18T08:00:15+00:00 https://aimfa.es/wp-content/uploads/menarini_baja-e1584518480651.jpg https://aimfa.es/comunicado-de-la-aeaps-respecto-al-covid-19/ 2020-03-19T10:38:00+00:00 https://aimfa.es/wp-content/uploads/logo_aeaps.jpg https://aimfa.es/comunicado-por-eyeforpharma-el-evento-de-barcelona-2020-sera-virtual/ 2020-03-20T09:32:58+00:00 https://aimfa.es/wp-content/uploads/barcelona-1.jpg https://aimfa.es/recordati-contribuye-qpoyando-a-hospitales-y-pacientes-en-la-lucha-contra-el-covid/ 2020-03-24T07:29:46+00:00 https://aimfa.es/wp-content/uploads/CASEN.jpg https://aimfa.es/los-productos-farmaceuticos-falsificados-comercializados-en-el-mundo-alcanzan-los-4-000-millones-de-euros/ 2020-03-24T08:07:05+00:00 https://aimfa.es/wp-content/uploads/falsificados.jpg https://aimfa.es/el-coronavirus-a-24-de-marzo-39-673-personas-afectadas-2-696-fallecidos-y-3-704-curados/ 2020-03-25T09:19:51+00:00 https://aimfa.es/wp-content/uploads/virus-1-1.jpg https://www.aimfa.es/wp-content/uploads/2020/03/coronavirus_marzo_20078_20200324114903.png https://aimfa.es/la-aemps-advierte-del-riesgo-de-comprar-medicamentos-falsificados-en-farmacias-on-line-ilegales/ 2020-03-26T09:49:44+00:00 https://aimfa.es/wp-content/uploads/medicamentos.jpg https://aimfa.es/laboratorios-rubio-fabricante-de-hidroxicloroquina-preparado-para-aumentar-su-produccion/ 2020-03-27T08:57:51+00:00 https://aimfa.es/wp-content/uploads/rubio_top.jpg https://aimfa.es/covid-19-qlik-y-mercanza-proporcionaran-licencias-gratuitas-de-qlik-sense/ 2020-03-27T09:49:28+00:00 https://aimfa.es/wp-content/uploads/qlickmercanza.jpg https://aimfa.es/segun-iqvia-el-mercado-presenta-un-crecimiento-en-el-tam-del-21-en-valores-y-05-en-unidades/ 2020-03-30T08:24:20+00:00 https://aimfa.es/el-53-de-los-ciudadanos-europeos-de-entre-16-y-74-anos-asegura-buscar-informacion-sanitaria-en-internet/ 2020-03-31T07:44:54+00:00 https://aimfa.es/wp-content/uploads/pacientes-internet.jpg https://aimfa.es/farmaindustria-ve-con-recelo-las-posibles-incautaciones-de-medicamentos/ 2020-04-01T07:50:26+00:00 https://aimfa.es/wp-content/uploads/farmaindustria_top.jpg https://aimfa.es/las-12-acciones-de-la-industria-en-europa-para-hacer-frente-a-la-crisis-sanitaria/ 2020-04-02T08:14:23+00:00 https://aimfa.es/wp-content/uploads/efpia.jpg https://aimfa.es/rovi-eleva-un-20-el-sueldo-de-su-plantilla-que-sigue-trabajando-durante-el-estado-de-alarma/ 2020-04-03T07:06:47+00:00 https://aimfa.es/wp-content/uploads/rovi_top.jpg https://aimfa.es/covid-19-la-aecc-lanza-un-canal-de-podcasts-para-informar-y-apoyar-a-pacientes-y-familiares/ 2020-04-06T07:19:44+00:00 https://aimfa.es/wp-content/uploads/aecc.jpg https://aimfa.es/trabajadores-de-farmaindustria-se-ponen-a-disposicion-del-sns-para-avanzar-contra-la-pandemia/ 2020-04-07T08:00:29+00:00 https://aimfa.es/wp-content/uploads/farmaindustria_top.jpg https://aimfa.es/estudio-de-gfk-covid-19-situacion-en-el-ambito-sanitario/ 2020-04-08T06:31:14+00:00 https://aimfa.es/wp-content/uploads/gfk_top.jpg https://aimfa.es/boehringer-ingelheim-ofrece-un-programa-de-soporte-psicologico-a-los-profesionales-sanitarios/ 2020-04-09T07:44:05+00:00 https://aimfa.es/wp-content/uploads/boehringer-1.jpg https://aimfa.es/el-gobierno-intervendra-los-precios-de-guantes-geles-y-mascarillas/ 2020-04-13T06:51:45+00:00 https://aimfa.es/wp-content/uploads/guantes.jpg https://aimfa.es/el-gasto-en-productos-farmaceuticos-y-sanitarios-del-sns-en-2019-alcanzo-los-23-616-millones-un-45-mas/ 2020-04-15T08:20:22+00:00 https://aimfa.es/wp-content/uploads/dinero_gasto.jpg https://aimfa.es/farmaindustria-crea-un-decalogo-para-impulsar-la-id-de-nuevos-medicamentos/ 2020-04-16T10:09:36+00:00 https://aimfa.es/wp-content/uploads/farmaindustria_top.jpg https://aimfa.es/leo-pharma-firma-un-acuerdo-de-licencia-para-un-nuevo-farmaco-para-la-dermatitis-atopica-y-el-asma/ 2020-04-17T07:19:33+00:00 https://aimfa.es/wp-content/uploads/logo-leo.jpg https://aimfa.es/segun-iqvia-el-mercado-crece-un-30-en-valores-y-un-16-en-unidades-en-el-tam-de-marzo/ 2020-04-22T06:37:13+00:00 https://aimfa.es/el-mercado-de-la-tecnologia-sanitaria-crece-un-2-antes-del-estallido-de-la-crisis/ 2020-04-23T07:23:51+00:00 https://aimfa.es/wp-content/uploads/tecnologia-1.jpg https://aimfa.es/la-ce-da-luz-verde-a-la-fusion-de-mylan-y-la-division-de-genericos-de-pfizer-con-condiciones/ 2020-04-24T06:38:11+00:00 https://aimfa.es/wp-content/uploads/MYLAN_PFIZER.jpg https://aimfa.es/farmaindustria-hay-que-mantener-los-ensayos-clinicos-sin-poner-en-riesgo-la-salud-de-los-pacientes/ 2020-04-27T10:12:18+00:00 https://aimfa.es/wp-content/uploads/farmaindustria_top.jpg https://aimfa.es/la-industria-farmaceutica-ante-un-momento-clave-para-su-futuro/ 2020-04-28T07:54:24+00:00 https://aimfa.es/wp-content/uploads/industria.jpg https://aimfa.es/la-industria-se-compromete-a-que-tratamientos-y-vacunas-para-covid-19-sean-asequibles-en-todo-el-mundo/ 2020-04-29T08:48:10+00:00 https://aimfa.es/wp-content/uploads/ifpma.jpg https://aimfa.es/el-acuerdo-farmaindustria-hacienda-sanidad-se-retomara-en-semanas/ 2020-04-30T06:45:31+00:00 https://aimfa.es/wp-content/uploads/farmaindustria_top.jpg https://aimfa.es/odec-pone-en-marcha-su-programa-de-formacion-de-casa-a-casa/ 2020-04-30T07:20:15+00:00 https://aimfa.es/wp-content/uploads/odec_top.jpg https://aimfa.es/martin-selles-vamos-a-tener-una-vacuna-contra-el-coronavirus-y-va-a-estar-disponible-para-todo-el-mundo/ 2020-05-04T08:54:47+00:00 https://aimfa.es/wp-content/uploads/farmaindustria_top.jpg https://aimfa.es/los-biosimilares-de-anticuerpos-monoclonales-han-supuesto-en-espana-un-ahorro-de-2-400-millones-de-euros/ 2020-05-05T06:57:08+00:00 https://aimfa.es/wp-content/uploads/medicamentos.jpg https://aimfa.es/medio-centenar-de-medicamentos-en-desarrollo-para-el-asma/ 2020-05-06T06:11:43+00:00 https://aimfa.es/wp-content/uploads/asma.jpg https://aimfa.es/neurologybytes-es-una-nueva-apuesta-digital-de-teva-en-neurologia/ 2020-05-08T07:44:44+00:00 https://aimfa.es/wp-content/uploads/teva.jpg https://aimfa.es/bristol-myers-squibb-registra-unas-perdidas-de-716-millones-en-el-primer-trimestre/ 2020-05-11T14:02:50+00:00 https://aimfa.es/wp-content/uploads/bristol_top.jpg https://aimfa.es/abbvie-completa-la-adquisicion-de-allergan/ 2020-05-12T07:24:26+00:00 https://aimfa.es/wp-content/uploads/abbvie-1.jpg https://aimfa.es/crean-la-primera-comunidad-de-pacientes-covid-19/ 2020-05-14T07:08:54+00:00 https://aimfa.es/wp-content/uploads/pacientalia.jpg https://aimfa.es/pharmamar-anuncia-los-abstracts-que-presentara-en-el-congreso-de-asco-2020/ 2020-05-15T07:38:35+00:00 https://aimfa.es/wp-content/uploads/pharmamar_top.jpg https://aimfa.es/primeum-convoca-el-estudio-europeo-de-remuneracion-variable-en-la-industria/ 2020-05-18T05:39:17+00:00 https://aimfa.es/wp-content/uploads/primeum_logo.jpg https://aimfa.es/takeda-triplica-inversion-en-id-en-el-ultimo-lustro-hasta-4-236-millones-de-euros/ 2020-05-20T07:05:06+00:00 https://aimfa.es/wp-content/uploads/takeda-pharmaceutical-co-scaled.jpg https://aimfa.es/la-telefarmacia-beneficia-a-116-000-pacientes-durante-los-primeros-45-dias-de-pandemia/ 2020-05-20T16:52:16+00:00 https://aimfa.es/wp-content/uploads/sefh.png https://aimfa.es/iqvia-el-mercado-crece-29-en-valores-y-un-13-en-unidades-en-el-tam-de-abril/ 2020-05-22T06:57:24+00:00 https://aimfa.es/las-relaciones-con-los-profesionales-sanitarios-y-el-modelo-comercial-es-lo-que-mas-preocupa-a-los-profesionales-de-la-industria/ 2020-05-22T17:25:07+00:00 https://www.aimfa.es/wp-content/uploads/2020/05/graf_iqvia.jpg https://aimfa.es/recomendaciones-ante-el-impacto-de-los-protocolos-de-distanciamiento-social-en-la-realizacion-de-investigaciones/ 2020-05-27T07:00:18+00:00 https://aimfa.es/wp-content/uploads/INSIGHTS_ANALYTICS..jpg https://aimfa.es/astrazeneca-presentara-nuevos-resultados-de-su-extenso-portfolio-en-oncologia/ 2020-05-28T07:11:55+00:00 https://aimfa.es/wp-content/uploads/astrazeneca_top.jpg https://aimfa.es/se-diagnostican-unos-2-000-nuevos-casos-anuales-de-esclerosis-multiple-en-espana/ 2020-05-29T06:50:31+00:00 https://aimfa.es/wp-content/uploads/esclerosis.jpg https://aimfa.es/cesif-entre-las-40-entidades-educativas-mas-innovadoras/ 2020-06-01T09:10:38+00:00 https://aimfa.es/wp-content/uploads/cesif_top.jpg https://aimfa.es/aeaps-y-talento-ephos-firman-un-acuerdo-editorial-de-colaboracion/ 2020-06-02T06:33:06+00:00 https://aimfa.es/wp-content/uploads/logo_aeaps.jpg https://aimfa.es/infonis-lanza-el-modulo-de-visita-medica-virtual/ 2020-06-03T07:10:25+00:00 https://aimfa.es/wp-content/uploads/infonis_top.jpg https://aimfa.es/la-industria-pide-accion-inmediata-a-la-ue-para-abordar-el-acceso-a-tratamientos-y-vacunas/ 2020-06-04T06:48:30+00:00 https://aimfa.es/wp-content/uploads/europa_top.jpg https://aimfa.es/the-lancet-retira-el-controvertido-estudio-de-la-hidroxicloroquina/ 2020-06-05T07:18:10+00:00 https://aimfa.es/wp-content/uploads/hidroxi.jpg https://aimfa.es/encuesta-sobre-rrss-e-industria-farmaceutica/ 2020-06-09T05:16:59+00:00 https://aimfa.es/wp-content/uploads/redes_sociales.jpg https://aimfa.es/pharma-mar-y-tty-firman-un-acuerdo-para-vender-yondelis-en-taiwan-hong-kong-y-macao/ 2020-06-10T08:29:39+00:00 https://aimfa.es/wp-content/uploads/pharmamar_top.jpg https://aimfa.es/el-mercado-farmaceutico-y-el-consumer-health-presentan-crecimientos-positivos-desde-inicio-del-ano/ 2020-06-11T08:05:13+00:00 https://aimfa.es/cesif-lanza-nuevas-formaciones/ 2020-06-12T07:33:25+00:00 https://aimfa.es/wp-content/uploads/cesif_top.jpg https://aimfa.es/la-industria-farmaceutica-lanza-una-serie-de-propuestas-para-la-reconstruccion-economica-y-social/ 2020-06-15T07:15:49+00:00 https://aimfa.es/wp-content/uploads/farmaindustria_top.jpg https://aimfa.es/ignacio-galvez-no-existe-a-dia-de-hoy-una-figura-de-market-access-definida/ 2020-06-17T08:19:00+00:00 https://aimfa.es/wp-content/uploads/marketaccess.jpg https://www.aimfa.es/wp-content/uploads/2020/06/galvez-150x150.png https://aimfa.es/el-sector-biotecnologico-espanol-ha-aumentado-un-13-su-inversion-en-id/ 2020-06-18T06:30:24+00:00 https://aimfa.es/wp-content/uploads/asebio.jpg https://aimfa.es/segun-iqvia-el-mercado-crece-un-18-en-valores-y-un-01-en-unidades-en-el-tam-de-mayo/ 2020-06-19T06:36:23+00:00 https://aimfa.es/gsk-lanza-la-campana-a-farmacias-marcando-distancias/ 2020-06-22T07:14:29+00:00 https://aimfa.es/wp-content/uploads/gsk-1.jpg https://aimfa.es/encarna-cruz-nueva-directora-general-de-biosim/ 2020-06-23T07:18:08+00:00 https://aimfa.es/wp-content/uploads/BioSim.jpg https://www.aimfa.es/wp-content/uploads/2020/06/biosim_encarna_-150x150.png https://aimfa.es/espana-estara-en-el-equipo-negociador-de-la-ue-para-la-compra-de-vacunas-frente-a-la-covid-19/ 2020-06-25T07:24:11+00:00 https://aimfa.es/wp-content/uploads/virus-1.jpg https://aimfa.es/gsk-organiza-la-conferencia-cientifica-interactiva-vaccine-virtual-days/ 2020-06-25T21:57:18+00:00 https://aimfa.es/wp-content/uploads/gsk-1.jpg https://aimfa.es/sanofi-planea-eliminar-1-680-empleos-en-europa/ 2020-06-29T07:14:18+00:00 https://aimfa.es/wp-content/uploads/sanofi_top.jpg https://aimfa.es/social-listening-aplicado-a-estudios-de-mercado/ 2020-10-29T13:34:20+00:00 https://aimfa.es/wp-content/uploads/social_listening.jpg https://aimfa.es/wp-content/uploads/Market-reaserch.gif https://aimfa.es/el-futuro-del-sector-pharma-digital-health/ 2020-11-04T08:19:13+00:00 https://aimfa.es/wp-content/uploads/vodafone.jpg https://aimfa.es/ipsos-nueva-empresa-asociada-a-insightsanalytics-espana/ 2020-11-04T10:33:23+00:00 https://aimfa.es/wp-content/uploads/INSIGHTS_ANALYTICS670x550..jpg https://aimfa.es/wp-content/uploads/ipsos.jpg https://aimfa.es/the-pharmaceutical-industry-a-relationship-at-a-crossroads/ 2020-11-04T18:37:05+00:00 https://aimfa.es/wp-content/uploads/CALIBER.jpg https://aimfa.es/la-agencia-europea-del-medicamento-valida-la-solicitud-de-comercializacion-del-filgotinib-para-el-tratamiento-de-la-colitis-ulcerosa/ 2020-11-06T06:49:44+00:00 https://aimfa.es/wp-content/uploads/galapagos670x550.jpg https://aimfa.es/uno-de-los-retos-de-la-digital-health-es-transformar-las-22-000-farmacias-espanolas/ 2020-11-06T06:51:44+00:00 https://aimfa.es/wp-content/uploads/digitalhealthsalud.jpg https://aimfa.es/cinfa-lanza-bolsas-para-medicamentos-que-se-convierten-en-jabon-al-contacto-con-el-agua/ 2020-11-06T06:52:28+00:00 https://aimfa.es/wp-content/uploads/cinfa_bolsas_670x550.jpg https://aimfa.es/novo-nordisk-anunciante-del-ano-en-los-premios-aspid-2020/ 2020-11-06T06:53:34+00:00 https://aimfa.es/wp-content/uploads/novonordik_670x550.jpg https://aimfa.es/wp-content/uploads/trofeoAspid.jpg https://aimfa.es/nuno-bras-nuevo-director-general-de-leo-pharma-para-iberia/ 2020-11-06T06:54:31+00:00 https://aimfa.es/wp-content/uploads/leopharma_670x550.jpg https://aimfa.es/wp-content/uploads/nunobras.jpg https://aimfa.es/segun-iqvia-el-mercado-crece-un-11-en-valores-y-decrece-un-08-en-unidades-en-el-tam-de-septiembre/ 2020-11-06T06:55:13+00:00 https://aimfa.es/rovi-esta-lista-para-producir-millones-de-unidades-de-la-vacuna-de-moderna-a-principios-de-2021/ 2020-11-06T06:56:17+00:00 https://aimfa.es/wp-content/uploads/rovi_370x295.jpg https://aimfa.es/pharmamar-anuncia-resultados-positivos-de-su-ensayo-aplicov-contra-el-coronavirus/ 2020-11-06T06:57:13+00:00 https://aimfa.es/wp-content/uploads/pharmamar.jpg https://aimfa.es/mas-de-3-000-medicos-utilizan-la-e-receta-en-espana-de-chip-card/ 2020-11-06T06:58:13+00:00 https://aimfa.es/wp-content/uploads/chipcard370x295.jpg https://aimfa.es/la-penetracion-en-el-mercado-ecommerce-supera-el-26-en-el-sector-farma/ 2020-11-06T06:58:41+00:00 https://aimfa.es/wp-content/uploads/redes-370x295-1.jpg https://aimfa.es/la-oms-lanza-una-campana-en-redes-sociales-para-fomentar-la-inversion-en-salud-mental/ 2020-11-06T06:59:17+00:00 https://aimfa.es/wp-content/uploads/move_top.jpg https://aimfa.es/anefp-emite-consejos-para-el-autocuidado-en-los-nuevos-tiempos-2/ 2020-11-06T07:00:17+00:00 https://aimfa.es/wp-content/uploads/img_post.jpg https://aimfa.es/casi-un-centenar-de-pacientes-acceden-a-tratamientos-de-medicina-oncologica-de-precision/ 2020-11-06T07:01:05+00:00 https://aimfa.es/wp-content/uploads/cancer-1.jpg https://aimfa.es/semergen-se-adapta-al-3-0-para-actualizar-las-novedades-de-primaria/ 2020-11-06T07:02:07+00:00 https://aimfa.es/wp-content/uploads/semergen.jpg https://aimfa.es/pharma-mar-pone-en-marcha-una-nueva-unidad-de-virologia/ 2020-11-06T07:02:44+00:00 https://aimfa.es/wp-content/uploads/pharmamar_top.jpg https://aimfa.es/abbott-lanza-en-espana-una-prueba-para-mejorar-la-capacidad-de-realizar-test-del-covid-19/ 2020-11-06T07:03:18+00:00 https://aimfa.es/wp-content/uploads/abbott_top.jpg https://aimfa.es/espana-se-suma-a-la-investigacion-de-la-vacuna-contra-el-coronavirus/ 2020-11-06T07:03:38+00:00 https://aimfa.es/wp-content/uploads/virus-1.jpg https://aimfa.es/sanidad-anuncia-que-esta-desarrollando-una-estrategia-de-salud-digital-del-sns/ 2020-11-06T07:04:06+00:00 https://aimfa.es/wp-content/uploads/logo_ministerio.jpg https://aimfa.es/los-casos-de-coronavirus-rozan-los-26-millones-y-se-alcanzan-las-860-000-muertes-a-nivel-mundial/ 2020-11-06T07:05:05+00:00 https://aimfa.es/wp-content/uploads/virus-1.jpg https://aimfa.es/el-gasto-en-farmaceutico-publico-se-estabiliza-en-un-crecimiento-del-3/ 2020-11-06T07:05:34+00:00 https://aimfa.es/wp-content/uploads/dinero_gasto.jpg https://aimfa.es/la-fda-aprueba-un-test-de-biopsia-liquida-para-tumores-solidos-de-roche/ 2020-11-06T07:06:07+00:00 https://aimfa.es/wp-content/uploads/roche_top.jpg https://aimfa.es/janssen-elige-a-espana-para-el-ensayo-de-fase-ii-con-su-vacuna-para-covid-19/ 2020-11-06T07:06:42+00:00 https://aimfa.es/wp-content/uploads/Janssen-1.jpg https://aimfa.es/segun-iqvia-el-mercado-crece-14-en-valores-aunque-decrece-05-en-unidades-en-el-tam-de-julio/ 2020-11-06T07:07:11+00:00 https://aimfa.es/un-estudio-demuestra-que-las-personas-con-diabetes-valoran-como-un-valor-anadido-las-tic/ 2020-11-06T07:07:52+00:00 https://aimfa.es/wp-content/uploads/movil.jpg https://aimfa.es/el-boe-publica-el-contrato-con-indra-para-la-app-de-rastreo-del-covid-19/ 2020-11-06T07:08:27+00:00 https://aimfa.es/wp-content/uploads/virus-1.jpg https://aimfa.es/la-fda-aprueba-ofatumumab-de-novartis-para-pacientes-con-esclerosis-multiple-recurrente/ 2020-11-06T07:08:49+00:00 https://aimfa.es/wp-content/uploads/novartis-2.jpg https://aimfa.es/el-gobierno-crea-la-secretaria-general-de-salud-digital/ 2020-11-06T07:09:10+00:00 https://aimfa.es/wp-content/uploads/digitalizacion.jpg https://aimfa.es/la-fda-designa-el-pevonedistat-de-takeda-como-gran-avance-terapeutico/ 2020-11-06T07:10:15+00:00 https://aimfa.es/wp-content/uploads/takeda-pharmaceutical-co-scaled.jpg https://aimfa.es/la-ue-aprueba-rozlytrek-terapia-con-indicacion-de-tumor-agnostica-de-roche/ 2020-11-06T07:10:47+00:00 https://aimfa.es/wp-content/uploads/roche_top.jpg https://aimfa.es/astrazeneca-fomenta-el-ejercicio-en-personas-con-cancer-de-pulmon/ 2020-11-06T07:11:10+00:00 https://aimfa.es/wp-content/uploads/astrazeneca_top.jpg https://aimfa.es/la-revista-el-publicista-publica-una-amplia-guia-de-masters-y-cursos-postgrado-2020-21/ 2020-11-06T07:11:39+00:00 https://aimfa.es/wp-content/uploads/formacion.png https://aimfa.es/anefp-emite-consejos-para-el-autocuidado-en-los-nuevos-tiempos/ 2020-11-06T07:13:48+00:00 https://aimfa.es/wp-content/uploads/anefp.jpg https://aimfa.es/la-agencia-europea-del-medicamento-da-luz-verde-al-filgotinib/ 2020-11-06T07:14:30+00:00 https://aimfa.es/wp-content/uploads/galapagos-1.png https://aimfa.es/una-veintena-de-asociaciones-exigen-que-el-presupuesto-sanitario-publico-crezca-en-47-000-millones-de-euros/ 2020-11-06T07:14:53+00:00 https://aimfa.es/wp-content/uploads/dinero_gasto.jpg https://aimfa.es/segun-iqvia-el-mercado-crece-un-19-en-valores-y-un-01-en-unidades-en-el-tam-de-junio/ 2020-11-06T07:15:26+00:00 https://aimfa.es/las-asociaciones-cientificas-exigen-la-financiacion-para-la-formacion-medica-continuada/ 2020-11-06T07:16:07+00:00 https://aimfa.es/wp-content/uploads/facme.jpg https://aimfa.es/fidia-se-introduce-en-la-oftalmologia-tras-la-compra-de-la-gama-cusi-de-novartis/ 2020-11-06T07:16:42+00:00 https://aimfa.es/wp-content/uploads/fidia_top.jpg https://aimfa.es/astrazeneca-se-asocia-con-iqvia-para-acelerar-los-estudios-de-su-candidato-a-la-vacuna-covid-19/ 2020-11-06T07:17:26+00:00 https://aimfa.es/wp-content/uploads/astrazeneca_top.jpg https://aimfa.es/mil-millones-de-dolares-contra-las-resistencias-antimicrobianas/ 2020-11-06T07:17:48+00:00 https://aimfa.es/wp-content/uploads/farmaindustria_top.jpg https://aimfa.es/la-fda-da-luz-verde-a-la-solicitud-de-licencia-del-tralokinumab-de-leo/ 2020-11-06T07:18:28+00:00 https://aimfa.es/wp-content/uploads/logo-leo.jpg https://aimfa.es/acuerdo-de-fabricacion-entre-rovi-y-moderna/ 2020-11-06T07:18:53+00:00 https://aimfa.es/wp-content/uploads/rovi_top-1.jpg https://aimfa.es/salvat-internacionaliza-la-cristalmina/ 2020-11-06T07:19:33+00:00 https://aimfa.es/wp-content/uploads/salvat_top.jpg https://aimfa.es/las-agencias-de-medicamentos-de-la-ue-elaboran-una-estrategia-comun-hasta-2025/ 2020-11-06T07:20:01+00:00 https://aimfa.es/wp-content/uploads/EMA_europa.jpg https://aimfa.es/un-10-de-trabajadores-europeos-ha-sufrido-una-depresion-en-algun-momento-de-su-vida/ 2020-11-06T07:20:21+00:00 https://aimfa.es/wp-content/uploads/EMA_europa.jpg https://aimfa.es/pharma-mar-se-dispara-un-151-en-bolsa-tras-anunciar-la-efectividad-de-su-farmaco-contra-el-covid-19/ 2020-11-06T07:20:45+00:00 https://aimfa.es/wp-content/uploads/pharmamar_top.jpg https://aimfa.es/gilead-garantiza-que-puede-cubrir-en-espana-la-situacion-actual-y-brotes-hasta-otono/ 2020-11-06T07:21:17+00:00 https://aimfa.es/wp-content/uploads/gilead_top.jpg https://aimfa.es/la-comision-europea-preve-tener-el-plan-de-cancer-en-septiembre/ 2020-11-06T07:21:40+00:00 https://aimfa.es/wp-content/uploads/cancer.jpg https://aimfa.es/el-50-de-las-grandes-empresas-considera-urgente-promover-la-rsc-tras-la-covid-19/ 2020-11-06T07:22:12+00:00 https://aimfa.es/wp-content/uploads/virus-1.jpg https://aimfa.es/la-industria-destino-483-millones-en-2019-a-actividades-de-investigacion-y-formacion/ 2020-11-06T07:22:37+00:00 https://aimfa.es/wp-content/uploads/farmaindustria_top.jpg https://aimfa.es/disney-y-novartis-colaboran-en-un-proyecto-de-humanizacion-de-la-atencion-sanitaria-para-ninos-con-cancer/ 2020-11-09T08:34:34+00:00 https://aimfa.es/wp-content/uploads/disney_670x550.jpg https://aimfa.es/asebio-renueva-su-web-de-pipelines-que-agrupa-mas-de-1-300-productos-de-desarrollo/ 2020-11-11T05:55:09+00:00 https://aimfa.es/wp-content/uploads/asebio_670x550.jpg https://aimfa.es/la-industria-de-la-investigacion-de-mercados-mundial-cierra-2019-en-positivo/ 2020-11-11T17:16:40+00:00 https://aimfa.es/wp-content/uploads/INSIGHTS_ANALYTICS670x550..jpg https://aimfa.es/esteve-preve-realizar-adquisiciones-para-ampliar-su-presencia-en-europa/ 2020-11-16T06:44:25+00:00 https://aimfa.es/wp-content/uploads/esteve_670x550.jpg https://aimfa.es/amazon-abre-su-farmacia-online-en-ee-uu-y-pone-en-jaque-a-las-grandes-cadenas-de-farmacias-del-pais/ 2020-11-18T07:04:49+00:00 https://aimfa.es/wp-content/uploads/amazon_pharmacy_6.jpg https://aimfa.es/segun-iqvia-el-mercado-crece-un-07-en-valores-y-un-13-en-unidades-en-el-tam-de-octubre/ 2020-11-20T18:52:58+00:00 https://aimfa.es/wp-content/uploads/mercado_670x550.jpg https://aimfa.es/463-millones-de-personas-viven-con-diabetes-en-el-mundo-cifra-que-va-en-aumento/ 2020-11-21T17:53:08+00:00 https://aimfa.es/wp-content/uploads/diabetes-2.jpg https://aimfa.es/wp-content/uploads/diabetes.jpeg https://aimfa.es/el-consumo-de-antibioticos-decrece-en-espana-hasta-niveles-de-2014/ 2020-11-21T23:44:43+00:00 https://aimfa.es/wp-content/uploads/medicamentos_670x550.jpg https://aimfa.es/doctoralia-y-la-semg-firman-un-convenio-para-potenciar-la-asistencia-sanitaria-digital/ 2020-11-23T07:58:42+00:00 https://aimfa.es/wp-content/uploads/salud_digital_670x550.jpg https://aimfa.es/pharma-mar-lanza-un-test-para-diferenciar-entre-gripe-y-covid-19/ 2020-11-30T13:12:55+00:00 https://aimfa.es/wp-content/uploads/scientist-working-on-sars-cov-2-coronavirus-covid-MT3NH78-1-scaled.jpg https://aimfa.es/acoif-renueva-su-imagen-corporativa-y-su-web/ 2020-12-01T09:04:43+00:00 https://aimfa.es/wp-content/uploads/acoif_413x343.jpg https://aimfa.es/viatris-se-culmina-el-lanzamiento-de-la-nueva-compania/ 2020-12-01T09:05:33+00:00 https://aimfa.es/wp-content/uploads/people-holding-on-to-each-other-P8U9R4Q-1-scaled.jpg https://aimfa.es/cegedim-health-data-amplia-su-base-de-datos-europea-thin-con-el-lanzamiento-de-los-datos-de-la-vida-real-espanoles/ 2020-12-01T16:48:44+00:00 https://aimfa.es/wp-content/uploads/data-in-computer-J4X8EZL-scaled.jpg https://aimfa.es/cesif-lanza-el-master-online-en-gestion-de-clinicas-medicas-y-consultas-privadas/ 2020-12-03T18:45:42+00:00 https://aimfa.es/wp-content/uploads/medicos_670x550.jpg https://aimfa.es/segun-iqvia-la-aplicacion-de-la-opr-snd-1121-2020-supondra-un-impacto-de-34me-sobre-el-mercado-actual/ 2020-12-03T19:12:05+00:00 https://aimfa.es/wp-content/uploads/mercado_670x550.jpg https://aimfa.es/en-aimfa-estrenamos-nueva-imagen-corporativa/ 2020-12-05T12:42:29+00:00 https://aimfa.es/wp-content/uploads/aimfa_670x550.jpg https://aimfa.es/en-que-paises-se-esta-manejando-la-pandemia-de-manera-mas-efectiva/ 2020-12-09T08:21:49+00:00 https://aimfa.es/wp-content/uploads/mundo_670x550.jpg https://aimfa.es/wp-content/uploads/ilustr.jpg https://aimfa.es/galapagos-aumenta-el-capital-social-mediante-el-ejercicio-del-derecho-de-suscripcion/ 2020-12-11T00:33:50+00:00 https://aimfa.es/wp-content/uploads/galapagos_670x550.jpg https://aimfa.es/amazon-lanza-un-servicio-para-almacenar-los-datos-de-las-companias-de-la-salud/ 2020-12-14T08:35:32+00:00 https://aimfa.es/wp-content/uploads/amazon-670x550-1.jpg https://aimfa.es/almirall-selecciona-a-seis-start-ups-de-salud-digital-para-su-programa-de-aceleracion-digital-garden/ 2020-12-15T08:16:18+00:00 https://aimfa.es/wp-content/uploads/medicos_670.jpg https://aimfa.es/espana-cuarta-economia-europea-pero-decima-en-gasto-sanitario/ 2020-12-17T07:32:00+00:00 https://aimfa.es/wp-content/uploads/euro_670.jpg https://aimfa.es/rompiendo-las-barreras-contra-la-vacuna-covid-19/ 2020-12-17T12:56:52+00:00 https://aimfa.es/wp-content/uploads/jeringuilla_670x550.jpg https://aimfa.es/reig-jofre-producira-en-espana-la-vacuna-de-janssen-para-el-covid-19/ 2020-12-18T06:47:32+00:00 https://aimfa.es/wp-content/uploads/laboratorio_670.jpg https://aimfa.es/fenin-propone-una-hoja-de-ruta-para-impulsar-el-sector-tras-la-pandemia/ 2020-12-21T07:01:00+00:00 https://aimfa.es/wp-content/uploads/fenin_670.jpg https://aimfa.es/segun-iqvia-el-mercado-crece-un-01-en-valores-y-decrece-20-en-unidades-en-el-tam-de-noviembre/ 2020-12-22T08:57:54+00:00 https://aimfa.es/wp-content/uploads/mercado_670x550.jpg https://aimfa.es/acuerdo-de-copromocion-entre-novo-nordisk-y-upjohn-pfizer-con-saxenda/ 2020-12-22T10:52:35+00:00 https://aimfa.es/wp-content/uploads/pfizer_top.jpg https://aimfa.es/gran-exito-de-asistentes-en-el-36o-seminario-aedemo-tv/ 2020-12-22T10:52:43+00:00 https://aimfa.es/wp-content/uploads/INSIGHTS_ANALYTICS..jpg https://aimfa.es/fenin-estrena-una-nueva-imagen-internacional/ 2020-12-22T10:52:51+00:00 https://aimfa.es/wp-content/uploads/FENIN_INTERNAC_TOP.jpg https://aimfa.es/nuevo-timo-whastapp-traves-sms-no-caigas/ 2020-12-22T10:52:59+00:00 https://aimfa.es/wp-content/uploads/whatsapp.jpg https://www.aimfa.es/wp-content/uploads/2019/09/WhatsaApp-1024x665.jpg https://aimfa.es/havas-health-you-nombra-nuevo-ceo-espana/ 2020-12-22T10:54:13+00:00 https://aimfa.es/wp-content/uploads/IMG_4880.jpeg https://www.aimfa.es/wp-content/uploads/2019/03/IMG_4880.jpeg https://aimfa.es/carlos-guedes-nuevo-head-of-business-development-glintt-espana/ 2020-12-22T10:54:21+00:00 https://aimfa.es/wp-content/uploads/carlos_guedes_top.jpg https://www.aimfa.es/wp-content/uploads/2018/09/carlos_guedes.jpg https://aimfa.es/jesus-fernandez-pacheco-nombrado-country-manager-hmr-espana/ 2020-12-22T10:54:29+00:00 https://aimfa.es/wp-content/uploads/logo_hmr.jpg https://www.aimfa.es/wp-content/uploads/2018/02/fernandezpacheco.jpg https://aimfa.es/menarini-joventut-se-alian-impulsar-deporte-adaptado/ 2020-12-22T10:54:35+00:00 https://aimfa.es/wp-content/uploads/joventud-top.jpg https://www.aimfa.es/wp-content/uploads/2018/01/menarini-y-el-joventud.jpg https://aimfa.es/laboratorios-vilardell-lanza-el-menu-de-guardia/ 2020-12-24T08:23:52+00:00 https://aimfa.es/wp-content/uploads/vilardell.jpg https://aimfa.es/insights-analytics-convoca-los-premios-2021/ 2021-01-04T07:54:00+00:00 https://aimfa.es/wp-content/uploads/insights_670.jpg https://aimfa.es/angelini-pharma-compra-la-suiza-arvelle-therapeutics/ 2021-01-05T08:02:00+00:00 https://aimfa.es/wp-content/uploads/fusiones_670.jpg https://aimfa.es/selvita-completa-la-adquisicion-de-fidelta-de-galapagos/ 2021-01-07T08:07:00+00:00 https://aimfa.es/wp-content/uploads/galapagos_670x550.jpg https://aimfa.es/andalucia-pone-fin-a-las-subastas-de-medicamentos/ 2021-01-08T08:45:49+00:00 https://aimfa.es/wp-content/uploads/dinero_670-1.jpg https://aimfa.es/siegfried-concluye-la-adquisicion-de-2-plantas-de-novartis-en-espana/ 2021-01-11T08:10:00+00:00 https://aimfa.es/wp-content/uploads/sigfried_670.jpg https://aimfa.es/boehringer-ingelheim-adquiere-la-compania-biotecnologica-nbe-therapeutics/ 2021-01-12T07:59:00+00:00 https://aimfa.es/wp-content/uploads/boehringer_670.jpg https://aimfa.es/cuantas-personas-se-han-vacunado-ya-contra-el-coronavirus/ 2021-01-13T08:26:23+00:00 https://aimfa.es/wp-content/uploads/vacunas_670.jpg https://aimfa.es/wp-content/uploads/graf_statista.jpg https://aimfa.es/pfizer-y-biontech-aumentan-a-2-000-millones-la-prevision-de-produccion-de-vacunas-en-2021/ 2021-01-14T08:18:34+00:00 https://aimfa.es/wp-content/uploads/vacunas_670-1.jpg https://aimfa.es/la-e-consulta-reduce-un-21-las-listas-de-espera-en-cardiologia/ 2021-01-18T08:07:00+00:00 https://aimfa.es/wp-content/uploads/cardio_670.jpg https://aimfa.es/nace-activa-una-nueva-plataforma-de-formacion-en-salud/ 2021-01-17T22:57:09+00:00 https://aimfa.es/wp-content/uploads/logo_activa_670.jpg https://aimfa.es/novartis-amplia-su-cartera-de-oncologia-con-la-licencia-de-tislelizumab-de-beigene/ 2021-01-19T08:10:38+00:00 https://aimfa.es/wp-content/uploads/novartis_670.jpg https://aimfa.es/bruselas-intensificara-su-lucha-contra-las-mascarillas-fraudulentas/ 2021-01-20T07:44:50+00:00 https://aimfa.es/wp-content/uploads/mascarilla_670.jpg https://aimfa.es/2021-el-ano-de-compromiso-en-programas-para-pacientes-a-largo-plazo/ 2021-01-21T07:40:54+00:00 https://aimfa.es/wp-content/uploads/pacientes_670.jpg https://aimfa.es/boehinger-ingelheim-anuncia-un-acuerdo-con-google-para-favorecer-la-investigacion/ 2021-01-22T09:00:48+00:00 https://aimfa.es/wp-content/uploads/boehringer_670-1.jpg https://aimfa.es/activa-convoca-el-programa-en-marketing-de-contenidos-en-salud/ 2021-01-25T07:53:00+00:00 https://aimfa.es/wp-content/uploads/streaming_670.jpg https://aimfa.es/la-presion-hospitalaria-por-covid-19-una-comparacion-entre-paises/ 2021-01-26T09:25:06+00:00 https://aimfa.es/wp-content/uploads/hospital_670.jpg https://aimfa.es/wp-content/uploads/graf_presion.jpg https://aimfa.es/el-gasto-farmaceutico-cierra-2020-en-11-077-millones-y-llega-a-cifras-de-2011/ 2021-01-27T07:52:51+00:00 https://aimfa.es/wp-content/uploads/dinero_670-1.jpg https://aimfa.es/fenin-se-adhiere-al-pacto-por-la-ciencia-y-la-innovacion-impulsado-por-el-gobierno/ 2021-01-28T09:25:44+00:00 https://aimfa.es/wp-content/uploads/fenin_670.jpg https://aimfa.es/bruselas-no-admitira-el-nuevo-plan-de-entrega-de-vacunas-que-plantea-az/ 2021-01-29T06:06:47+00:00 https://aimfa.es/wp-content/uploads/vacunas_670-1.jpg https://aimfa.es/activa-convoca-el-programa-en-optimizacion-de-email-marketing-en-salud/ 2021-02-01T08:10:00+00:00 https://aimfa.es/wp-content/uploads/informatica_670.jpg https://aimfa.es/almirall-se-alia-con-happify-health-para-desarrollar-soluciones-terapeuticas-digitales/ 2021-02-03T07:56:29+00:00 https://aimfa.es/wp-content/uploads/almirall_670.jpg https://aimfa.es/la-aceleradora-de-startups-de-telefonica-y-ge-healthcare-apoyaran-a-empresas-emergentes-en-ia-sanitaria/ 2021-02-04T11:40:09+00:00 https://aimfa.es/wp-content/uploads/inteligencia_artificial-670.jpg https://aimfa.es/vlmyrx-integra-a-ogilvy-health-en-su-marca/ 2021-02-05T08:21:12+00:00 https://aimfa.es/wp-content/uploads/vmr.jpg https://aimfa.es/roche-lanzara-la-prueba-rapida-de-antigeno-nasal-que-permite-que-el-paciente-recoja-su-propia-muestra/ 2021-02-08T08:00:00+00:00 https://aimfa.es/wp-content/uploads/diagnostico.jpg https://aimfa.es/ranking-de-las-webs-mas-visitadas-del-mundo/ 2021-02-09T06:49:02+00:00 https://aimfa.es/wp-content/uploads/google_670.jpg https://aimfa.es/la-industria-firma-contratos-de-vacunas-para-10-300-millones-de-dosis/ 2021-02-10T08:27:56+00:00 https://aimfa.es/wp-content/uploads/vacunas-2.jpg https://aimfa.es/las-farmaceuticas-las-grandes-beneficiadas-de-la-pandemia/ 2021-02-12T06:49:13+00:00 https://aimfa.es/wp-content/uploads/vacuna_670.jpg https://aimfa.es/mujeres-en-la-ciencia-la-industria-farmaceutica-un-sector-adelantado-en-espana/ 2021-02-12T07:05:26+00:00 https://aimfa.es/wp-content/uploads/mujeresporlaciencia_670.jpg https://aimfa.es/barcelona-health-hub-es-reconocida-como-una-de-las-principales-organizaciones-de-salud-digital/ 2021-02-15T08:10:00+00:00 https://aimfa.es/wp-content/uploads/santpau.jpg https://aimfa.es/biosim-recoge-cada-mes-los-5-articulos-mas-relevantes-sobre-biosimialres/ 2021-02-17T07:47:00+00:00 https://aimfa.es/wp-content/uploads/biosim_670.jpg https://aimfa.es/sobi-lanza-acerca-las-enfermedades-raras-un-centro-de-referencia-para-pacientes-con-patologias-poco-frecuentes/ 2021-02-18T06:34:48+00:00 https://aimfa.es/wp-content/uploads/adn_670.jpg https://aimfa.es/lanzamiento-de-remiren-una-nueva-oportunidad-para-la-retina/ 2021-02-19T08:35:21+00:00 https://aimfa.es/wp-content/uploads/remiren.jpg https://aimfa.es/2020-el-ano-de-las-videollamadas/ 2021-02-22T08:30:45+00:00 https://aimfa.es/wp-content/uploads/videollamada_670.jpg https://aimfa.es/wp-content/uploads/grafstatista.jpg https://aimfa.es/abbvie-y-caribou-biosciences-anuncian-un-acuerdo-para-el-desarrollo-de-medicamentos-car-t/ 2021-02-23T07:35:53+00:00 https://aimfa.es/wp-content/uploads/abbvie_670.jpg https://aimfa.es/astrazeneca-retirara-la-indicacion-de-imfinzi-en-ee-uu-para-el-cancer-de-vejiga-avanzado/ 2021-02-24T07:31:24+00:00 https://aimfa.es/wp-content/uploads/astrazeneca_670.jpg https://aimfa.es/la-ema-situa-rybelsus-novo-nordisk-entre-los-avances-destacados-de-2020/ 2021-02-25T07:29:58+00:00 https://aimfa.es/wp-content/uploads/novonordisk_670.jpg https://aimfa.es/iqvia-analiza-las-lecciones-de-la-covid-19-y-los-aprendizajes-de-futuro/ 2021-02-26T07:50:24+00:00 https://aimfa.es/wp-content/uploads/iqvia_fernandez_670.jpg https://aimfa.es/la-falta-de-inversion-principal-causa-de-la-caida-de-eficiencia-del-sns/ 2021-03-01T08:08:00+00:00 https://aimfa.es/wp-content/uploads/sns_670.jpg https://aimfa.es/faes-farma-supera-por-primera-vez-los-70-millones-de-beneficio-consolidado/ 2021-03-02T08:55:39+00:00 https://aimfa.es/wp-content/uploads/faes_670.jpg https://aimfa.es/logista-pharma-crea-un-servicio-para-mejorar-el-seguimiento-de-la-distribucion-de-vacunas-del-covid-19/ 2021-03-03T08:47:43+00:00 https://aimfa.es/wp-content/uploads/vacunas_670-2.jpg https://aimfa.es/alexion-lanza-la-campana-3millonesyanoesraro-para-una-mayor-visibilidad-e-investigacion-en-enfermedades-raras/ 2021-03-04T07:59:05+00:00 https://aimfa.es/wp-content/uploads/alexion.jpg https://aimfa.es/10-medidas-clave-para-acelerar-la-optima-digitalizacion-del-sistema-sanitario-espanol/ 2021-03-05T11:05:17+00:00 https://aimfa.es/wp-content/uploads/digital_670.jpg https://aimfa.es/el-cgcom-se-adhiere-al-manifiesto-dondeestanellas-para-aumentar-la-presencia-de-medicas-en-ambitos-formativos-y-de-comunicacion/ 2021-03-08T08:15:00+00:00 https://aimfa.es/wp-content/uploads/Foto-firma-manifiesto.jpg https://aimfa.es/la-plataforma-de-formacion-activa-ofrece-formacion-bonificada/ 2021-03-09T08:10:00+00:00 https://aimfa.es/wp-content/uploads/logo_activa_670.jpg https://aimfa.es/faes-farma-adquiere-global-farma/ 2021-03-10T07:34:42+00:00 https://aimfa.es/wp-content/uploads/faes_670.jpg https://aimfa.es/rusia-afirma-que-fabricara-su-vacuna-sputnik-v-en-espana/ 2021-03-11T08:04:21+00:00 https://aimfa.es/wp-content/uploads/sputnik_vaccine.jpg https://aimfa.es/saludsinbulos-y-noysi-se-juntan-para-comunicarse-con-mas-de-50-sociedades-cientificas/ 2021-03-16T08:10:00+00:00 https://aimfa.es/wp-content/uploads/ordenadores.jpg https://aimfa.es/8-de-cada-10-pacientes-con-glaucoma-no-muestran-sintomas/ 2021-03-17T08:02:00+00:00 https://aimfa.es/wp-content/uploads/glaucoma.jpg https://aimfa.es/el-mercado-crece-en-el-tam-de-febrero-un-30-en-valores-y-un-113-en-unidades/ 2021-03-15T07:05:03+00:00 https://aimfa.es/wp-content/uploads/mercado_670x550.jpg https://aimfa.es/el-programa-europa-digital-recibe-la-luz-verde-del-consejo/ 2021-03-18T06:31:36+00:00 https://aimfa.es/wp-content/uploads/digital_670-2.jpg https://aimfa.es/santen-presenta-puralidtm-lipogel-en-espana/ 2021-03-19T08:32:00+00:00 https://aimfa.es/wp-content/uploads/puralid.jpg https://aimfa.es/licencia-para-crecer-en-el-mercado-farmaceutico-sin-patente/ 2021-03-22T12:41:12+00:00 https://aimfa.es/wp-content/uploads/genericos-1.jpg https://aimfa.es/barcelona-se-perfila-como-el-hub-europeo-de-referencia-en-digital-health/ 2021-03-23T08:28:33+00:00 https://aimfa.es/wp-content/uploads/santpau.jpg https://aimfa.es/el-consumo-de-medicamentos-en-los-hospitales-publicos-aumenta-un-5-en-el-ano-del-covid-19/ 2021-03-24T08:01:00+00:00 https://aimfa.es/wp-content/uploads/medicamentos_670x550.jpg https://aimfa.es/las-alianzas-a-nivel-mundial-y-la-inversion-en-id-propulsan-a-boehringer-ingelheim/ 2021-03-25T08:59:13+00:00 https://aimfa.es/wp-content/uploads/boehringer-2.jpg https://aimfa.es/un-94-de-los-espanoles-ha-sufrido-dolor-ocasional-en-los-ultimos-6-meses/ 2021-03-26T07:49:00+00:00 https://aimfa.es/wp-content/uploads/dolor-1.jpg https://aimfa.es/galapagos-nombra-a-bart-filius-como-presidente-y-ceo/ 2021-03-29T07:03:00+00:00 https://aimfa.es/wp-content/uploads/bart.jpg https://aimfa.es/radio-salil-y-sportsalil-saltan-a-las-redes-sociales-y-al-contenido-online/ 2021-03-30T06:49:00+00:00 https://aimfa.es/wp-content/uploads/salud-1.jpg https://aimfa.es/brill-pharma-lanza-hylo-intense/ 2021-03-31T10:10:28+00:00 https://aimfa.es/wp-content/uploads/hylo.jpg https://aimfa.es/msd-adquiere-a-traves-de-organon-alydia-health-por-240-millones-de-dolares/ 2021-04-05T06:47:50+00:00 https://aimfa.es/wp-content/uploads/msd_670.jpg https://aimfa.es/gasto-por-covid-19-2-610-millones-y-un-38-de-la-inversion-en-ppss/ 2021-04-06T07:28:51+00:00 https://aimfa.es/wp-content/uploads/virus_670.jpg https://aimfa.es/el-sector-de-la-salud-en-espana-pierde-mas-de-2-000-empleos-en-marzo/ 2021-04-07T06:25:43+00:00 https://aimfa.es/wp-content/uploads/medicos_670.jpg https://aimfa.es/la-comision-europea-destina-123-millones-a-la-investigacion-de-las-nuevas-variantes-del-covid-19/ 2021-04-08T08:24:22+00:00 https://aimfa.es/wp-content/uploads/scientist-working-on-sars-cov-2-coronavirus-covid-MT3NH78-1-scaled.jpg https://aimfa.es/la-telemedicina-y-la-inteligencia-artificial-se-abren-paso-en-las-consultas-de-reumatologia/ 2021-04-09T09:27:06+00:00 https://aimfa.es/wp-content/uploads/adn_670.jpg https://aimfa.es/5-habilidades-necesarias-para-los-lideres-que-se-enfrentan-a-la-nueva-normalidad/ 2021-04-12T11:40:19+00:00 https://aimfa.es/wp-content/uploads/lider.jpg https://aimfa.es/bruselas-negocia-la-compra-de-2-000-millones-de-vacunas-contra-las-nuevas-variantes/ 2021-04-13T07:52:37+00:00 https://aimfa.es/wp-content/uploads/europ_670.jpg https://aimfa.es/la-inteligencia-artificial-ayuda-a-predecir-la-evolucion-de-los-pacientes-con-covid-19/ 2021-04-14T11:21:48+00:00 https://aimfa.es/wp-content/uploads/inteligencia_artificial-670.jpg https://aimfa.es/anefp-renueva-su-consejo-directivo/ 2021-04-15T08:42:24+00:00 https://aimfa.es/wp-content/uploads/albertbueno.jpg https://aimfa.es/mosiri-cabezas-nueva-directora-de-estrategia-digital-para-espana-de-astrazeneca/ 2021-04-16T08:09:54+00:00 https://aimfa.es/wp-content/uploads/mosiri.jpg https://aimfa.es/el-plan-de-recuperacion-dedicara-solo-el-15-de-sus-fondos-a-reforzar-la-sanidad/ 2021-04-19T07:37:28+00:00 https://aimfa.es/wp-content/uploads/Ministerio.jpg https://aimfa.es/el-mercado-decrece-en-valores-un-33-y-en-unidades-un-08-en-el-acumulado-a-marzo/ 2021-04-20T07:15:00+00:00 https://aimfa.es/wp-content/uploads/mercado_670x550.jpg https://aimfa.es/sanofi-potencia-su-negocio-de-consumer-healthcare-en-espana-con-una-nueva-sociedad/ 2021-04-21T07:21:33+00:00 https://aimfa.es/wp-content/uploads/opella.jpg https://aimfa.es/un-informe-plantea-la-necesidad-de-invertir-en-ia-para-mejorar-los-sistemas-sanitarios-en-europa/ 2021-04-22T11:48:33+00:00 https://aimfa.es/wp-content/uploads/digital_670-2.jpg https://aimfa.es/cinco-hospitales-espanoles-estudian-la-seguridad-de-combinar-otras-vacunas-con-la-de-astrazeneca/ 2021-04-23T08:35:51+00:00 https://aimfa.es/wp-content/uploads/vacuna_670.jpg https://aimfa.es/cuando-volveremos-a-la-normalidad/ 2021-04-26T07:15:00+00:00 https://aimfa.es/wp-content/uploads/ambientes_csd.jpg https://aimfa.es/wp-content/uploads/graf-normalidad.jpeg https://aimfa.es/medtronic-lanza-su-portal-de-formacion-digital-para-profesionales-sanitarios/ 2021-04-27T06:48:00+00:00 https://aimfa.es/wp-content/uploads/medtronic.jpg https://aimfa.es/la-comision-europea-demanda-a-astrazeneca-por-sus-incumplimientos-en-la-entrega-de-vacunas/ 2021-04-28T07:10:00+00:00 https://aimfa.es/wp-content/uploads/europ_670.jpg https://aimfa.es/activa-convoca-el-programa-en-gestion-de-social-media-en-salud/ 2021-04-29T07:10:00+00:00 https://aimfa.es/wp-content/uploads/logo_activa_670.jpg https://aimfa.es/aspe-y-fenin-reclaman-el-iva-superreducido-del-4-para-los-productos-sanitarios/ 2021-04-30T09:00:32+00:00 https://aimfa.es/wp-content/uploads/autocuidado.jpg https://aimfa.es/la-fundacion-merck-salud-ofrece-una-serie-de-claves-que-marcaran-2021-para-el-sector-sanitario/ 2021-05-03T07:49:34+00:00 https://aimfa.es/wp-content/uploads/digital-5.jpg https://aimfa.es/sanidad-permitira-la-venta-al-publico-de-test-de-autodiagnostico-de-covid-19/ 2021-05-04T15:19:28+00:00 https://aimfa.es/wp-content/uploads/covid_r2i.jpg https://aimfa.es/los-usuarios-con-mas-de-600-seguidores-ya-pueden-crear-espacios-de-twitter-asi-son-sus-salas-de-audio/ 2021-05-05T08:30:48+00:00 https://aimfa.es/wp-content/uploads/twitter_HQ.jpg https://aimfa.es/disenan-una-prueba-para-distinguir-con-precision-entre-infecciones-virales-y-bacterianas/ 2021-05-06T11:16:17+00:00 https://aimfa.es/wp-content/uploads/vacuna_670.jpg https://aimfa.es/farmaindustria-considera-erroneo-la-exencion-de-patentes-que-protegen-las-vacunas-contra-el-covid-19/ 2021-05-07T06:21:56+00:00 https://aimfa.es/wp-content/uploads/vacunas_670-2.jpg https://aimfa.es/almirall-propone-a-ruud-dobber-astrazeneca-como-miembro-del-consejo-de-administracion/ 2021-05-10T09:37:25+00:00 https://aimfa.es/wp-content/uploads/ruud.jpg https://aimfa.es/lilly-dona-terapias-covid-19-para-su-uso-en-paises-de-ingresos-bajos/ 2021-05-11T07:36:21+00:00 https://aimfa.es/wp-content/uploads/lilly-1.jpg https://aimfa.es/cinfa-distribuira-el-primer-test-de-antigenos-covid-19-sin-receta/ 2021-05-12T08:16:16+00:00 https://aimfa.es/wp-content/uploads/TEst.jpg https://aimfa.es/alberto-bueno-reelegido-presidente-de-anefp/ 2021-05-13T07:01:39+00:00 https://aimfa.es/wp-content/uploads/alberto_bueno.jpg https://aimfa.es/doctaforum-se-incorpora-a-aeaps/ 2021-05-17T06:43:45+00:00 https://aimfa.es/wp-content/uploads/doctaFORUM.jpg https://aimfa.es/14176-2/ 2021-05-18T06:38:04+00:00 https://aimfa.es/wp-content/uploads/KP_670I.jpg https://aimfa.es/gfk-confirmado-como-medidor-recomendado-para-la-medicion-digital-en-espana/ 2021-05-19T06:38:25+00:00 https://aimfa.es/wp-content/uploads/mediciondigital.jpg https://aimfa.es/la-aemps-aprobo-en-2020-la-puesta-en-marcha-de-mas-de-mil-ensayos/ 2021-05-20T07:28:41+00:00 https://aimfa.es/wp-content/uploads/vacunas_670.jpg https://aimfa.es/primeum-espana-convoca-su-sondeo-farma-de-fuerza-de-ventas/ 2021-05-25T07:03:00+00:00 https://aimfa.es/wp-content/uploads/visitador-medico.jpg https://aimfa.es/galapagos-anuncia-el-ingreso-del-primer-paciente-en-el-estudio-filosophy-para-avanzar-en-la-comprension-de-la-eficacia-y-seguridad-de-jyseleca-filgotinib-en-un-entorno-real/ 2021-05-24T07:40:02+00:00 https://aimfa.es/wp-content/uploads/galapagos_670x550.jpg https://aimfa.es/nueva-gama-oral-b-laboratory-para-farmacias/ 2021-05-26T06:50:00+00:00 https://aimfa.es/wp-content/uploads/oralb.jpg https://aimfa.es/el-mercado-de-oncologia-no-remite-en-su-crecimiento/ 2021-05-27T06:47:00+00:00 https://aimfa.es/wp-content/uploads/cancer-2.jpg https://aimfa.es/sanofi-y-gsk-inician-la-evaluacion-en-fase-3-de-su-vacuna-frente-al-covid-19-y-preven-su-autorizacion-a-final-de-ano/ 2021-05-28T10:33:33+00:00 https://aimfa.es/wp-content/uploads/vacunas-3.jpg https://aimfa.es/genericos-y-biosimilares-tendran-un-diferencial-de-precio-sobre-los-originales-durante-el-primer-ano/ 2021-05-31T07:27:29+00:00 https://aimfa.es/wp-content/uploads/medicamentos_genericos.jpg https://aimfa.es/novo-nordisk-lanza-una-app-enfocada-en-el-tratamiento-de-la-hemofilia/ 2021-06-01T07:46:38+00:00 https://aimfa.es/wp-content/uploads/hemofilia.jpg https://aimfa.es/el-paciente-se-situa-en-el-centro-de-los-nuevos-premios-de-la-fundacion-farmaindustria/ 2021-06-02T07:36:22+00:00 https://aimfa.es/wp-content/uploads/gente-2.jpg https://aimfa.es/la-inversion-privada-en-las-biotech-espanolas-aumenta-casi-un-50-en-2020/ 2021-06-03T08:16:34+00:00 https://aimfa.es/wp-content/uploads/biotec.jpg https://aimfa.es/jaume-pey-reelegido-como-tesorero-de-la-asociacion-europea-de-la-industria-de-autocuidado/ 2021-06-04T09:36:11+00:00 https://aimfa.es/wp-content/uploads/jaume_pey.jpg https://aimfa.es/europa-apuesta-por-las-vacunas-a-precios-asequibles-antes-que-por-la-suspension-de-patentes/ 2021-06-07T07:59:44+00:00 https://aimfa.es/wp-content/uploads/europ_670.jpg https://aimfa.es/los-20-perfiles-mejor-pagados-del-sector-farmaceutico/ 2021-06-09T07:00:00+00:00 https://aimfa.es/wp-content/uploads/visitador-medico.jpg https://aimfa.es/organon-nueva-compania-centrada-en-la-salud-de-la-mujer/ 2021-06-10T08:22:47+00:00 https://aimfa.es/wp-content/uploads/organon.jpg https://aimfa.es/el-parlamento-europeo-pide-suspender-temporalmente-las-patentes-de-las-vacunas/ 2021-06-11T07:35:02+00:00 https://aimfa.es/wp-content/uploads/europ_670.jpg https://aimfa.es/la-artrosis-y-la-osteoporosis-son-dos-epidemias-silentes/ 2021-06-14T08:28:06+00:00 https://aimfa.es/wp-content/uploads/osteoporosis.jpg https://aimfa.es/se-incrementa-la-evolucion-de-medicos-colegiados-en-espana/ 2021-06-15T07:09:17+00:00 https://aimfa.es/wp-content/uploads/doctores.jpg https://aimfa.es/el-entorno-laboral-de-zambon-espana-destacado-por-su-bienestar/ 2021-06-16T06:10:15+00:00 https://aimfa.es/wp-content/uploads/benvivere.jpg https://aimfa.es/las-agencias-asociadas-a-aeaps-recogen-hoy-9-premios-aspid-en-su-edicion-2021/ 2021-06-17T06:36:00+00:00 https://aimfa.es/wp-content/uploads/aeaps.jpg https://aimfa.es/wp-content/uploads/cartel_aspid.jpg https://aimfa.es/el-plan-de-farmaindustria-para-impulsar-la-produccion-de-medicamentos-esenciales-generara-1-700-millones-de-euros-de-inversion/ 2021-06-18T08:06:46+00:00 https://aimfa.es/wp-content/uploads/fabricacion.jpg https://aimfa.es/aimfa-convoca-una-encuesta-sobre-marketing-digital-entre-sus-asociados/ 2021-06-19T11:51:29+00:00 https://aimfa.es/wp-content/uploads/marketing-digital-1.jpg https://aimfa.es/novo-nordisk-defiende-la-economia-circular-como-solucion-a-los-retos-del-futuro/ 2021-06-21T07:12:09+00:00 https://aimfa.es/wp-content/uploads/circular.jpg https://aimfa.es/la-eurocamara-apoya-la-creacion-de-una-base-de-datos-en-la-ema-para-el-suministro-de-medicamentos/ 2021-06-23T08:38:01+00:00 https://aimfa.es/wp-content/uploads/europ_670.jpg https://aimfa.es/flexibilidad-total-para-decidir-como-y-donde-trabajar-eje-del-nuevo-modelo-laboral-hibrido-y-personalizado-de-novartis/ 2021-06-24T11:31:38+00:00 https://aimfa.es/wp-content/uploads/teletrabajo_670.jpg https://aimfa.es/nace-farma-in-la-primera-red-social-para-profesionales-de-la-farmacia-comunitaria/ 2021-06-25T08:01:27+00:00 https://aimfa.es/wp-content/uploads/Wikifarmcia.jpg https://aimfa.es/tres-programas-de-cesif-entre-los-mejores-master-del-ranking-del-periodico-el-mundo/ 2021-06-28T06:47:00+00:00 https://aimfa.es/wp-content/uploads/profesores.jpg https://aimfa.es/stada-apuesta-por-el-consumer-healthcare-en-europa-al-adquirir-16-marcas-establecidas-de-sanofi/ 2021-06-29T08:00:41+00:00 https://aimfa.es/wp-content/uploads/farmacias.jpg https://aimfa.es/pfizer-distribuira-productos-de-terapia-genica-a-toda-europa-desde-madrid/ 2021-06-30T07:25:28+00:00 https://aimfa.es/wp-content/uploads/genes.jpg https://aimfa.es/el-consumo-de-biosimilares-en-atencion-primaria-aumento-mas-de-un-300-respecto-a-2018/ 2021-07-01T07:41:25+00:00 https://aimfa.es/wp-content/uploads/biologic.jpg https://aimfa.es/el-big-data-y-la-inteligencia-artificial-claves-para-llegar-a-la-medicina-4p/ 2021-07-02T07:26:40+00:00 https://aimfa.es/wp-content/uploads/inteligencia_artificial-670.jpg https://aimfa.es/novartis-biome-la-red-global-de-centros-de-innovacion-digital-llega-a-espana/ 2021-07-05T10:43:00+00:00 https://aimfa.es/wp-content/uploads/novartis_670.jpg https://aimfa.es/abbvie-anuncia-su-adhesion-a-la-red-empresarial-por-la-diversidad-e-inclusion-lgtbi-en-el-entorno-empresarial/ 2021-07-06T06:58:45+00:00 https://aimfa.es/wp-content/uploads/redi.jpg https://aimfa.es/el-gobierno-preve-aprobar-el-plan-de-la-industria-farmaceutica-durante-el-primer-semestre-de-2022/ 2021-07-07T08:52:40+00:00 https://aimfa.es/wp-content/uploads/Ministerio.jpg https://aimfa.es/novo-nordisk-muestra-su-apoyo-a-ninos-diabeticos-a-traves-de-un-programa-de-becas/ 2021-07-08T06:46:00+00:00 https://aimfa.es/wp-content/uploads/fede.jpg https://aimfa.es/el-gasto-total-del-sistema-sanitario-publico-ascendio-en-2019-un-54-2-451-euros-por-habitante/ 2021-07-09T07:09:09+00:00 https://aimfa.es/wp-content/uploads/dinero_670-1.jpg https://aimfa.es/las-start-ups-de-salud-digital-recaudan-14-700-millones-en-la-primera-mitad-de-2021-en-eeuu/ 2021-07-12T16:00:46+00:00 https://aimfa.es/wp-content/uploads/digital_670-2.jpg https://aimfa.es/la-visita-medica-evoluciona-hacia-un-nuevo-modelo-comercial-hibrido/ 2021-07-13T07:07:59+00:00 https://aimfa.es/wp-content/uploads/visita_medica-e1566985633585.jpg https://aimfa.es/wp-content/uploads/AuditChanneldynamics.jpg https://aimfa.es/fallece-juan-lopez-belmonte-presidente-de-laboratorios-rovi/ 2021-07-14T00:28:41+00:00 https://aimfa.es/wp-content/uploads/lopez_belmonte.jpg https://aimfa.es/la-comision-europea-evita-posicionarse-sobre-la-obligatoriedad-de-las-vacunas/ 2021-07-19T07:02:00+00:00 https://aimfa.es/wp-content/uploads/europa_comision.jpg https://aimfa.es/grifols-se-convierte-en-patrocinador-oficial-del-futbol-femenino-de-la-uefa/ 2021-07-16T07:31:00+00:00 https://aimfa.es/wp-content/uploads/grifols.jpeg https://aimfa.es/conoces-las-lineas-estrategicas-y-los-objetivos-de-aimfa/ 2021-07-15T09:04:07+00:00 https://aimfa.es/wp-content/uploads/trebol670.jpg https://aimfa.es/wp-content/uploads/junta_baja.jpg https://aimfa.es/lilly-adquiere-protomer-technologies/ 2021-07-20T08:35:43+00:00 https://aimfa.es/wp-content/uploads/lilly-1.jpg https://aimfa.es/evolucion-del-mercado-en-junio-iqvia/ 2021-07-21T08:27:51+00:00 https://aimfa.es/wp-content/uploads/mercado_670x550.jpg https://aimfa.es/brill-pharma-lanza-matrix-ocular-3-una-matriz-unica-para-la-superficie-ocular/ 2021-07-22T07:06:00+00:00 https://aimfa.es/wp-content/uploads/matrix.jpg https://aimfa.es/aimfa-realiza-estudio-sobre-la-implementacion-del-marketing-digital-entre-las-companias-asociadas/ 2021-07-23T10:19:46+00:00 https://aimfa.es/wp-content/uploads/mkt-digital.jpg https://aimfa.es/bayer-apoya-el-crecimiento-de-la-salud-rural-a-traves-de-la-digitalizacion/ 2021-07-26T06:31:58+00:00 https://aimfa.es/wp-content/uploads/digital-4.jpg https://aimfa.es/asebio-lamenta-que-el-rd-sobre-los-test-covid-19-no-incluya-su-propuesta-en-favor-de-la-industria-espanola/ 2021-07-27T08:07:11+00:00 https://aimfa.es/wp-content/uploads/testcovid_670.jpg https://aimfa.es/iqvia-estima-el-impacto-de-la-opr-de-2021-en-farmacias-en-106-millones/ 2021-07-28T08:19:05+00:00 https://aimfa.es/wp-content/uploads/dinero_670-1.jpg https://aimfa.es/cofares-apuesta-por-startups-innovadoras-del-sector-sanitario/ 2021-07-29T08:58:10+00:00 https://aimfa.es/wp-content/uploads/digital_670x550.jpg https://aimfa.es/las-recetas-crecen-un-9-y-suben-las-ventas-en-farmacias-de-proximidad-segun-el-observatorio-de-fefe/ 2021-07-30T08:40:37+00:00 https://aimfa.es/wp-content/uploads/mercado_670x550.jpg https://aimfa.es/merck-invierte-en-la-medicina-de-precision/ 2021-08-02T08:13:36+00:00 https://aimfa.es/wp-content/uploads/medicina_precision.jpg https://aimfa.es/takeda-impulsa-la-investigacion-en-cancer-de-pulmon/ 2021-08-03T11:00:20+00:00 https://aimfa.es/wp-content/uploads/takeda-1.jpg https://aimfa.es/grifols-aumenta-un-22-su-beneficio-en-el-primer-semestre-hasta-267-millones-de-euros/ 2021-08-04T07:01:00+00:00 https://aimfa.es/wp-content/uploads/grifols.jpeg https://aimfa.es/novartis-apuesta-por-la-transformacion-digital-con-un-acuerdo-con-the-valley/ 2021-08-05T09:11:19+00:00 https://aimfa.es/wp-content/uploads/novartis_670.jpg https://aimfa.es/el-fenofibrato-reduce-in-vitro-un-70-la-infeccion-por-coronavirus/ 2021-08-09T08:24:30+00:00 https://aimfa.es/wp-content/uploads/fenofibrato.jpg https://aimfa.es/como-afrontamos-la-vuelta-a-las-oficinas-expectativas-miedos-y-consejos-ante-el-fin-del-teletrabajo/ 2021-08-30T10:44:56+00:00 https://aimfa.es/wp-content/uploads/teletrabajo_670.jpg https://aimfa.es/boehringer-ingelheim-y-lilly-anuncian-los-optimos-resultados-de-empagliflozina/ 2021-08-31T08:31:46+00:00 https://aimfa.es/wp-content/uploads/corazon.jpg https://aimfa.es/laboratorios-gebro-pharma-factura-797-millones-de-euros-con-un-crecimiento-del-67/ 2021-09-01T08:52:01+00:00 https://aimfa.es/wp-content/uploads/gebro-1.jpg https://aimfa.es/activa-convoca-el-programa-project-management/ 2021-09-02T07:46:16+00:00 https://aimfa.es/wp-content/uploads/logo_activa_670.jpg https://aimfa.es/segun-iqvia-el-mercado-farmaceutico-actual-en-espana-crece-en-valores-04-y-decrece-en-unidades-36-en-lo-que-llevamos-de-ano/ 2021-09-03T06:26:00+00:00 https://aimfa.es/wp-content/uploads/mercado_670x550.jpg https://aimfa.es/descubierto-el-mecanismo-molecular-que-vincula-el-colesterol-con-el-cancer/ 2021-09-06T08:08:01+00:00 https://aimfa.es/wp-content/uploads/cancer-1.jpg https://aimfa.es/kyowa-kirin-lanza-xlh-link-una-web-para-profesionales-sanitarios-orientada-a-mejorar-su-aprendizaje-acerca-de-la-hipofosfatemia-ligada-al-cromosoma-x/ 2021-09-07T08:09:19+00:00 https://aimfa.es/wp-content/uploads/molecula.jpg https://aimfa.es/barcelona-acogera-a-mas-de-70-expertos-en-inteligencia-artificial/ 2021-09-08T08:51:25+00:00 https://aimfa.es/wp-content/uploads/santpau.jpg https://aimfa.es/cesif-lanza-una-nueva-edicion-de-su-programa-abierto-de-especializacion-en-strategic-insights-business-pharma/ 2021-09-10T06:45:50+00:00 https://aimfa.es/wp-content/uploads/programa_cesif.jpg https://aimfa.es/la-efpia-pide-mantener-los-incentivos-a-farmacos-huerfanos-y-pediatricos-en-la-nueva-estrategia-europea/ 2021-09-13T08:02:15+00:00 https://aimfa.es/wp-content/uploads/europa.jpg https://aimfa.es/uriach-traspasa-a-mch-private-equity-y-a-inversores-espanoles-el-100-de-su-negocio-b2b/ 2021-09-14T09:04:12+00:00 https://aimfa.es/wp-content/uploads/uriach.jpg https://aimfa.es/podemos-investigar-el-contenido-que-se-publica-en-una-red-social/ 2021-09-15T07:00:00+00:00 https://aimfa.es/wp-content/uploads/redes_sociales-1.jpg https://aimfa.es/pfizer-se-incorpora-como-nuevo-miembro-de-la-ceoe/ 2021-09-16T07:30:06+00:00 https://aimfa.es/wp-content/uploads/pfizer-2.jpg https://aimfa.es/los-beneficios-de-la-innovacion-incremental-de-los-medicamentos-para-la-seguridad-del-paciente/ 2021-09-20T16:33:15+00:00 https://aimfa.es/wp-content/uploads/farmacia670.jpg https://aimfa.es/cinfa-reune-a-374-asociaciones-de-pacientes-bajo-la-iniciativa-solidaria-la-voz-del-paciente/ 2021-09-21T07:55:36+00:00 https://aimfa.es/wp-content/uploads/mayores.jpg https://aimfa.es/segun-iqvia-el-mercado-en-espana-crece-en-valores-07-y-decrece-en-unidades-33-en-lo-que-llevamos-de-ano/ 2021-09-22T06:48:00+00:00 https://aimfa.es/wp-content/uploads/mercado_670x550.jpg https://aimfa.es/la-nueva-directiva-de-aeaps-afronta-importantes-cambios-estrategicos-para-la-asociacion/ 2021-09-23T07:15:00+00:00 https://aimfa.es/wp-content/uploads/aeAPS-1.jpg https://aimfa.es/por-que-es-tan-importante-analizar-el-rendimiento-de-las-redes-sociales/ 2021-09-24T09:35:35+00:00 https://aimfa.es/wp-content/uploads/redes.jpg https://aimfa.es/cambia-el-perfil-del-consumidor-con-la-pandemia-acude-menos-a-la-farmacia-pero-compra-mas/ 2021-09-27T08:38:57+00:00 https://aimfa.es/wp-content/uploads/farmacias-1.jpg https://aimfa.es/la-industria-farmaceutica-se-adapta-al-panorama-digital/ 2021-09-28T07:04:37+00:00 https://aimfa.es/wp-content/uploads/salud_digital.jpg https://aimfa.es/plgs-celebra-su-xxi-asamblea-general/ 2021-09-29T07:12:00+00:00 https://aimfa.es/wp-content/uploads/plgs1.jpg https://aimfa.es/wp-content/uploads/plgs2.jpg https://aimfa.es/sanofi-detiene-el-desarrollo-de-su-vacuna-pese-a-los-resultados-positivos-en-los-ensayos/ 2021-09-30T09:12:12+00:00 https://aimfa.es/wp-content/uploads/vacuna_670.jpg https://aimfa.es/donde-esta-el-personal-para-manejar-big-data-e-inteligencia-artificial/ 2021-10-01T07:33:28+00:00 https://aimfa.es/wp-content/uploads/digital_670-1.jpg https://aimfa.es/el-mercado-farmaceutico-en-europa-top-4-sep-2021/ 2021-10-04T07:15:00+00:00 https://aimfa.es/wp-content/uploads/europa.jpg https://aimfa.es/cesif-pasa-a-formar-parte-de-metrodora-education-un-grupo-educativo-centrado-en-la-formacion-sanitaria/ 2021-10-05T07:15:00+00:00 https://aimfa.es/wp-content/uploads/alumnos.jpg https://aimfa.es/el-empleo-en-el-sector-de-la-salud-en-espana-aumenta-un-45-en-septiembre/ 2021-10-06T07:05:00+00:00 https://aimfa.es/wp-content/uploads/medicos_670x550.jpg https://aimfa.es/brill-pharma-comprometida-con-la-isla-de-la-palma/ 2021-10-07T07:06:00+00:00 https://aimfa.es/wp-content/uploads/volcan.jpeg https://aimfa.es/lacer-inaugura-su-nueva-sede-corporativa-en-barcelona/ 2021-10-11T08:45:36+00:00 https://aimfa.es/wp-content/uploads/lacer.jpg https://aimfa.es/1-de-cada-4-personas-sufrira-un-trastorno-mental-a-lo-largo-de-su-vida/ 2021-10-13T08:03:06+00:00 https://aimfa.es/wp-content/uploads/mental.jpg https://aimfa.es/los-fabricantes-de-vacunas-contra-la-covid-19-de-todo-el-mundo-producen-1-500-millones-de-dosis-al-mes/ 2021-10-15T09:38:27+00:00 https://aimfa.es/wp-content/uploads/vacuna_670.jpg https://aimfa.es/cesif-abre-la-3a-convocatoria-del-programa-executive-en-digital-healthcare-business/ 2021-10-18T08:27:47+00:00 https://aimfa.es/wp-content/uploads/digital_670-2.jpg https://aimfa.es/por-que-se-celebra-hoy-el-dia-del-cancer-de-mama/ 2021-10-19T16:11:39+00:00 https://aimfa.es/wp-content/uploads/cancer_mama.jpeg https://aimfa.es/faes-farma-amplia-su-presencia-internacional-con-la-apertura-de-una-nueva-sede-en-colombia/ 2021-10-20T10:14:20+00:00 https://aimfa.es/wp-content/uploads/faes-2.jpg https://aimfa.es/santen-presenta-en-espana-cooltears-hydro/ 2021-10-21T06:53:00+00:00 https://aimfa.es/wp-content/uploads/cooltears.jpg https://aimfa.es/en-septiembre-el-mercado-experimento-un-crecimiento-de-64-en-valores-y-13-en-volumen-versus-el-mismo-periodo-el-ano-anterior/ 2021-10-22T06:27:00+00:00 https://aimfa.es/wp-content/uploads/mercado_670x550.jpg https://aimfa.es/informe-el-mercado-de-la-investigacion-de-mercados-en-2020/ 2021-10-25T07:15:00+00:00 https://aimfa.es/wp-content/uploads/investigacion_mercados.jpg https://aimfa.es/boehringer-ingelheim-invertira-35-000-millones-en-innovacion-sanitaria-hasta-2030/ 2021-10-26T07:22:40+00:00 https://aimfa.es/wp-content/uploads/boehringer_670-1.jpg https://aimfa.es/segun-iqvia-el-mercado-crece-en-valores-15-y-decrece-en-unidades-06-en-el-acumulado-a-septiembre/ 2021-10-27T08:08:02+00:00 https://aimfa.es/wp-content/uploads/mercado_670x550.jpg https://aimfa.es/los-drones-aterrizan-en-la-distribucion-farmaceutica/ 2021-10-28T08:21:05+00:00 https://aimfa.es/wp-content/uploads/drones.jpg https://aimfa.es/ordesa-nuevo-miembro-de-aimfa/ 2021-11-02T07:52:07+00:00 https://aimfa.es/wp-content/uploads/ordesa-1.jpg https://aimfa.es/club-bayer-un-canal-digital-con-el-objetivo-de-promover-la-formacion-de-los-profesionales-de-la-farmacia/ 2021-11-02T21:38:49+00:00 https://aimfa.es/wp-content/uploads/bayer-1.jpg https://aimfa.es/activa-convoca-una-nueva-edicion-de-su-programa-en-marketing-de-contenidos-en-salud/ 2021-11-03T07:57:51+00:00 https://aimfa.es/wp-content/uploads/logo_activa_670.jpg https://aimfa.es/amazon-percibido-como-el-principal-competidor-de-la-farmacia/ 2021-11-04T08:00:00+00:00 https://aimfa.es/wp-content/uploads/amazon-670x550-1.jpg https://aimfa.es/novartis-vende-a-roche-su-33-en-la-farmaceutica-por-17-800-millones/ 2021-11-05T07:46:40+00:00 https://aimfa.es/wp-content/uploads/novartis_670.jpg https://aimfa.es/google-se-apoya-en-la-ia-para-acelerar-el-descubrimiento-de-nuevos-farmacos/ 2021-11-08T08:53:11+00:00 https://aimfa.es/wp-content/uploads/google_670.jpg https://aimfa.es/la-diabetes-tipo-2-afecta-ya-a-4-millones-de-personas-en-espana/ 2021-11-09T11:19:52+00:00 https://aimfa.es/wp-content/uploads/Diabetes.jpg https://aimfa.es/distrito-ehealth-una-alternativa-para-la-transformacion-digital-del-sector-salud/ 2021-11-10T11:56:59+00:00 https://aimfa.es/wp-content/uploads/mkt-digital.jpg https://aimfa.es/la-industria-apuesta-por-las-farmacias-para-la-venta-de-consumer-health/ 2021-11-11T12:02:17+00:00 https://aimfa.es/wp-content/uploads/farmacias.jpg https://aimfa.es/cinfa-da-voz-a-las-mujeres-ante-diferentes-luchas-vitales/ 2021-11-12T05:48:10+00:00 https://aimfa.es/wp-content/uploads/cinfa_ellas.jpg https://aimfa.es/expertos-advierten-que-la-transformacion-digital-de-la-sanidad-espanola-debe-ser-un-proceso-estrategico-bien-ejecutado/ 2021-11-15T07:44:00+00:00 https://aimfa.es/wp-content/uploads/digital_670-2.jpg https://aimfa.es/una-posible-vacuna-abre-una-nueva-via-en-el-abordaje-del-alzheimer/ 2021-11-16T07:57:56+00:00 https://aimfa.es/wp-content/uploads/alzheimer.jpg https://aimfa.es/activa-plataforma-de-formacion-en-salud-convoca-nuevamente-para-el-2022-su-oferta-formativa-digital/ 2021-11-17T08:18:00+00:00 https://aimfa.es/wp-content/uploads/logo_activa_670.jpg https://aimfa.es/las-fake-news-disfrazadas-de-articulos-cientificos-han-calado-hasta-el-dia-de-hoy/ 2021-11-18T07:30:00+00:00 https://aimfa.es/wp-content/uploads/vacunas_670.jpg https://aimfa.es/crece-el-retorno-de-la-inversion-del-sector-biofarmaceutico-en-id-por-primera-vez-en-mas-de-media-decada/ 2021-11-19T08:18:34+00:00 https://aimfa.es/wp-content/uploads/vacuna_670.jpg https://aimfa.es/gebro-pharma-acuerda-con-novartis-la-venta-de-dos-soluciones-terapeuticas-contra-el-asma/ 2021-11-23T09:09:12+00:00 https://aimfa.es/wp-content/uploads/gebro-2.jpg https://aimfa.es/segun-iqvia-el-mercado-crece-en-valores-12-y-decrece-en-unidades-28-en-lo-que-llevamos-de-ano/ 2021-11-24T09:13:15+00:00 https://aimfa.es/wp-content/uploads/mercado_670x550.jpg https://aimfa.es/iqvia-celebra-la-xxii-edicion-de-los-premios-top20-con-mas-de-150-hospitales-participantes/ 2021-11-25T07:27:00+00:00 https://aimfa.es/wp-content/uploads/top20.jpg https://aimfa.es/wp-content/uploads/top20_1.jpg https://aimfa.es/la-hospitalizacion-a-domicilio-se-configura-como-un-modelo-imprescindible-frente-al-desafio-de-la-cronicidad/ 2021-11-26T11:02:01+00:00 https://aimfa.es/wp-content/uploads/hospitalpaciente.jpg https://aimfa.es/la-nueva-variante-b-1-1-529-del-coronavirus-hallada-en-sudafrica-siembra-la-alarma/ 2021-11-29T07:11:30+00:00 https://aimfa.es/wp-content/uploads/virus_670x550.jpg https://aimfa.es/roche-recompra-su-participacion-en-novartis-por-20-700-millones-de-dolares/ 2021-11-30T07:21:00+00:00 https://aimfa.es/wp-content/uploads/roche-1.jpg https://aimfa.es/insights-analytics-espana-convoca-el-premio-junior-de-investigacion-2022/ 2021-12-01T08:10:00+00:00 https://aimfa.es/wp-content/uploads/doctorado.jpg https://aimfa.es/sanofi-refuerza-su-hub-digital-en-barcelona-con-alrededor-de-100-nuevas-incorporaciones/ 2021-12-02T08:33:57+00:00 https://aimfa.es/wp-content/uploads/sanofi-1.jpg https://aimfa.es/twitter-prohibe-a-sus-usuarios-que-compartan-imagenes-o-videos-sin-consentimiento-de-quienes-aparecen-en-ellos/ 2021-12-03T10:10:43+00:00 https://aimfa.es/wp-content/uploads/twitter_HQ.jpg https://aimfa.es/activa-convoca-el-programa-gestion-de-social-media-en-salud/ 2021-12-09T08:00:00+00:00 https://aimfa.es/wp-content/uploads/logo_activa_670.jpg https://aimfa.es/galapagos-amplia-su-capital-social-mediante-ejercicios-de-derechos-de-suscripcion/ 2021-12-10T07:51:52+00:00 https://aimfa.es/wp-content/uploads/galapagos_670x550.jpg https://aimfa.es/la-salud-digital-en-europa-quien-la-paga-y-por-que-es-importante/ 2021-12-13T07:33:00+00:00 https://aimfa.es/wp-content/uploads/mkt-digital.jpg https://aimfa.es/descubre-todas-las-actividades-de-aimfa-del-ano-2021/ 2021-12-13T10:36:14+00:00 https://aimfa.es/wp-content/uploads/somosaimfa.jpg https://aimfa.es/la-aplicacion-de-la-orden-snd-1308-2021-supondra-un-impacto-de-68-millones-sobre-el-mercado/ 2021-12-14T07:41:00+00:00 https://aimfa.es/wp-content/uploads/mercado_670x550.jpg https://aimfa.es/lara-vadillo-nueva-directora-de-comunicacion-de-pharmamar/ 2021-12-15T08:28:12+00:00 https://aimfa.es/wp-content/uploads/lara.jpg https://aimfa.es/novo-nordisk-y-seedo-lanzan-mas-grande-que-yo-el-movimiento-para-cambiar-el-relato-social-sobre-la-obesidad/ 2021-12-16T07:22:00+00:00 https://aimfa.es/wp-content/uploads/novonordisk_670.jpg https://aimfa.es/segun-iqvia-el-mercado-crece-en-valores-22-y-decrece-en-unidades-15-en-lo-que-llevamos-de-ano/ 2021-12-17T09:16:40+00:00 https://aimfa.es/wp-content/uploads/mercado_670x550.jpg https://aimfa.es/el-metaverso-que-es-y-como-puede-aprovecharlo-la-salud/ 2021-12-20T06:17:15+00:00 https://aimfa.es/wp-content/uploads/virtual.jpg https://aimfa.es/atrys-health-adquiere-simm-molecular/ 2021-12-21T07:58:00+00:00 https://aimfa.es/wp-content/uploads/molecular.jpg https://aimfa.es/laboratorios-rubio-adquiere-fisiopharma-en-su-apuesta-por-los-productos-otc/ 2021-12-22T07:34:08+00:00 https://aimfa.es/wp-content/uploads/rubio.jpg https://aimfa.es/sanofi-genzyme-se-une-a-asebio-para-impulsar-el-sector-biotecnologico-nacional/ 2021-12-23T09:18:57+00:00 https://aimfa.es/wp-content/uploads/biotecnologia.jpeg https://aimfa.es/web3-la-evolucion-de-internet-hacia-la-descentralizacion/ 2021-12-24T09:05:22+00:00 https://aimfa.es/wp-content/uploads/web30.jpg https://aimfa.es/la-inversion-en-id-de-la-industria-farmaceutica-logro-en-2020-su-segundo-mejor-registro-de-la-historia-pese-a-la-pandemia/ 2021-12-27T09:23:54+00:00 https://aimfa.es/wp-content/uploads/probetas.jpg https://aimfa.es/wp-content/uploads/grafico_ID_01.png https://aimfa.es/wp-content/uploads/grafico_ID_02.png https://aimfa.es/wp-content/uploads/graficos_ID_03.png https://aimfa.es/wp-content/uploads/grafico_ID_04.png https://aimfa.es/la-situacion-del-consumidor-en-2022/ 2022-01-03T09:14:57+00:00 https://aimfa.es/wp-content/uploads/consumo.jpg https://aimfa.es/whatsapp-prepara-una-nueva-funcion-para-geolocalizar-negocios-cercanos/ 2022-01-04T10:01:36+00:00 https://aimfa.es/wp-content/uploads/whatsapp_670x550.jpg https://aimfa.es/la-inteligencia-artificial-mejora-la-precision-en-la-seleccion-de-antibioticos/ 2022-01-05T08:11:28+00:00 https://aimfa.es/wp-content/uploads/inteligencia_artificial-670.jpg https://aimfa.es/el-gasto-publico-a-traves-de-recetas-aumenta-un-59-hasta-noviembre/ 2022-01-07T08:17:00+00:00 https://aimfa.es/wp-content/uploads/dinero_670-1.jpg https://aimfa.es/la-venta-online-en-espana-de-productos-farmaceuticos-retrocede-un-217-en-el-segundo-trimestre-de-2021/ 2022-01-10T09:15:43+00:00 https://aimfa.es/wp-content/uploads/visita_online.jpg https://aimfa.es/almirall-recibira-44-millones-tras-completar-astrazeneca-la-transferencia-de-dos-farmacos-a-covis-pharma/ 2022-01-11T08:08:55+00:00 https://aimfa.es/wp-content/uploads/almirall_670.jpg https://aimfa.es/iqvia-y-tonic-app-se-unen-para-ofrecer-a-la-comunidad-medica-informacion-relevante/ 2022-01-12T12:33:33+00:00 https://aimfa.es/wp-content/uploads/movil-1.jpg https://aimfa.es/la-ema-descarta-gripalizar-el-covid/ 2022-01-13T07:41:19+00:00 https://aimfa.es/wp-content/uploads/vacunas_670-1.jpg https://aimfa.es/activa-convoca-el-programa-project-management-habilidades-tecnicas-emocionales-e-interpersonales-en-investigacion-clinica/ 2022-01-17T07:47:00+00:00 https://aimfa.es/wp-content/uploads/logo_activa_670.jpg https://aimfa.es/las-normas-relativas-a-los-precios-de-referencia-no-deben-aplicarse-a-los-medicamentos-huerfanos/ 2022-01-14T07:45:08+00:00 https://aimfa.es/wp-content/uploads/medicamentos-1.jpg https://aimfa.es/la-telefarmacia-obtiene-un-96-de-satisfaccion-entre-los-pacientes/ 2022-01-18T08:58:20+00:00 https://aimfa.es/wp-content/uploads/telefarmacia.jpg https://aimfa.es/organon-se-une-a-biosim/ 2022-01-19T08:54:08+00:00 https://aimfa.es/wp-content/uploads/organon.jpg https://aimfa.es/el-mercado-crece-en-valores-36-y-en-unidades-07-en-el-ano-2021-respecto-al-ano-2020/ 2022-01-20T06:02:37+00:00 https://aimfa.es/wp-content/uploads/mercado_670x550.jpg https://aimfa.es/el-70-de-los-medicamentos-en-curso-son-first-in-class/ 2022-01-21T06:38:51+00:00 https://aimfa.es/wp-content/uploads/medicamentos-2.jpg https://aimfa.es/el-mercado-de-productos-dieteticos-se-consolido-en-espana-en-la-pasada-decada-y-alcanzo-los-1-000-millones/ 2022-01-25T07:31:00+00:00 https://aimfa.es/wp-content/uploads/dieta.jpg https://aimfa.es/mifarma-es-completa-su-evolucion-y-cambia-su-nombre-a-atida-com/ 2022-01-26T08:37:30+00:00 https://aimfa.es/wp-content/uploads/ecommerce-2.jpg https://aimfa.es/diplomatura-internacional-en-visita-medica/ 2022-01-27T07:53:00+00:00 https://aimfa.es/wp-content/uploads/anuncio.jpg https://aimfa.es/los-espan%cc%83oles-quieren-compartir-sus-datos-de-salud/ 2022-01-28T08:15:50+00:00 https://aimfa.es/wp-content/uploads/pacientes-1.jpg https://aimfa.es/galapagos-nombra-a-paul-stoffels-como-nuevo-consejero-delegado/ 2022-01-31T06:57:36+00:00 https://aimfa.es/wp-content/uploads/paulstoffels.jpg https://aimfa.es/la-app-no-rumour-health-ya-esta-disponible/ 2022-02-01T07:58:00+00:00 https://aimfa.es/wp-content/uploads/rumors.jpg https://aimfa.es/el-nuevo-sistema-de-ensayos-clinicos-europeo-puede-ser-una-oportunidad-para-espana/ 2022-02-02T10:37:45+00:00 https://aimfa.es/wp-content/uploads/probetas.jpg https://aimfa.es/cientificos-descubren-el-origen-del-vinculo-entre-la-presion-arterial-y-la-diabetes/ 2022-02-03T07:21:00+00:00 https://aimfa.es/wp-content/uploads/diabetes-3.jpg https://aimfa.es/aumenta-el-arsenal-terapeutico-contra-el-cancer/ 2022-02-04T08:29:13+00:00 https://aimfa.es/wp-content/uploads/cancer-2.jpg https://aimfa.es/wp-content/uploads/onco.jpg https://aimfa.es/el-segundo-ano-de-covid-dejo-un-exceso-de-30-298-muertes-en-espana/ 2022-02-07T08:21:56+00:00 https://aimfa.es/wp-content/uploads/covid_r2i.jpg https://aimfa.es/descubren-un-nuevo-tipo-de-comunicacion-celular-en-el-cerebro/ 2022-02-08T07:31:00+00:00 https://aimfa.es/wp-content/uploads/cerebro.jpg https://aimfa.es/pronokal-group-es-adquirida-por-nestle-health-science/ 2022-02-09T07:57:49+00:00 https://aimfa.es/wp-content/uploads/nestle.jpg https://aimfa.es/consumo-de-medicamentos-financiados-en-espana-desde-2010/ 2022-02-10T08:13:00+00:00 https://aimfa.es/wp-content/uploads/Ministerio.jpg https://aimfa.es/iqvia-ingresa-en-la-ceoe/ 2022-02-11T07:44:46+00:00 https://aimfa.es/wp-content/uploads/iqvia-2.jpg https://aimfa.es/amgen-se-une-al-barcelona-health-hub/ 2022-02-14T07:20:00+00:00 https://aimfa.es/wp-content/uploads/santpau.jpg https://aimfa.es/que-podemos-aprender-de-las-sanciones-a-facebook-y-google-en-francia/ 2022-02-15T08:01:00+00:00 https://aimfa.es/wp-content/uploads/google_670.jpg https://aimfa.es/la-ema-dio-su-visto-bueno-a-92-medicamentos-en-2021/ 2022-02-16T09:00:15+00:00 https://aimfa.es/wp-content/uploads/ema.jpg https://aimfa.es/el-valor-de-las-operaciones-corporativas-del-sector-salud-se-dispara-un-65-en-2021/ 2022-02-17T07:22:00+00:00 https://aimfa.es/wp-content/uploads/acuerdos.jpg https://aimfa.es/angelini-pharma-inaugura-nueva-sede-social/ 2022-02-18T07:57:03+00:00 https://aimfa.es/wp-content/uploads/angelini.jpg https://aimfa.es/activa-convoca-una-nueva-edicion-del-programa-en-optimizacion-de-email-marketing-en-salud/ 2022-02-21T07:41:00+00:00 https://aimfa.es/wp-content/uploads/logo_activa_670.jpg https://aimfa.es/solo-el-50-de-los-medicamentos-huerfanos-son-financiados-por-el-sns/ 2022-02-22T09:06:56+00:00 https://aimfa.es/wp-content/uploads/medicamentos-3.jpg https://aimfa.es/gsk-consumer-healthcare-se-convierte-en-haleon/ 2022-02-23T06:51:44+00:00 https://aimfa.es/wp-content/uploads/haleon.jpg https://aimfa.es/la-responsabilidad-y-la-transformacion-de-la-comunicacion-de-salud-dos-grandes-retos-para-sus-protagonistas/ 2022-02-24T07:46:00+00:00 https://aimfa.es/wp-content/uploads/aeaps-2.jpg https://aimfa.es/wp-content/uploads/aeaps_seminario.jpg https://aimfa.es/la-unidad-de-oftalmologia-de-bayer-espana-lanza-la-primera-plataforma-europea-de-certificacion-online-en-excelencia-y-buenas-practicas/ 2022-02-25T07:23:00+00:00 https://aimfa.es/wp-content/uploads/oftal.jpg https://aimfa.es/sobi-presenta-33-propuestas-para-mejorar-la-atencion-y-calidad-de-vida-de-las-personas-con-enfermedades-raras/ 2022-02-28T07:31:00+00:00 https://aimfa.es/wp-content/uploads/sobi.jpg https://aimfa.es/feder-y-alexion-se-unen-en-el-reto-virtual-ilumina-por-las-enfermedades-raras/ 2022-03-01T07:29:00+00:00 https://aimfa.es/wp-content/uploads/ENFERMEDADES-RARAS-620x349-1.jpg https://aimfa.es/grunenthal-recibe-el-premio-a-la-innovacion-y-digitalizacion-empresarial/ 2022-03-02T06:10:22+00:00 https://aimfa.es/wp-content/uploads/digital_670x550.jpg https://aimfa.es/roche-donara-medicamentos-esenciales-a-ucrania/ 2022-03-03T06:17:19+00:00 https://aimfa.es/wp-content/uploads/roche-1.jpg https://aimfa.es/el-potencial-de-las-nuevas-tecnologias-ante-el-aumento-de-la-diabetes/ 2022-03-04T05:21:59+00:00 https://aimfa.es/wp-content/uploads/diabetes-3.jpg https://aimfa.es/pharma-mar-recibe-25-millones-de-dolares-de-jazz-pharmaceuticals-por-su-antitumoral/ 2022-03-07T07:36:10+00:00 https://aimfa.es/wp-content/uploads/pharmamar-1.jpg https://aimfa.es/la-mujer-retrocede-en-las-farma-espanolas-y-se-aleja-de-la-cuota-del-30-en-los-consejos/ 2022-03-08T09:08:53+00:00 https://aimfa.es/wp-content/uploads/evento13.jpg https://aimfa.es/javier-mourino-es-el-nuevo-director-de-personas-y-comunicacion-de-zambon-iberia/ 2022-03-09T08:03:53+00:00 https://aimfa.es/wp-content/uploads/Mourino.jpg https://aimfa.es/dia-mundial-del-rinon-pacientes-profesionales-y-empresas-apuestan-por-un-plan-nacional-renal/ 2022-03-10T08:16:49+00:00 https://aimfa.es/wp-content/uploads/rinones.jpg https://aimfa.es/el-economista-juan-yermo-sera-el-nuevo-director-general-de-farmaindustria/ 2022-03-11T08:15:00+00:00 https://aimfa.es/wp-content/uploads/Juan-Yermo-Feique.jpg https://aimfa.es/kilometrosporlaerc-campana-por-el-dia-mundial-del-rinon-que-busca-concienciar-sobre-la-importancia-de-la-enfermedad-renal/ 2022-03-12T16:55:37+00:00 https://aimfa.es/wp-content/uploads/vifor.jpg https://aimfa.es/tendencias-del-mercado-en-enero/ 2022-03-14T07:19:00+00:00 https://aimfa.es/wp-content/uploads/mercados1.jpg https://aimfa.es/ucb-invierte-en-un-nuevo-centro-de-terapia-genica-de-ultima-generacion/ 2022-03-15T08:02:00+00:00 https://aimfa.es/wp-content/uploads/ucb.jpg https://aimfa.es/sanofi-recibe-una-inversion-de-blackstone-para-desarrollar-la-forma-subcutanea-de-sarclisa/ 2022-03-16T08:15:22+00:00 https://aimfa.es/wp-content/uploads/sanofi-1.jpg https://aimfa.es/el-coste-del-consumo-de-farmacos-en-los-hospitales-del-sns-cierra-2021-con-un-alza-del-73/ 2022-03-18T20:16:54+00:00 https://aimfa.es/wp-content/uploads/dinero_670-1.jpg https://aimfa.es/roche-en-espana-apuesta-por-el-idi-incrementando-un-32-su-inversion-hasta-los-1435-millones-de-euros/ 2022-03-22T06:14:41+00:00 https://aimfa.es/wp-content/uploads/roche-1.jpg https://aimfa.es/recordati-completa-la-adquisicion-de-eusa-pharma-por-707-millones-de-euros/ 2022-03-23T07:16:53+00:00 https://aimfa.es/wp-content/uploads/recordati.jpg https://aimfa.es/nestle-refuerza-la-innovacion-en-complementos-pediatricos/ 2022-03-24T08:03:00+00:00 https://aimfa.es/wp-content/uploads/nancare.jpg https://aimfa.es/talento-ephos-lanza-un-nuevo-master-para-profesionales-del-sector-farmaceutico/ 2022-03-28T06:41:49+00:00 https://aimfa.es/wp-content/uploads/eventos3-1.jpg https://aimfa.es/el-servicio-murciano-de-salud-lanza-12-retos-tecnologicos-bajo-el-paraguas-europeo-de-innovacion/ 2022-03-28T08:10:38+00:00 https://aimfa.es/wp-content/uploads/medico3.jpg https://aimfa.es/grifols-apuesta-por-la-vacuna-contra-el-alzheimer-y-finaliza-la-fase-ii-de-los-ensayos-de-abvac40/ 2022-03-28T10:59:36+00:00 https://aimfa.es/wp-content/uploads/grifols.jpeg https://aimfa.es/janssen-recibe-luz-verde-de-la-ema-para-carvykti/ 2022-03-29T05:20:50+00:00 https://aimfa.es/wp-content/uploads/janssen-1.jpg https://aimfa.es/el-segmento-otc-presenta-crecimientos-a-doble-digito/ 2022-03-30T06:39:49+00:00 https://aimfa.es/wp-content/uploads/mercados1.jpg https://aimfa.es/farmaindustria-crea-un-organo-para-velar-por-la-proteccion-de-datos-en-ensayos-clinicos/ 2022-04-01T04:46:34+00:00 https://aimfa.es/wp-content/uploads/farmaindustria-1.jpg https://aimfa.es/la-inversion-en-transformacion-digital-en-el-ambito-sanitario-se-multiplica-casi-por-cinco-en-los-dos-ultimos-anos/ 2022-04-01T15:55:40+00:00 https://aimfa.es/wp-content/uploads/integra.jpg https://aimfa.es/%ef%bf%bclas-marcas-de-farmacia-ya-pueden-autoevaluar-su-estrategia-e-commerce/ 2022-04-04T07:08:00+00:00 https://aimfa.es/wp-content/uploads/upshelf.jpg https://aimfa.es/molnupiravir-elimina-el-virus-sars-cov-2-al-tercer-dia-de-terapia/ 2022-04-04T06:33:15+00:00 https://aimfa.es/wp-content/uploads/molpinuvir.jpg https://aimfa.es/el-cnio-y-pharmamar-inician-un-proyecto-para-probar-farmacos-contra-el-cancer-de-mama/ 2022-04-05T11:00:59+00:00 https://aimfa.es/wp-content/uploads/pharmamar-1.jpg https://aimfa.es/novartis-renueva-su-estructura-para-acelerar-el-crecimiento-y-fortalecer-su-cartera/ 2022-04-06T05:58:58+00:00 https://aimfa.es/wp-content/uploads/novartis_670.jpg https://aimfa.es/pfizer-adquiere-reviral-por-525-millones-de-dolares-y-amplia-su-cartera-contra-el-rsv/ 2022-04-08T06:55:44+00:00 https://aimfa.es/wp-content/uploads/pfizer-2.jpg https://aimfa.es/veltassa-permite-a-los-pacientes-un-control-a-largo-plazo-del-potasio-y-una-terapia-optimizada-con-israa/ 2022-04-18T06:43:00+00:00 https://aimfa.es/wp-content/uploads/veltassa.jpg https://aimfa.es/un-estudio-descarta-la-asociacion-entre-uso-del-movil-y-tumores-cerebrales/ 2022-04-19T06:46:47+00:00 https://aimfa.es/wp-content/uploads/mobile-1.jpg https://aimfa.es/whatsapp-crea-comunidades-una-nueva-funcionalidad-para-mejorar-la-gestion-de-los-grupos/ 2022-04-20T06:48:00+00:00 https://aimfa.es/wp-content/uploads/whatsapp_670x550.jpg https://aimfa.es/wp-content/uploads/image1.jpg https://aimfa.es/wp-content/uploads/image2.jpg https://aimfa.es/de-estar-encerrado-en-su-cuerpo-a-ser-capaz-de-comunicarse-con-la-mente/ 2022-04-21T05:26:30+00:00 https://aimfa.es/wp-content/uploads/paralisis.jpg https://aimfa.es/veronica-diaz-nombrada-directora-medica-de-galapagos-espana/ 2022-04-22T06:58:00+00:00 https://aimfa.es/wp-content/uploads/Veronica-Diaz-galapagos.jpg https://aimfa.es/msd-lanza-la-campana-inmunidad-unidos-por-la-prevencion-con-vacunas/ 2022-04-25T09:33:14+00:00 https://aimfa.es/wp-content/uploads/msdinmuno.jpg https://aimfa.es/cgcof-y-neuraxpharm-ponen-en-marcha-el-proyecto-lumens-dar-luz-a-la-salud-mental/ 2022-04-27T06:32:00+00:00 https://aimfa.es/wp-content/uploads/saludmental.jpg https://aimfa.es/el-creciente-interes-ante-las-categorias-de-consumer-health/ 2022-04-28T06:14:41+00:00 https://aimfa.es/wp-content/uploads/farmacia670.jpg https://aimfa.es/buena-evolucion-para-la-biotecnologia-espanola/ 2022-04-29T05:27:19+00:00 https://aimfa.es/wp-content/uploads/biotec-1.jpg https://aimfa.es/llyc-analiza-las-principales-oportunidades-que-ofrece-la-digitalizacion-al-sector-salud/ 2022-05-02T06:42:00+00:00 https://aimfa.es/wp-content/uploads/healthsummit.jpg https://aimfa.es/la-industria-farmaceutica-europea-quiere-recuperar-terreno-cedido-a-estados-unidos-y-china/ 2022-05-03T06:39:00+00:00 https://aimfa.es/wp-content/uploads/congreso.jpg https://aimfa.es/viatris-presenta-su-vacuna-antigripal-influvac-tetra-para-aumentar-la-tasa-de-inmunizacion/ 2022-05-04T06:53:00+00:00 https://aimfa.es/wp-content/uploads/vacunas-3.jpg https://aimfa.es/la-inteligencia-artificial-reduce-el-porcentaje-de-polipos-precancerosos-en-el-cribado-del-cancer-colorrectal/ 2022-05-05T07:03:00+00:00 https://aimfa.es/wp-content/uploads/cancer-2.jpg https://aimfa.es/pharmamar-registra-un-ebitda-de-206-millones-6/ 2022-05-06T07:34:00+00:00 https://aimfa.es/wp-content/uploads/pharmamar-1.jpg https://aimfa.es/segun-iqvia-el-mercado-crece-un-63-en-el-tam-de-marzo/ 2022-05-09T07:18:00+00:00 https://aimfa.es/wp-content/uploads/mercados1.jpg https://aimfa.es/destacados-resultados-de-almirall-en-el-primer-trimestre-de-2022/ 2022-05-10T06:31:59+00:00 https://aimfa.es/wp-content/uploads/almirall_670.jpg https://aimfa.es/pfizer-compra-biohaven-por-11-000-millones-y-se-adentra-en-los-tratamientos-para-la-migrana/ 2022-05-11T05:48:42+00:00 https://aimfa.es/wp-content/uploads/pfizer-2.jpg https://aimfa.es/los-premios-aspid-2022-reconocen-la-creatividad-e-innovacion-de-las-agencias-de-aeaps-que-incorpora-a-tres-nuevas-asociadas-entre-sus-miembros/ 2022-05-12T08:12:04+00:00 https://aimfa.es/wp-content/uploads/aeaps-2.jpg https://aimfa.es/farmaindustria-se-posiciona-como-asociacion-empresarial-lider-en-comunicacion-digital-por-segundo-ano-consecutivo/ 2022-05-13T04:28:18+00:00 https://aimfa.es/wp-content/uploads/farmaindustria-1.jpg https://aimfa.es/un-modelo-de-inteligencia-artificial-puede-predecir-si-la-enfermedad-de-crohn-reaparecera-tras-la-cirugia/ 2022-05-16T06:34:20+00:00 https://aimfa.es/wp-content/uploads/chron.jpg https://aimfa.es/el-cancer-de-piel-alcanza-a-mas-de-siete-millones-de-europeos/ 2022-05-17T04:30:41+00:00 https://aimfa.es/wp-content/uploads/cancerpiel.jpg https://aimfa.es/astrazeneca-se-une-a-south-summit-para-impulsar-el-ecosistema-innovador-en-espana/ 2022-05-18T06:39:22+00:00 https://aimfa.es/wp-content/uploads/astrazeneca_670.jpg https://aimfa.es/novartis-invirtio-100-millones-de-euros-en-la-realizacion-de-ensayos-clinicos-en-espana-en-2021/ 2022-05-19T08:38:44+00:00 https://aimfa.es/wp-content/uploads/novartis_670.jpg https://aimfa.es/la-aemps-autoriza-en-mayo-117-nuevos-medicamentos-el-80-genericos/ 2022-05-20T05:59:22+00:00 https://aimfa.es/wp-content/uploads/Ministerio.jpg https://aimfa.es/teletrabajo-el-gran-reto-que-implica-un-cambio-de-cultura-laboral-en-espana/ 2022-05-23T07:47:29+00:00 https://aimfa.es/wp-content/uploads/teletrabajo_670.jpg https://aimfa.es/la-inversion-en-tecnologia-sanitaria-decrecio-un-27-en-2021-segun-fenin/ 2022-05-24T07:47:05+00:00 https://aimfa.es/wp-content/uploads/tecno1.jpg https://aimfa.es/el-impacto-de-las-redes-sociales-en-la-compra-de-consumer-health/ 2022-05-25T06:39:00+00:00 https://aimfa.es/wp-content/uploads/online.jpg https://aimfa.es/la-ema-publica-la-guia-para-el-desarrollo-de-nuevos-antibioticos/ 2022-05-27T09:17:36+00:00 https://aimfa.es/wp-content/uploads/ema.jpg https://aimfa.es/1-500-pacientes-al-mes-encuentran-su-farmaco-traves-de-farmahelp/ 2022-05-30T07:42:27+00:00 https://aimfa.es/wp-content/uploads/medicamentos-3.jpg https://aimfa.es/chiesi-espana-nombra-a-goretti-hidalgo-como-nueva-responsable-de-comunicacion-corporativa/ 2022-05-31T06:54:27+00:00 https://aimfa.es/wp-content/uploads/goreti.jpg https://aimfa.es/multa-record-a-google-por-no-respetar-el-derecho-al-olvido/ 2022-06-01T09:35:22+00:00 https://aimfa.es/wp-content/uploads/google_670.jpg https://aimfa.es/anefp-se-suma-a-sustainableselfcare-y-pone-en-valor-los-logros-en-sostenibilidad-del-sector/ 2022-06-02T08:48:58+00:00 https://aimfa.es/wp-content/uploads/sustainable.jpg https://aimfa.es/el-perte-sanitario-la-llave-para-reconectar-investigacion-e-industria/ 2022-06-06T07:12:00+00:00 https://aimfa.es/wp-content/uploads/perte.jpg https://aimfa.es/el-mercado-cierra-abril-con-886-millones-de-recetas-un-617-mas-que-en-abril-de-2021/ 2022-06-08T06:41:00+00:00 https://aimfa.es/wp-content/uploads/mercado_670x550.jpg https://aimfa.es/segun-infonis-el-mercado-de-analgesicos-n2b-explica-el-19-del-crecimiento-del-mercado-en-unidades-en-abril/ 2022-06-07T06:27:00+00:00 https://aimfa.es/wp-content/uploads/inflonis_mercado.jpg https://aimfa.es/el-sector-del-autocuidado-de-la-salud-respalda-sin-reservas-el-nuevo-green-deal-europeo/ 2022-06-09T09:17:12+00:00 https://aimfa.es/wp-content/uploads/aesgp.jpg https://aimfa.es/boehringer-ingelheim-preve-invertir-un-20-mas-en-espana-en-2022/ 2022-06-10T08:33:06+00:00 https://aimfa.es/wp-content/uploads/boehringer_670-1.jpg https://aimfa.es/organon-presenta-las-lineas-de-accion-de-en-defensa-a-la-responsabilidad-social-y-medioambiental/ 2022-06-14T07:04:00+00:00 https://aimfa.es/wp-content/uploads/organon_mujer.jpg https://aimfa.es/activa-convoca-nuevamente-su-programa-marketing-de-contenidos-en-salud/ 2022-06-13T07:10:00+00:00 https://aimfa.es/wp-content/uploads/activa_contenidos.jpg https://aimfa.es/gebro-pharma-y-bit-pharma-firman-un-acuerdo-para-la-comercializacion-de-nicaplant-en-espana/ 2022-06-16T07:10:00+00:00 https://aimfa.es/wp-content/uploads/gebro-1.jpg https://aimfa.es/bayer-convoca-una-nueva-edicion-de-semillero-de-ideas-para-el-apoyo-de-la-accion-social-y-medioambiental-en-sus-entornos/ 2022-06-17T07:00:00+00:00 https://aimfa.es/wp-content/uploads/semillero.jpg https://aimfa.es/astrazeneca-invirtio-93-millones-en-2021-en-espana/ 2022-06-15T13:54:58+00:00 https://aimfa.es/wp-content/uploads/astrazeneca_670.jpg https://aimfa.es/novo-nordisk-elegida-anunciante-del-ano-en-los-premios-aspid/ 2022-06-20T08:05:08+00:00 https://aimfa.es/wp-content/uploads/novonor_aspid.jpg https://aimfa.es/pfizer-invierte-905-millones-de-euros-en-valneva-para-impulsar-su-division-de-vacunas/ 2022-06-21T08:00:36+00:00 https://aimfa.es/wp-content/uploads/pfizer-2.jpg https://aimfa.es/la-cnmc-recomienda-flexibilizar-la-fijacion-de-precios-de-los-medicamentos/ 2022-06-23T07:34:24+00:00 https://aimfa.es/wp-content/uploads/cnmc.jpg https://aimfa.es/segun-infonis-el-crecimiento-del-mercado-farmaceutico-en-mayo-alcanza-los-dos-digitos-en-unidades-mientras-que-en-valores-supera-el-85-de-crecimiento/ 2022-06-23T07:36:28+00:00 https://aimfa.es/wp-content/uploads/infonis_datos.jpg https://aimfa.es/bayer-abre-las-puertas-de-su-lifehub-el-primer-espacio-de-innovacion-de-salud-digital-y-transformacion/ 2022-06-24T07:57:07+00:00 https://aimfa.es/wp-content/uploads/bayer-1.jpg https://aimfa.es/la-mitad-del-gasto-en-colaboraciones-economicas-de-la-industria-en-espana-se-destina-a-id/ 2022-06-27T08:28:10+00:00 https://aimfa.es/wp-content/uploads/farmaindustria-1.jpg https://aimfa.es/gebro-pharma-distribuira-en-espana-dos-farmacos-de-novartis-para-la-diabetes/ 2022-06-28T10:55:00+00:00 https://aimfa.es/wp-content/uploads/gebro-1.jpg https://aimfa.es/novartis-eliminara-hasta-8-000-puestos-de-trabajo-en-el-mundo-dentro-del-marco-de-su-plan-de-reduccion-de-costes/ 2022-06-29T07:38:59+00:00 https://aimfa.es/wp-content/uploads/novartis_670.jpg https://aimfa.es/menarini-y-newamsterdam-llegan-a-un-acuerdo-de-licencia-exclusiva-por-valor-de-142-millones/ 2022-06-30T06:54:14+00:00 https://aimfa.es/wp-content/uploads/menarini.jpg https://aimfa.es/la-aepd-publica-una-guia-dirigida-a-los-profesionales-del-sector-sanitario/ 2022-07-01T06:50:00+00:00 https://aimfa.es/wp-content/uploads/aepd.jpg https://aimfa.es/el-gasto-farmaceutico-a-traves-de-recetas-del-sns-aumento-un-69-en-los-cinco-primeros-meses-del-ano/ 2022-07-04T08:35:11+00:00 https://aimfa.es/wp-content/uploads/dinero_670-1.jpg https://aimfa.es/boehringer-ingelheim-recibe-el-sello-oro-de-network4sdgs-por-su-compromiso-medioambiental/ 2022-07-05T07:22:02+00:00 https://aimfa.es/wp-content/uploads/boehringer-2.jpg https://aimfa.es/segun-iqvia-el-mercado-de-prescripcion-crecio-un-83-en-valores-en-el-tam-de-mayo/ 2022-07-06T07:04:00+00:00 https://aimfa.es/wp-content/uploads/mercados1.jpg https://aimfa.es/gfk-y-nielseniq-se-combinan-para-configurar-un-proveedor-mundial-lider-en-informacion-y-analisis-del-consumidor-y-los-retailers/ 2022-07-08T07:09:00+00:00 https://aimfa.es/wp-content/uploads/gfk-1.jpg https://aimfa.es/las-especialidades-medicas-mas-visitadas-en-espana-son-atencion-primaria-medicina-interna-pediatria-cardiologia-oncologia-y-neumologia/ 2022-07-07T07:18:00+00:00 https://aimfa.es/wp-content/uploads/visitador-medico.jpg https://aimfa.es/el-nuevo-codigo-de-conducta-de-proteccion-de-datos-es-un-aliciente-mas-para-la-puesta-en-marcha-de-los-ensayos-clinicos-en-espana/ 2022-07-11T07:53:27+00:00 https://aimfa.es/wp-content/uploads/farmaindustria-1.jpg https://aimfa.es/pharma-mar-obtiene-la-aprobacion-de-su-farmaco-contra-el-cancer-de-pulmon-en-qatar/ 2022-07-12T11:43:53+00:00 https://aimfa.es/wp-content/uploads/pharmamar-1.jpg https://aimfa.es/la-farmacia-se-mantiene-como-principal-canal-de-venta-en-productos-otc/ 2022-07-13T10:47:21+00:00 https://aimfa.es/wp-content/uploads/farmacias-1.jpg https://aimfa.es/accion-psoriasis-impulsa-un-ano-mas-su-campana-veraniega-destapate2022-patrocinada-por-leo-pharma/ 2022-07-14T07:33:41+00:00 https://aimfa.es/wp-content/uploads/leo-1.jpg https://aimfa.es/grunenthal-anuncia-un-acuerdo-con-bayer-para-adquirir-nebido/ 2022-07-15T10:12:54+00:00 https://aimfa.es/wp-content/uploads/grunenthal-1.jpg https://aimfa.es/espana-incorporo-1-307-nuevos-farmaceuticos-y-87-oficinas-en-2021/ 2022-07-18T08:24:30+00:00 https://aimfa.es/wp-content/uploads/farmacia670.jpg https://aimfa.es/haleon-oficializa-su-escision-de-gsk-para-especializarse-en-consumer-health/ 2022-07-19T09:43:44+00:00 https://aimfa.es/wp-content/uploads/gsk-2.jpg https://aimfa.es/la-industria-propone-una-veintena-de-medidas-para-mejorar-el-acceso-de-los-pacientes-a-los-nuevos-medicamentos/ 2022-07-21T08:18:25+00:00 https://aimfa.es/wp-content/uploads/market-acces_670.jpg https://aimfa.es/segun-infonis-el-mercado-crece-en-junio-un-59-en-unidades-y-un-51-en-valores/ 2022-07-22T09:45:15+00:00 https://aimfa.es/wp-content/uploads/infonis_datos.jpg https://aimfa.es/amazon-adquiere-one-medical-por-3-800-millones/ 2022-07-25T07:15:00+00:00 https://aimfa.es/wp-content/uploads/amazon-670x550-1.jpg https://aimfa.es/italfarmaco-refuerza-su-presencia-en-el-mercado-tras-comprar-el-100-de-lacer/ 2022-07-26T06:24:00+00:00 https://aimfa.es/wp-content/uploads/italfarmaco-1.jpg https://aimfa.es/almirall-eleva-un-51-sus-ventas-netas-core-en-el-primer-semestre/ 2022-07-27T08:18:14+00:00 https://aimfa.es/wp-content/uploads/almirall_670.jpg https://aimfa.es/segun-iqvia-el-mercado-crece-un-83-en-valores-del-tam-de-junio/ 2022-07-28T08:58:25+00:00 https://aimfa.es/wp-content/uploads/mercados1.jpg https://aimfa.es/zentiva-adquiere-la-division-hospitalaria-de-aristo-pharma-iberia-en-espana/ 2022-07-29T07:00:00+00:00 https://aimfa.es/wp-content/uploads/Zentiva.jpg https://aimfa.es/rovi-lidera-sustainalytics-en-la-industria-farmaceutica-mundial/ 2022-08-22T09:35:17+00:00 https://aimfa.es/wp-content/uploads/Rovi.jpg https://aimfa.es/novo-nordisk-quiere-superar-su-propio-exito-de-ventas-con-la-semaglutida/ 2022-08-23T09:09:39+00:00 https://aimfa.es/wp-content/uploads/novonordisk_670.jpg https://aimfa.es/wp-content/uploads/tabla.jpg https://aimfa.es/la-ue-aprueba-la-comercializacion-de-sunlenca-de-gilead-para-vih-1-multirresistente/ 2022-08-24T08:38:51+00:00 https://aimfa.es/wp-content/uploads/gilead1.jpg https://aimfa.es/el-gobierno-da-luz-verde-a-la-creacion-de-la-agencia-estatal-de-salud-publica/ 2022-08-25T09:42:37+00:00 https://aimfa.es/wp-content/uploads/Ministerio.jpg https://aimfa.es/segun-iqvia-en-el-tam-de-julio-el-total-mercado-crecio-un-78/ 2022-08-26T08:59:55+00:00 https://aimfa.es/wp-content/uploads/mercados1.jpg https://aimfa.es/no-hay-un-enfoque-de-inteligencia-artificial-unico-que-funcione-para-la-prevencion-el-diagnostico-o-el-tratamiento-mediante-la-medicina-de-precision/ 2022-08-29T09:55:59+00:00 https://aimfa.es/wp-content/uploads/inteligencia_artificial-670.jpg https://aimfa.es/un-algoritmo-de-inteligencia-artificial-que-detecta-anomalias-cerebrales-podria-ayudar-a-curar-la-epilepsia/ 2022-08-30T07:36:00+00:00 https://aimfa.es/wp-content/uploads/cerebro-1.jpg https://aimfa.es/nace-la-agencia-estatal-de-salud-publica/ 2022-08-31T08:54:23+00:00 https://aimfa.es/wp-content/uploads/Ministerio.jpg https://aimfa.es/segun-infonis-el-mercado-crece-un-84-en-unidades-y-un-72-en-valores-en-el-tam-de-julio/ 2022-09-01T07:09:00+00:00 https://aimfa.es/wp-content/uploads/infonis_datos.jpg https://aimfa.es/italfarmaco-obtiene-la-aprobacion-de-china-para-su-tratamiento-oral-contra-la-ela/ 2022-09-05T08:28:31+00:00 https://aimfa.es/wp-content/uploads/italfarmaco-1.jpg https://aimfa.es/en-el-primer-semestre-de-este-ano-los-problemas-de-suministro-de-medicamentos-han-experimentado-un-incremento-del-31-respecto-al-semestre-anterior/ 2022-09-06T14:11:05+00:00 https://aimfa.es/wp-content/uploads/medicamentos-2.jpg https://aimfa.es/fundacion-merck-salud-premia-la-busqueda-de-tratamientos-para-el-sarcoma-de-ewing-uno-de-los-tumores-solidos-mas-frecuentes-en-ninos-y-adolescentes/ 2022-09-07T11:54:03+00:00 https://aimfa.es/wp-content/uploads/medicos_670.jpg https://aimfa.es/chiesi-presenta-un-nuevo-tratamiento-para-la-epoc-en-el-congreso-de-la-ers/ 2022-09-08T08:32:15+00:00 https://aimfa.es/wp-content/uploads/chiesi-1.jpg https://aimfa.es/los-laboratorios-farmaceuticos-aplicaron-421-iniciativas-de-ecodiseno-a-mas-de-117-millones-de-envases-en-2021/ 2022-09-09T08:52:45+00:00 https://aimfa.es/wp-content/uploads/envases.jpg https://aimfa.es/abbvie-una-de-las-mejores-companias-para-trabajar-en-europa-segun-el-ranking-de-great-place-to-work/ 2022-09-12T09:13:01+00:00 https://aimfa.es/wp-content/uploads/abbvie_670.jpg https://aimfa.es/empleados-de-janssen-celebran-la-cycling-for-children/ 2022-09-13T14:28:05+00:00 https://aimfa.es/wp-content/uploads/bicicletas.jpg https://aimfa.es/novo-nordisk-espana-ha-puesto-en-marcha-50-ensayos-clinicos-con-mas-de-1-500-pacientes-en-los-ultimos-5-anos/ 2022-09-14T08:32:14+00:00 https://aimfa.es/wp-content/uploads/novonordisk_670.jpg https://aimfa.es/la-nanoparticula-clave-tras-la-vacuna-universal-contra-todos-los-coronavirus/ 2022-09-15T08:38:10+00:00 https://aimfa.es/wp-content/uploads/virus_670x550.jpg https://aimfa.es/la-asociacion-para-el-autocuidado-de-la-salud-anefp-se-adhiere-a-foretica/ 2022-09-16T08:11:07+00:00 https://aimfa.es/wp-content/uploads/anefp1.jpg https://aimfa.es/boehringer-ingelheim-lanza-un-nuevo-canal-de-podcasts-de-la-mano-de-pacientes-y-especialistas-para-concienciar-sobre-la-fibrosis-pulmonar-idiopatica-fpi/ 2022-09-19T08:16:20+00:00 https://aimfa.es/wp-content/uploads/boehringer_670-1.jpg https://aimfa.es/metaverso-ciberseguridad-y-redes-sociales-en-el-centro-de-la-iii-semana-digital-de-anefp/ 2022-09-20T08:56:26+00:00 https://aimfa.es/wp-content/uploads/semana-digital.jpg https://aimfa.es/psyma-iberica-refuerza-su-equipo-directivo/ 2022-09-21T07:50:03+00:00 https://aimfa.es/wp-content/uploads/psyma670.jpg https://aimfa.es/wp-content/uploads/psyma.png https://aimfa.es/airpadd-un-millon-de-euros-para-un-proyecto-europeo-de-diseno-de-medicamentos/ 2022-09-26T09:36:30+00:00 https://aimfa.es/wp-content/uploads/tecnologia-2.jpg https://aimfa.es/la-aplicacion-del-proyecto-de-precios-de-referencia-2022-supondra-un-impacto-de-34me-sobre-el-mercado-farmaceutico-actual/ 2022-09-27T08:48:25+00:00 https://aimfa.es/wp-content/uploads/dinero_670-1.jpg https://aimfa.es/la-salud-mental-el-mayor-problema-de-salud-al-que-se-enfrenta-la-poblacion-espanola/ 2022-09-29T06:19:00+00:00 https://aimfa.es/wp-content/uploads/cerebro.jpg https://aimfa.es/segun-infonis-el-mercado-crece-un-45-en-unidades-y-un-58-en-valores-en-el-mes-de-agosto/ 2022-09-30T06:21:00+00:00 https://aimfa.es/wp-content/uploads/infonis_datos.jpg https://aimfa.es/marketing-de-contendios-en-salud-ultimas-plazas/ 2022-10-02T10:47:22+00:00 https://aimfa.es/wp-content/uploads/logo_activa_670.jpg https://aimfa.es/siemens-la-u-de-barcelona-y-el-clinic-crean-la-catedra-de-atencion-sanitaria-digital/ 2022-10-03T08:50:45+00:00 https://aimfa.es/wp-content/uploads/salud_digital.jpg https://aimfa.es/cinfanext-la-nueva-plataforma-de-innovacion-abierta-de-cinfa/ 2022-10-04T08:26:19+00:00 https://aimfa.es/wp-content/uploads/Cinfa1.jpg https://aimfa.es/el-gasto-farmaceutico-a-traves-de-receta-aumenta-un-6-hasta-agosto/ 2022-10-05T06:57:00+00:00 https://aimfa.es/wp-content/uploads/dinero_670-1.jpg https://aimfa.es/rovi-invertira-40-millones-en-una-nueva-planta-de-produccion-de-compuestos-en-fraga/ 2022-10-06T08:03:14+00:00 https://aimfa.es/wp-content/uploads/Rovi.jpg https://aimfa.es/sanofi-vuelve-a-meter-el-dedo-en-la-diabetes-con-teplizumab/ 2022-10-09T08:18:34+00:00 https://aimfa.es/wp-content/uploads/sanofi-1.jpg https://aimfa.es/wp-content/uploads/teplizumab.jpg https://aimfa.es/un-millon-de-pixeles-contra-el-cancer-de-mama/ 2022-10-10T08:34:49+00:00 https://aimfa.es/crece-el-consumo-mundial-de-antidepresivos/ 2022-10-10T17:24:01+00:00 https://aimfa.es/wp-content/uploads/depres.jpg https://aimfa.es/wp-content/uploads/depresion.jpg https://aimfa.es/novartis-instalara-en-salamanca-la-planta-mas-moderna-de-europa-de-medicamentos-oncologicos/ 2022-10-13T08:22:25+00:00 https://aimfa.es/wp-content/uploads/novartis_670.jpg https://aimfa.es/las-claves-de-la-primera-edicion-del-green-week-selfcare-de-anefp/ 2022-10-14T10:43:46+00:00 https://aimfa.es/wp-content/uploads/green.jpg https://aimfa.es/menarini-joventut-nuevo-nombre-del-joventut-bcr/ 2022-10-17T07:45:00+00:00 https://aimfa.es/wp-content/uploads/Menarini_Joventut.jpg https://aimfa.es/boehringer-ingelheim-lanza-una-web-sobre-ppg-para-fomentar-su-diagnostico-precoz/ 2022-10-18T07:33:25+00:00 https://aimfa.es/wp-content/uploads/boehringer_670-1.jpg https://aimfa.es/el-programa-profarma-otorga-la-calificacion-de-compania-excelente-a-pharmamar/ 2022-10-20T08:13:29+00:00 https://aimfa.es/wp-content/uploads/pharmamar-1.jpg https://aimfa.es/los-hospitales-se-hacen-mas-flexibles-y-modulares/ 2022-10-24T08:21:20+00:00 https://aimfa.es/wp-content/uploads/hospitales.jpg https://aimfa.es/anefp-pone-el-foco-en-los-pacientes-con-covid-persistente/ 2022-10-25T11:48:44+00:00 https://aimfa.es/wp-content/uploads/covid_r2i.jpg https://aimfa.es/bayer-salvat-y-takeda-protagonizan-los-principales-cambios-en-profarma/ 2022-10-26T08:25:00+00:00 https://aimfa.es/wp-content/uploads/proframa670.jpg https://aimfa.es/wp-content/uploads/profarma.jpg https://aimfa.es/cinfa-y-lanzadera-se-unen-en-la-busqueda-de-proyectos-de-salud-innovadores/ 2022-10-27T06:29:00+00:00 https://aimfa.es/wp-content/uploads/digital_670-2.jpg https://aimfa.es/el-equipo-de-direccion-de-healthcare-de-merck-en-espana-se-renueva/ 2022-10-28T07:09:00+00:00 https://aimfa.es/wp-content/uploads/merck670.jpg https://aimfa.es/wp-content/uploads/merck_equipo.jpg https://aimfa.es/tendencias-del-mercado-en-septiembre-2022/ 2022-10-31T07:47:00+00:00 https://aimfa.es/wp-content/uploads/mercados1.jpg https://aimfa.es/la-ema-acepta-la-solicitud-de-autorizacion-de-comercializacion-del-lebrikizumab-de-almirall/ 2022-11-02T07:58:00+00:00 https://aimfa.es/wp-content/uploads/almirall_670.jpg https://aimfa.es/el-numero-de-farmacias-en-espana-aumenta-un-ano-mas/ 2022-11-02T23:50:34+00:00 https://aimfa.es/wp-content/uploads/farmacia670.jpg https://aimfa.es/karyopharm-y-menarini-group-anuncian-la-designacion-de-medicamento-huerfano-para-selinexor/ 2022-11-04T07:37:00+00:00 https://aimfa.es/wp-content/uploads/menarini.jpg https://aimfa.es/segun-infonis-el-mercado-crece-en-septiembre-un-48-en-unidades-y-un-5-en-valores/ 2022-11-05T11:11:31+00:00 https://aimfa.es/wp-content/uploads/infonis_datos.jpg https://aimfa.es/llega-a-espana-kesimpta-ofatumumab-de-novartis/ 2022-11-07T15:46:32+00:00 https://aimfa.es/wp-content/uploads/novartis_670.jpg https://aimfa.es/el-gasto-farmaceutico-publico-a-traves-de-receta-aumenta-un-57-hasta-septiembre/ 2022-11-08T12:28:52+00:00 https://aimfa.es/wp-content/uploads/dinero_670-1.jpg